
<html lang="en"     class="pb-page"  data-request-id="cd2d4e35-9109-41f3-a5a2-cd2103a00134"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm701348d;issue:issue:10.1021/jmcmar.2008.51.issue-4;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Lipophilic Modifications to Dinucleoside Polyphosphates and Nucleotides that Confer Antagonist Properties at the Platelet P2Y12 Receptor" /></meta><meta name="dc.Creator" content="James G.  Douglass" /></meta><meta name="dc.Creator" content="Roshni I.  Patel" /></meta><meta name="dc.Creator" content="Benjamin R.  Yerxa" /></meta><meta name="dc.Creator" content="Sammy R.  Shaver" /></meta><meta name="dc.Creator" content="Paul S.  Watson" /></meta><meta name="dc.Creator" content="Krzysztof  Bednarski" /></meta><meta name="dc.Creator" content="Robert  Plourde" /></meta><meta name="dc.Creator" content="Catherine C.  Redick" /></meta><meta name="dc.Creator" content="Kurt  Brubaker" /></meta><meta name="dc.Creator" content="Arthur C.  Jones" /></meta><meta name="dc.Creator" content="José L.  Boyer" /></meta><meta name="dc.Description" content="Platelet P2Y12 receptors play a central role in the regulation of platelet function and inhibition of this receptor by treatment with drugs such as clopidogrel results in a reduction of atherothrom..." /></meta><meta name="Description" content="Platelet P2Y12 receptors play a central role in the regulation of platelet function and inhibition of this receptor by treatment with drugs such as clopidogrel results in a reduction of atherothrom..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 31, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm701348d" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm701348d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm701348d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm701348d" /></link>
        
    
    

<title>Lipophilic Modifications to Dinucleoside Polyphosphates and Nucleotides that Confer Antagonist Properties at the Platelet P2Y12 Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm701348d" /></meta><meta property="og:title" content="Lipophilic Modifications to Dinucleoside Polyphosphates and Nucleotides that Confer Antagonist Properties at the Platelet P2Y12 Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0015.jpeg" /></meta><meta property="og:description" content=" Platelet P2Y12 receptors play a central role in the regulation of platelet function and inhibition of this receptor by treatment with drugs such as clopidogrel results in a reduction of atherothrombotic events. We discovered that modification of natural and synthetic dinucleoside polyphosphates and nucleotides with lipophilic substituents on the ribose and base conferred P2Y12 receptor antagonist properties to these molecules producing potent inhibitors of ADP-mediated platelet aggregation. We describe methods for the preparation of these functionalized dinucleoside polyphosphates and nucleotides and report their associated activities. By analysis of these results and by deconstruction of the necessary structural elements through selected syntheses, we prepared a series of highly functionalized nucleotides, resulting in the selection of an adenosine monophosphate derivative (62) for further clinical development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm701348d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm701348d">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm701348d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm701348d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm701348d&amp;href=/doi/10.1021/jm701348d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1007-1025</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm7013937" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm701093y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Lipophilic Modifications to Dinucleoside Polyphosphates and Nucleotides that Confer Antagonist Properties at the Platelet P2Y<sub>12</sub> Receptor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+G.++Douglass">James G. Douglass</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roshni+I.++Patel">Roshni I. Patel</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+R.++Yerxa">Benjamin R. Yerxa</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sammy+R.++Shaver">Sammy R. Shaver</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+S.++Watson">Paul S. Watson</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Krzysztof++Bednarski">Krzysztof Bednarski</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Plourde">Robert Plourde</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Catherine+C.++Redick">Catherine C. Redick</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kurt++Brubaker">Kurt Brubaker</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arthur+C.++Jones">Arthur C. Jones</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+L.++Boyer">José L. Boyer</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Tel: (919) 941-9777 . Fax: (919) 941-9177. E-mail: <a href="/cdn-cgi/l/email-protection#e68c828993818a879595a68f8895968f9483968e87948bc885898b"><span class="__cf_email__" data-cfemail="4329272c36242f223030032a2d30332a3126332b22312e6d202c2e">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Department of Chemistry.</div><div class="corresp-fn" id="afn2">‡Department of Molecular Pharmacology.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm701348d&amp;href=/doi/10.1021%2Fjm701348d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1007–1025</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 31, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 October 2007</li><li><span class="item_label"><b>Published</b> online</span>31 January 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 February 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm701348d" title="DOI URL">https://doi.org/10.1021/jm701348d</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1007%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJames%2BG.%2BDouglass%252C%2BRoshni%2BI.%2BPatel%252C%2BBenjamin%2BR.%2BYerxa%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D4%26contentID%3Djm701348d%26title%3DLipophilic%2BModifications%2Bto%2BDinucleoside%2BPolyphosphates%2Band%2BNucleotides%2Bthat%2BConfer%2BAntagonist%2BProperties%2Bat%2Bthe%2BPlatelet%2BP2Y12%2BReceptor%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1025%26publicationDate%3DFebruary%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm701348d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1355</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">33</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm701348d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Lipophilic Modifications to Dinucleoside Polyphosphates and Nucleotides that Confer Antagonist Properties at the Platelet P2Y12 Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;G. Douglass&quot;},{&quot;first_name&quot;:&quot;Roshni&quot;,&quot;last_name&quot;:&quot;I. Patel&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;R. Yerxa&quot;},{&quot;first_name&quot;:&quot;Sammy&quot;,&quot;last_name&quot;:&quot;R. Shaver&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;S. Watson&quot;},{&quot;first_name&quot;:&quot;Krzysztof&quot;,&quot;last_name&quot;:&quot;Bednarski&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Plourde&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;C. Redick&quot;},{&quot;first_name&quot;:&quot;Kurt&quot;,&quot;last_name&quot;:&quot;Brubaker&quot;},{&quot;first_name&quot;:&quot;Arthur&quot;,&quot;last_name&quot;:&quot;C. Jones&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;L. Boyer&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;1007-1025&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm701348d&quot;},&quot;abstract&quot;:&quot;Platelet P2Y12 receptors play a central role in the regulation of platelet function and inhibition of this receptor by treatment with drugs such as clopidogrel results in a reduction of atherothrombotic events. We discovered that modification of natural and synthetic dinucleoside polyphosphates and nucleotides with lipophilic substituents on the ribose and base conferred P2Y12 receptor antagonist properties to these molecules producing potent inhibitors of ADP-mediated platelet aggregation. We describe methods for the preparation of these functionalized dinucleoside polyphosphates and nucleotides and report their associated activities. By analysis of these results and by deconstruction of the necessary structural elements through selected syntheses, we prepared a series of highly functionalized nucleotides, resulting in the selection of an adenosine monophosphate derivative (62) for further clinical development.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701348d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701348d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701348d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701348d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701348d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701348d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm701348d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701348d&amp;href=/doi/10.1021/jm701348d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm701348d" /></input><a href="/doi/pdf/10.1021/jm701348d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (393 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm701348d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm701348d%26sid%3Dliteratum%253Aachs%26pmid%3D18232657%26genre%3Darticle%26aulast%3DDouglass%26date%3D2008%26atitle%3DLipophilic%2BModifications%2Bto%2BDinucleoside%2BPolyphosphates%2Band%2BNucleotides%2Bthat%2BConfer%2BAntagonist%2BProperties%2Bat%2Bthe%2BPlatelet%2BP2Y12%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D4%26spage%3D1007%26epage%3D1025%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=290645" title="Aggregation">Aggregation</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Platelet P2Y<sub>12</sub> receptors play a central role in the regulation of platelet function and inhibition of this receptor by treatment with drugs such as clopidogrel results in a reduction of atherothrombotic events. We discovered that modification of natural and synthetic dinucleoside polyphosphates and nucleotides with lipophilic substituents on the ribose and base conferred P2Y<sub>12</sub> receptor antagonist properties to these molecules producing potent inhibitors of ADP-mediated platelet aggregation. We describe methods for the preparation of these functionalized dinucleoside polyphosphates and nucleotides and report their associated activities. By analysis of these results and by deconstruction of the necessary structural elements through selected syntheses, we prepared a series of highly functionalized nucleotides, resulting in the selection of an adenosine monophosphate derivative (<b>62</b>) for further clinical development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Extracellular nucleotides and dinucleoside polyphosphates participate in the regulation of a broad range of physiological functions in numerous cell types and tissues, acting as agonists or antagonists on P2 cell surface receptors.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> The P2 receptor superfamily is composed of two subfamilies designated P2X and P2Y, each having multiple receptor subtypes. The P2X subfamily, composed of ligand-gated cation channels, has seven subtypes (P2X<sub>1</sub>−P2X<sub>7</sub>). The P2Y subfamily, composed of G-protein-coupled receptors has eight subtypes (P2Y<sub>1</sub>, P2Y<sub>2</sub>, P2Y<sub>4</sub>, P2Y<sub>6</sub>, P2Y<sub>11</sub>, P2Y<sub>12</sub>, P2Y<sub>13</sub>, and P2Y<sub>14</sub>). In addition to its ubiquitous role in cellular energy pathways, adenosine 5′-triphosphate (ATP, <b>3</b>, Figure<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is the endogenous agonist of the seven P2X receptor subtypes as well as the P2Y<sub>2</sub> and P2Y<sub>11</sub> receptors. Adenosine 5′-diphosphate (ADP, <b>2</b>) is the natural agonist of P2Y<sub>1</sub>, P2Y<sub>12</sub>, and P2Y<sub>13</sub> receptors. The pyrimidine nucleotide uridine 5′-triphosphate (UTP, <b>6</b>) is also an agonist of P2Y<sub>2</sub>, with potency comparable to that of ATP. UTP also serves as the ligand for the P2Y<sub>4</sub> receptor, while its corresponding diphosphate, UDP (<b>5</b>), is the agonist of the P2Y<sub>6</sub> receptor. UDP-glucose is the agonist of the most recently described member of the P2Y subfamily, the P2Y<sub>14</sub> receptor.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Dinucleoside polyphosphates are also endogenous substances released into in the extracellular space, where they are known to stimulate several P2 receptors with activities comparable to that of their nucleotide counterparts. Natural and synthetic dinucleoside polyphosphates have agonist potencies comparable to those of ATP and UTP at P2Y<sub>2</sub> receptors and to that of UDP at the P2Y<sub>6</sub> receptor. The inherently greater stability of dinucleoside polyphosphates compared to that of their corresponding nucleotides has led us to develop two different P2Y<sub>2</sub> dinucleoside tetraphosphate agonists (<b>13</b> and <b>14</b>) for the treatment of dry eye disease and cystic fibrosis.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Platelets are small disk-shaped anucleated cells found in circulation, which are responsible for initiating and stabilizing blood clots. While this function is vital in the maintenance of hemostasis, platelet activation under various pathological conditions can potentially lead to life-threatening thrombotic events.</div><div class="NLM_p">Platelets express a variety of cell-surface receptors, three of which belong to the P2 superfamily (P2X<sub>1</sub>, P2Y<sub>1</sub>, and P2Y<sub>12</sub>). The role of P2X<sub>1</sub> on platelet function is not completely understood; it has been demonstrated recently using P2X<sub>1</sub> receptor knockout mice that this receptor plays an important role in thrombus formation under high shear conditions, as might be found in a partially occluded vessel.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In contrast, the participation of P2Y<sub>1</sub> and P2Y<sub>12</sub> receptors in platelet activation and aggregation have been studied extensively.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8, 9, 10)</a></div><div class="NLM_p">Activation of P2Y<sub>1</sub> by ADP results in platelet shape change and transient aggregation, whereas activation of P2Y<sub>12</sub> leads to degranulation and release of more endogenous nucleotides, leading to sustained aggregation. ADP is found in high concentrations in platelet granules and is released in response to stimulation with a number of platelet-aggregating agents and by the exposure of platelets to foreign surfaces or to the pro-aggregatory subendothelium following the injury of the blood vessel wall. Activated platelets also produce thromboxane A2 (TXA<sub>2</sub>) and release fibrinogen and other active substances from storage granules. TXA<sub>2</sub> amplifies shape change and leads to further activation of the platelet. Platelet activation and degranulation leads to further recruitment of platelets to the site of injury. Ultimately, fibrinogen cross-links platelets via the glycoprotein IIb/IIIa receptor, leading to the formation of a stable thrombus.</div><div class="NLM_p">ADP-promoted aggregation requires the simultaneous activation of both the P2Y<sub>1</sub> and P2Y<sub>12</sub> receptors, and inhibition of ADP binding at either receptor is sufficient to prevent platelet aggregation. The P2Y<sub>12</sub> receptor is found primarily on platelets and in the central nervous system, whereas the P2Y<sub>1</sub> receptor has a more widespread distribution.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The comparatively limited distribution of P2Y<sub>12</sub> receptors, coupled to the fact that this receptor has been validated by the thienopyridines as a clinical target, makes the P2Y<sub>12</sub> receptor an attractive drug discovery target for the development of medicines to treat cardiovascular diseases.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a></div><div class="NLM_p">In addition to its role as the agonist of multiple P2 receptors, ATP also antagonizes the action of ADP at the platelet P2Y<sub>1</sub> and P2Y<sub>12</sub> receptors.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Substitutions at the 2 and 6 positions of ATP have been shown to amplify both the potency and selectivity of this antagonist (see Figure<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> for ring numbering). The ATP analogue AR-C69931MX (cangrelor, <b>7</b>) is a highly potent P2Y<sub>12</sub> antagonist representative of this molecular class and is currently being evaluated in clinical trials for use during percutaneous coronary interventions.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Further work by the Astra Zeneca group led to the development of AZD6140 (<b>8</b>), a heavily modified adenosine-like molecule being evaluated as an oral drug for chronic therapy for the prevention of thrombotic events in patients with acute coronary syndrome.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Several other molecular chemotypes have been shown to reversibly inhibit ADP-induced platelet aggregation. Scarborough et al.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> reported on a series of benzothiazolo[2,3-c]thiadiazines and dioxo quinazolin sulfonyl ureas, which show high potency in platelet aggregation and P2Y<sub>12</sub> receptor binding assays. Recently, Wang et al.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> described results for a quinolin/piperazin 5-oxopentanoic acid derivative, which showed an improved therapeutic index over clopidogrel in animal models.</div><div class="NLM_p">The clinical use of the thienopyridines clopidogrel (<b>9</b>) and ticlopidine (<b>10</b>) has been shown to reduce the incidence of myocardial infarction and stroke in patients with a history of vascular disease and to provide protection from adverse events following stent implantation.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a> However, these drugs bind to the P2Y<sub>12</sub> receptor in an irreversible manner following conversion to their respective active species by hepatic metabolism.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The irreversible nature of the inhibition of platelet function by clopidogrel and ticlopidine preclude their use in acute cardiovascular and cerebrovascular conditions where the strict control of platelet function is needed. Furthermore, significant interindividual variability in response to the drug has been seen in patients treated with clopidogrel.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Treatment with thienopyridines has also been associated with thrombotic thrombocytopenic purpura, a rare but potentially fatal side effect.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> More recently, prasugrel, a third generation thienopyridine with apparently improved pharmacokinetic properties, has been developed.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> Nevertheless, in spite of apparent progress in the thienopyridine class of irreversible inhibitors, opportunities still remain for the development of safe, rapidly reversible platelet aggregation inhibitors for the treatment of both acute and chronic clinical conditions.</div><div class="NLM_p">Dinucleoside polyphosphates (Np<sub>n</sub>N′), particularly those having adenine as the base, have been detected in chromaffin cells and platelet granules.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> Physiological roles of diadenosine polyphosphates include inhibition of adenosine kinase,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> release of nitric oxide from epithelial cells,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> neurotransmitter release at synaptic junctions,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and inhibition of platelet aggregation.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> In addition to being a potent P2Y<sub>2</sub> agonist, Ap<sub>4</sub>A (<b>11</b>) is a modestly potent antagonist of ADP-induced platelet aggregation. Several analogues of Ap<sub>4</sub>A with modifications in the phosphate chain (e.g., <b>12</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> were prepared in an effort to improve their biological stability and to examine their potency for the inhibition of platelet aggregation.</div><div class="NLM_p last">Because of our long-standing interest in the pharmacological properties and structure–activity relationships (SAR) of dinucleoside polyphosphates as agonists of the P2 superfamily of receptors, particularly P2Y<sub>2</sub>, we synthesized a number of analogues bearing lipophilic modifications to the ribose and the base. During the course of this work, we found that esterification of one or more of the 2′- or 3′-ribose hydroxyls of a P2Y<sub>2</sub> receptor agonist produced compounds that antagonized the ability of ADP to induce platelet aggregation. In this article, we describe the identification and SAR of substitutions to dinucleoside polyphosphates and nucleotides that confer antagonist properties for the P2Y<sub>12</sub> receptor.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ready access to commercially available nucleotides and an in-house collection of dinucleoside polyphosphates led us to choose these molecules as starting materials for our syntheses. To streamline the synthesis of the required analogues, the 5′-phosphate group was used as a protecting group. This strategy eliminated the long protection/deprotection procedures that have traditionally been the norm in nucleoside chemistry and facilitated the use of preparative reverse-phase HPLC to purify these water soluble but lipophilic products.</div><div class="NLM_p">Starting with <b>15</b>, <b>16</b>, and <b>17</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) as inspiration, we considered alternative modifications to the ribose hydroxyl groups. In addition to not being particularly stable, the monoesters of 2′, 3′-ribose diols demonstrate no chemoselectivity toward either the 2′ or 3′ group, providing mixtures of products upon reaction with acylating agents.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Furthermore, mixtures of products often result upon subsequent separation and purification because of the migration of the ester moiety between the adjacent hydroxyl groups. To achieve greater stability and access to regiochemically discreet analogues, cyclic acetals were prepared and examined. Previously, it was observed that acetal modifications to an analogue of <b>3</b> resulted in compounds that showed activity at several P2X receptors.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">A general method of forming cyclic acetals of acid sensitive dinucleoside polyphosphates and nucleotides was developed for the purpose of this work. Modest yielding reactions (see Table<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were achieved with most substrates using the sodium salts of the starting dinucleoside polyphosphates or nucleotides with either 99% formic acid or anhydrous trifluoroacetic acid as both the catalyst and solvent in conjunction with 2–4 equivalents of the aldehyde or aldehyde dimethylacetal.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of Platelet Aggregation and Selectivity for Dinucleoside Tri and Tetraphosphate Acetal Analogues<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0002.gif" alt="" id="gr3" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="bottom"><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="bottom">formula</th><th align="center" valign="bottom">B<sub>1</sub></th><th align="center" valign="bottom">B<sub>2</sub></th><th align="center" valign="bottom">R</th><th align="center" valign="bottom">n</th><th align="center" valign="bottom">conversion (%)</th><th align="center" valign="bottom">isolated yield<a class="ref internalNav" href="#tbl1-fn4" aria-label="d">d</a> (%)</th><th align="center" valign="bottom">platelet aggregation IC<sub>50</sub> (µM) mean ± SEM</th><th align="center" valign="bottom">P2Y<sub>1</sub> (EC<sub>50</sub>)</th><th align="center" valign="bottom">P2Y<sub>2</sub> (EC<sub>50</sub>)</th><th align="center" valign="bottom">P2Y<sub>6</sub> (EC<sub>50</sub>)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">11</td><td align="left" valign="top"><i>I</i></td><td align="left" valign="top">A</td><td align="left" valign="top">A</td><td align="left" valign="top">NA</td><td align="left" valign="top">3</td><td align="left" valign="top">ND</td><td align="left" valign="top">ND</td><td align="left" valign="top">63% inhibition at 100 µM</td><td align="left" valign="top">0.426 ± 0.236</td><td align="left" valign="top">0.072 ± 0.022</td><td align="left" valign="top">NR</td></tr><tr valign="top"><td align="left" valign="top">13</td><td align="left" valign="top"><i>I</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">NA</td><td align="left" valign="top">3</td><td align="left" valign="top">ND</td><td align="left" valign="top">ND</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">0.034 ± 0.011</td><td align="left" valign="top">18.64 ± 6.11</td></tr><tr valign="top"><td align="left" valign="top">18</td><td align="left" valign="top"><i>I</i></td><td align="left" valign="top">U</td><td align="left" valign="top">C</td><td align="left" valign="top">NA</td><td align="left" valign="top">3</td><td align="left" valign="top">ND</td><td align="left" valign="top">ND</td><td align="left" valign="top">NR</td><td align="left" valign="top">SR</td><td align="left" valign="top">0.044 ± 0.004</td><td align="left" valign="top">SR</td></tr><tr valign="top"><td align="left" valign="top">19</td><td align="left" valign="top"><i>I</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">NA</td><td align="left" valign="top">2</td><td align="left" valign="top">ND</td><td align="left" valign="top">ND</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">13.54 ± 5.71</td><td align="left" valign="top">0.40 ± 0.258</td></tr><tr valign="top"><td align="left" valign="top">15</td><td align="left" valign="top">NA</td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">NA</td><td align="left" valign="top">3</td><td align="left" valign="top">ND</td><td align="left" valign="top">31</td><td align="left" valign="top">46% inhibition at 100 µM</td><td align="left" valign="top">NR</td><td align="left" valign="top">0.130 ± 0.031</td><td align="left" valign="top">SR</td></tr><tr valign="top"><td align="left" valign="top">16</td><td align="left" valign="top">NA</td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">NA</td><td align="left" valign="top">3</td><td align="left" valign="top">ND</td><td align="left" valign="top">33.5</td><td align="left" valign="top">7.59 ± 0.42</td><td align="left" valign="top">NR</td><td align="left" valign="top">5.47 ± 1.16</td><td align="left" valign="top">SR</td></tr><tr valign="top"><td align="left" valign="top">17</td><td align="left" valign="top">NA</td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">NA</td><td align="left" valign="top">3</td><td align="left" valign="top">ND</td><td align="left" valign="top">31</td><td align="left" valign="top">52% inhibition at 100 µM</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td></tr><tr valign="top"><td align="left" valign="top">20</td><td align="left" valign="top"><i>II</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">benzyl</td><td align="left" valign="top">3</td><td align="left" valign="top">41</td><td align="left" valign="top">30</td><td align="left" valign="top">27.1 ± 6.64</td><td align="left" valign="top">NR</td><td align="left" valign="top">0.094 ± 0.033</td><td align="left" valign="top">SR</td></tr><tr valign="top"><td align="left" valign="top">21</td><td align="left" valign="top"><i>IV</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">benzyl</td><td align="left" valign="top">3</td><td align="left" valign="top">21</td><td align="left" valign="top">18</td><td align="left" valign="top">1.82 ± 0.717</td><td align="left" valign="top">NR</td><td align="left" valign="top">14.6 ± 0.94</td><td align="left" valign="top">SR</td></tr><tr valign="top"><td align="left" valign="top">22</td><td align="left" valign="top"><i>II</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">phenyl<a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></td><td align="left" valign="top">3</td><td align="left" valign="top">52</td><td align="left" valign="top">42</td><td align="left" valign="top">16.7 ± 3.45</td><td align="left" valign="top">NR</td><td align="left" valign="top">0.192 ± 0.052</td><td align="left" valign="top">SR</td></tr><tr valign="top"><td align="left" valign="top">23</td><td align="left" valign="top"><i>IV</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">phenyl<a class="ref internalNav" href="#tbl1-fn3" aria-label="c">c</a></td><td align="left" valign="top">3</td><td align="left" valign="top">18</td><td align="left" valign="top">6.7</td><td align="left" valign="top">8.29 ± 1.7</td><td align="left" valign="top">NR</td><td align="left" valign="top">3.07 ± 2.15</td><td align="left" valign="top">NR</td></tr><tr valign="top"><td align="left" valign="top">24</td><td align="left" valign="top"><i>II</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">styryl<a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></td><td align="left" valign="top">3</td><td align="left" valign="top">42</td><td align="left" valign="top">38</td><td align="left" valign="top">8.8 ± 3.96</td><td align="left" valign="top">NR</td><td align="left" valign="top">0.155 ± 0.116</td><td align="left" valign="top">NA</td></tr><tr valign="top"><td align="left" valign="top">25</td><td align="left" valign="top"><i>IV</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">styryl<a class="ref internalNav" href="#tbl1-fn3" aria-label="c">c</a></td><td align="left" valign="top">3</td><td align="left" valign="top">24</td><td align="left" valign="top">9.7</td><td align="left" valign="top">5.51 ± 2.12</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">SR</td></tr><tr valign="top"><td align="left" valign="top">26</td><td align="left" valign="top"><i>II</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">phenylethynyl<a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></td><td align="left" valign="top">3</td><td align="left" valign="top">37</td><td align="left" valign="top">32</td><td align="left" valign="top">8.68 ± 2.01</td><td align="left" valign="top">NR</td><td align="left" valign="top">0.068 ± 0.019</td><td align="left" valign="top">NA</td></tr><tr valign="top"><td align="left" valign="top">27</td><td align="left" valign="top"><i>IV</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">phenylethynyl<a class="ref internalNav" href="#tbl1-fn3" aria-label="c">c</a></td><td align="left" valign="top">3</td><td align="left" valign="top">9</td><td align="left" valign="top">3.5</td><td align="left" valign="top">3.3 ± 1.98</td><td align="left" valign="top">NR</td><td align="left" valign="top">0.35 ± 0.134</td><td align="left" valign="top">NR</td></tr><tr valign="top"><td align="left" valign="top">28</td><td align="left" valign="top"><i>II</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">propyl</td><td align="left" valign="top">3</td><td align="left" valign="top">40</td><td align="left" valign="top">23</td><td align="left" valign="top">44% inhibition at 100 µM</td><td align="left" valign="top">NR</td><td align="left" valign="top">0.098 ± 0.037</td><td align="left" valign="top">30</td></tr><tr valign="top"><td align="left" valign="top">29</td><td align="left" valign="top"><i>IV</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">propyl</td><td align="left" valign="top">3</td><td align="left" valign="top">50</td><td align="left" valign="top">30</td><td align="left" valign="top">60% inhibition at 100 µM</td><td align="left" valign="top">NR</td><td align="left" valign="top">SR</td><td align="left" valign="top">SR</td></tr><tr valign="top"><td align="left" valign="top">30</td><td align="left" valign="top"><i>II</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">heptyl</td><td align="left" valign="top">3</td><td align="left" valign="top">31</td><td align="left" valign="top">25</td><td align="left" valign="top">16.88 ± 5.19</td><td align="left" valign="top">NR</td><td align="left" valign="top">0.147 ± 0.075</td><td align="left" valign="top">SR</td></tr><tr valign="top"><td align="left" valign="top">31</td><td align="left" valign="top"><i>IV</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">heptyl</td><td align="left" valign="top">3</td><td align="left" valign="top">63</td><td align="left" valign="top">32</td><td align="left" valign="top">10.69 ± 3.91</td><td align="left" valign="top">NR</td><td align="left" valign="top">NA</td><td align="left" valign="top">NR</td></tr><tr valign="top"><td align="left" valign="top">32</td><td align="left" valign="top"><i>II</i></td><td align="left" valign="top">U</td><td align="left" valign="top">C</td><td align="left" valign="top">benzyl</td><td align="left" valign="top">3</td><td align="left" valign="top">22</td><td align="left" valign="top">20</td><td align="left" valign="top">46% inhibition at 100 µM</td><td align="left" valign="top">NR</td><td align="left" valign="top">0.545 ± 0.189</td><td align="left" valign="top">NR</td></tr><tr valign="top"><td align="left" valign="top">33</td><td align="left" valign="top"><i>III</i></td><td align="left" valign="top">U</td><td align="left" valign="top">C</td><td align="left" valign="top">benzyl</td><td align="left" valign="top">3</td><td align="left" valign="top">30</td><td align="left" valign="top">25</td><td align="left" valign="top">46% inhibition at 100 µM</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td></tr><tr valign="top"><td align="left" valign="top">34</td><td align="left" valign="top"><i>IV</i></td><td align="left" valign="top">U</td><td align="left" valign="top">C</td><td align="left" valign="top">benzyl</td><td align="left" valign="top">3</td><td align="left" valign="top">20</td><td align="left" valign="top">19</td><td align="left" valign="top">3.06 ± 0.62</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td></tr><tr valign="top"><td align="left" valign="top">35</td><td align="left" valign="top"><i>II</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">benzyl</td><td align="left" valign="top">2</td><td align="left" valign="top">52</td><td align="left" valign="top">38</td><td align="left" valign="top">34.73 ± 2.7</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">0.154 ± 0.041</td></tr><tr valign="top"><td align="left" valign="top">36</td><td align="left" valign="top"><i>IV</i></td><td align="left" valign="top">U</td><td align="left" valign="top">U</td><td align="left" valign="top">benzyl</td><td align="left" valign="top">2</td><td align="left" valign="top">28</td><td align="left" valign="top">20</td><td align="left" valign="top">4.63 ± 0.239</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td><td align="left" valign="top">NR</td></tr><tr valign="top"><td align="left" valign="top">37</td><td align="left" valign="top"><i>II</i></td><td align="left" valign="top">A</td><td align="left" valign="top">A</td><td align="left" valign="top">benzyl</td><td align="left" valign="top">3</td><td align="left" valign="top">42</td><td align="left" valign="top">27.6</td><td align="left" valign="top">6.54 ± 0.63</td><td align="left" valign="top">NR</td><td align="left" valign="top">0.052 ± 0.006</td><td align="left" valign="top">NR</td></tr><tr valign="top"><td align="left" valign="top">38</td><td align="left" valign="top"><i>IV</i></td><td align="left" valign="top">A</td><td align="left" valign="top">A</td><td align="left" valign="top">benzyl</td><td align="left" valign="top">3</td><td align="left" valign="top">11</td><td align="left" valign="top">6.1</td><td align="left" valign="top">11.71 ± 5.17</td><td align="left" valign="top">NR</td><td align="left" valign="top">SR</td><td align="left" valign="top">NR</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Formula, B<sub>1</sub>, B<sub>2</sub>, R, and n are as defined in Scheme<a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Conversion % was determined by HPLC. Inhibition of platelet aggregation and selectivity (activity at P2Y<sub>1</sub>, P2Y<sub>2</sub>, and P2Y<sub>6</sub> receptors) are expressed in µM. SR = slight response (5 to 20% of the maximal activity at highest concentration tested, usually 100 µM); NR = no response at highest concentration tested (usually 100 µM); ND = not determined; NA = not applicable.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Mixture of 2 diastereomers.</p></div><div class="footnote" id="tbl1-fn3"><sup>c</sup><p class="last">Mixture of 4 diastereomers.</p></div><div class="footnote" id="tbl1-fn4"><sup>d</sup><p class="last">Low isolated yields relative to % conversions are a reflection of the degree of difficulty of the purifications.</p></div></div></div><div class="NLM_p">Treatment of symmetrical dinucleoside tri and tetraphosphates <b>11</b>, <b>13</b>, and <b>19</b> with a variety of aldehydes in acid gave a mixture of mono and diacetals (<b>37</b>–<b>38</b>, <b>20</b>–<b>31</b>, and <b>35</b>–<b>36</b>, respectively; formulas II and IV, Scheme<a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Likewise, similar treatment of the unsymmetrical dinucleoside tetraphosphate <b>18</b> gave the two possible regioisomeric monoacetals (<b>32</b> and <b>33</b>; formulas II and III) and diacetal <b>34</b> (formula IV). The structures of these compounds and their biological evaluation as antagonists of ADP-induced aggregation in a washed platelet assay are presented in Table<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0011.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Dinucleoside Polyphosphate Acetals</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Dinucleoside tetraphosphates <b>42</b> and <b>47</b>–<b>50</b> were prepared via an indirect synthetic strategy that also provided access to a variety of substituted nucleotide derivatives. This synthetic procedure gave better results than the direct action of an isocyanate on diacetals <b>38</b> and <b>34</b>.</div><div class="NLM_p">These alternative strategies are outlined in Schemes<a class="ref internalNav" href="#sch2" aria-label="2">2</a> and<a class="ref internalNav" href="#sch3" aria-label="3">3</a>. For the adenosine analogues, ADP (<b>2</b>) was converted to acetal <b>40</b> with phenylacetaldehyde dimethyl acetal in formic acid and transformed to the urea with phenylisocyanate in DMF to give <b>41</b>. Carbonyldiimidazole activation of <b>41</b> facilitated self-condensation to give <b>42</b>. To evaluate the effect of the urea modification in the platelet aggregation assay, <b>2</b> was also directly converted to the urea with phenylisocyanate to give <b>39</b>.<sup>38</sup> For the cytidine analogues, cytidine monophosphate (<b>43</b>) was converted to urea with <i>p</i>-fluorophenylisocyanate in DMF to give <b>44</b>. Use of <b>44</b> in the dinucleoside polyphosphate-forming reaction gave a better outcome than <b>43</b>. UTP (<b>6</b>) was activated with dicyclohexylcarbodiimide, leading to the cyclical trimeta-phosphate,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and was condensed with <b>44</b> to give <b>47</b>. Treatment of <b>47</b> with phenylacetaldehyde dimethylacetal in formic acid gave monoacetals <b>48</b> and <b>49</b> and diacetal <b>50</b>. For purposes of biological comparison, the same acetal and urea modifications were made to <b>43</b>, to give nucleotides <b>45</b> and <b>46</b>. Similarly, AMP (<b>1</b>) was converted to its corresponding 2′,3′-acetal (Scheme<a class="ref internalNav" href="#sch4" aria-label="4">4</a>) providing nucleotides <b>52</b>–<b>55</b>. Compounds <b>52</b>–<b>55</b> were further modified to urea moieties at the 6-position of the purine by reaction of the amino group with an appropriate isocyanate in DMF. For these substrates, the isocyanate also acted as a weak condensing agent for the phosphate group, leading to variable amounts of the corresponding dinucleoside diphosphates as a byproduct (Scheme<a class="ref internalNav" href="#sch4" aria-label="4">4</a>). These byproducts were easily separated from the desired nucleotides (<b>56</b>–<b>66</b>) during purification by HPLC. Biological results for these analogues are presented in Table<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The biological results for compounds derived from <b>1</b> are presented in Table<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0012.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Diadenosine Tetraphosphate and Adenosine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Phenylacetaldehyde dimethyl acetal, HCOOH, 35°C; (b) PhNCO, DMF, 45°C; (c) PhNCO, NBu<sub>3</sub>, DMF 30°C; (d) CDI, NBu<sub>3</sub>, DMF, rt.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0013.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Uridine Cytidine Tetraphosphate and Cytidine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Phenylacetaldehyde dimethyl acetal, HCOOH, rt; (b) <i>p</i>-F-PhNCO, DMF, 60°C, then 30°C; (c) <i>p</i>-F-PhNCO, NBu<sub>3</sub>, DMF, rt; (d) <b>5</b>·(NBu<sub>3</sub>)<sub>2</sub>, DCC, DMF, 30°C; (e) phenylacetaldehyde dimethyl acetal, HCOOH, 30°C.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0014.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Adenosine Monophosphate Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>CHO, TFA, or HCOOH, rt; (b) PhNCO, DMF, 45°C; (c) R<sub>2</sub>NCO, DMF.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of Platelet Aggregation and Selectivity for Dinucleoside Tetraphosphate Acetal and Urea Analogues, and Their Synthetic Intermediates<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0003.gif" alt="" id="gr8" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left" valign="top"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0004.gif" alt="" id="_i9" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Platelet aggregation, inhibition, and selectivity (agonist activity at P2Y<sub>1</sub>, P2Y<sub>2</sub>, and P2Y<sub>6</sub> receptors) are expressed in µM. SR = slight response (5 to 20% of the maximal activity at highest concentration tested, usually 100 µM); NR = no response at highest concentration tested (usually 100 µM); NT = not tested; NA = not applicable.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibition of Platelet Aggregation and Selectivity for Adenosine Acetal and Urea Analogues<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0005.gif" alt="" id="gr10" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left" valign="top"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0006.gif" alt="" id="_i11" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">R<sub>1</sub> and R<sub>2</sub> are as defined in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Inhibition of platelet aggregation is expressed in µM. SR = slight response (5 to 20% of the maximal activity at highest concentration tested, usually 100 µM); NR = no response at highest concentration tested (usually 100 µM); NA = not applicable.</p></div></div></div><div class="NLM_p">Acetal-forming reactions using benzaldehyde, cinnamaldehyde, and phenylpropargyl aldehyde produced mixtures of diastereomers because of the nonselective establishment of the stereogenic acetal carbon (see Figure<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> As a result, the dinucleoside tri and tetraphosphate monoacetals derived from these aldehydes comprise two inseparable diastereomers, while the diacetals comprise four inseparable diastereomers. This pattern of selectivity was not observed for the acetals derived from aldehydes with an sp<sup>3</sup> carbon adjacent to the carbonyl (phenylacetaldehyde, butanal, and octanal).<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a></div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Acetal diastereoisomerism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the dinucleoside polyphosphates, the acetal configuration of phenylacetaldehyde diacetal <b>21</b>, octanal diacetal <b>31</b>, and phenylacetaldehyde diacetal <b>38</b> was established to be cis via 2D NMR experiments (NOESY).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The data indicated that the nature of the base (adenine in <b>11</b> vs uracil in <b>13</b>) and the number of acetals being formed had no effect on the outcome of the acetal-forming reaction. On this basis, assignment of the <i>cis</i>-acetal configuration was inferred for dinucleoside polyphosphates <b>20</b>, <b>28</b>–<b>38</b>, and <b>42</b>. The configuration of the acetal in cytidine analogue <b>45</b> was shown to be cis via NOE experiments.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> On the basis of this result, the configuration of the acetal carbon in dinucleoside tetraphosphates <b>46</b> and <b>48</b>−<b>50</b> was inferred to be cis.</div><div class="NLM_p">For compounds derived from monophosphate <b>1</b>, acetal-forming reactions provided either a single acetal diastereomer, such as <b>52</b>, or a mixture of two possible diastereomers such as nucleotides <b>53</b>–<b>55</b> (Table<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The level of diastereoselectivity in these analogues could be quantified by HPLC and/or <sup>1</sup>H NMR (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Details">Experimental Details</a>). The <i>cis</i>-acetal configuration of <b>52</b> was established via 2D NMR experiments (NOESY) and was consistent with previous results in the cytidine nucleotide series (<b>45</b>), the adenosine nucleotide series (<b>58</b>), the dinucleoside polyphosphate series, and with the observations of others.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a></div><div class="NLM_p">As they were derived from compounds <b>53</b>−<b>55</b>, the urea products <b>60</b>–<b>66</b> were obtained as mixtures of diastereomers. Likewise, compounds <b>56</b>–<b>59</b> were all the single cis isomer, as they were derived from <b>52</b>. NOE experiments were performed on a representative of this latter group (compound <b>58</b>) to confirm that the configuration of the acetal carbon was unchanged after the urea-forming reaction.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Assignment of the diastereomeric ratios for other analogues were made by correlation and integration of selected protons in the spectra of the mixture.</div><div class="NLM_p last">Taking advantage of the relative instability of the minor (cis) styryl acetal diastereomer in <b>61</b> toward aqueous acid, we cleaved its acetal to make the separation from the trans isomer <b>62</b> possible. NOE experiments performed on <b>62</b> confirmed the trans orientation of the acetal moiety in this molecule (see Figure<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57825" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57825" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Platelet Aggregation Studies</h3><div class="NLM_p">While the natural dinucleoside tetraphosphates <b>13</b> and <b>18</b> and the dinucleoside triphosphate <b>19</b> are agonists of the P2Y<sub>2</sub> receptor and the P2Y<sub>6</sub> receptor,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> respectively, they are devoid of activity at any of the platelet nucleotide receptors. Only compound <b>11</b>, a potent P2Y<sub>2</sub> agonist (which has been found in platelet granules and is a close analogue of the natural P2Y<sub>12</sub> antagonist <b>3</b> has shown modest potency to inhibit platelet aggregation (63% inhibition at 100 µM in a washed platelet preparation). One of the initial results that led to this study was the observation that the <i>N</i>-methyl anthranilic acid esters (<b>15</b> and <b>16</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>)<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> or benzoic acid esters (<b>17</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) of diuridine tetraphosphate <b>13</b> modestly antagonized ADP-induced platelet aggregation (46% inhibition at 100 µM, IC<sub>50</sub> = 9 µM, and 52% inhibition at 100 µM, respectively). In an effort to determine whether the degree or type of substitution was important for inhibition of platelet aggregation activity, we decided to replace the ester moieties with a series of acetal substituents (propyl, heptyl, phenyl, benzyl, styryl, and ethynyl phenyl).</div><div class="NLM_p">Review of the activities of the diuridine tetraphosphate monoacetals of <b>13</b> (compounds <b>20</b>, <b>22</b>, <b>24</b>, <b>26</b>, <b>28</b>, and <b>30</b>) revealed modest antagonism of platelet aggregation (Table<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). These diuridine tetraphosphate monoacetals demonstrated higher potency for inhibiting ADP-induced platelet aggregation than monoester <b>15</b>. There appeared to be a slight preference for the styryl (<b>24</b>) and ethynyl phenyl (<b>26</b>) derivatives. Interestingly, benzyl acetal diuridine triphosphate <b>35</b> (34.73 µM) was found to be comparable in potency to its tetraphosphate <b>20</b>, suggesting that there is some tolerance for variation in the polyphosphate chain length. Consistent with the trend observed for esters <b>15</b> and <b>16</b>, substitution of diuridine tetraphosphate <b>13</b> with two lipophilic acetals (compounds <b>21</b>, <b>23</b>, <b>25</b>, <b>26</b>, <b>29</b>, and <b>31</b>, Table<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) provided analogues with slightly improved potency when compared with their monosubstituted counterparts. Notably, the slight preference for the styryl and ethynyl phenyl derivatives remained consistent. The dibenzyl acetal diuridine triphosphate <b>36</b> also showed good potency as an inhibitor of ADP-induced platelet aggregation (IC<sub>50</sub> = 4.63 µM), which was consistent with that observed for the analogous tetraphosphate <b>21</b> (IC<sub>50</sub> = 1.82 µM).</div><div class="NLM_p">Modification of diadenosine tetraphosphate <b>11</b> with either one or two benzyl acetals (<b>37</b> and <b>38</b>) provided potencies comparable to those of analogues derived from diuridine tetraphosphate <b>13</b>. Lastly, for the unsymmetrical cytidine−uridine dinucleoside tetraphosphate <b>18</b>, the two possible monobenzyl acetals (<b>32</b> and <b>33</b>) were only weakly active in the platelet aggregation assay, while the corresponding dibenzyl acetal <b>34</b> had a potency of 3.06 µM. This value was comparable to that of the most potent analogues in the diuridine tetraphosphate acetal series. These results established the importance of polysubstitution on the 2′,3′-ribose hydroxyl groups for the enhancement of potency and confirmed that more chemically stable acetal substituents could replace the <i>N</i>-methyl anthranilic ester moieties without the loss of potency.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p">None of the tested lipophilic modifications at the ribose hydroxyl groups of <b>13</b> led to compounds with sufficient potency as platelet aggregation inhibitors to be advanced further into development. However, the benzyl acetal modifications to diadenosine tetraphosphate <b>11</b> and uridine−cytidine tetraphosphate <b>18</b> provided diacetals of comparable potency to those derived from <b>13</b>, and these molecules offered an exocyclic amino group as an additional point of modification. Accordingly, modification of <b>38</b> to a phenyl urea at the 6-amino position provided diurea <b>42</b>. Remarkably, <b>42</b> was 20-fold more potent than its unsubstituted diadenosine tetraphosphate diacetal core <b>38</b> (0.52 vs 11.71 µM). Similarly, conversion of <b>34</b> to a <i>p</i>-fluoro-phenylurea in the 4-position resulted in <b>50</b>, which was 60-fold more potent than its cytidine−uridine tetraphosphate diacetal core <b>34</b> (0.048 vs 3.06 µM). This dramatic effect led us to further examine the contributions of the benzyl acetal and the <i>p</i>-fluoro-phenylurea moieties on the potency of the cytidine−uridine tetraphosphate core. The <i>p</i>-fluoro-phenylurea of Up<sub>4</sub>C (<b>47</b>) was found to be inactive. The monobenzyl acetal (U)/<i>p</i>-fluoro-phenylurea of Up<sub>4</sub>C (<b>48</b>) was found to have an IC<sub>50</sub> = 23.93 µM, while the monobenzyl acetal (C)/<i>p</i>-fluoro-phenylurea of Up<sub>4</sub>C (<b>49</b>) was found to have an IC<sub>50</sub> = 12.92 µM. Interestingly, it was essential for both riboses to be converted to acetals in the dinucleoside tetraphosphate core to achieve high nanomolar activity.</div><div class="NLM_p">We next examined this dramatic substituent effect on CMP (<b>43</b>). Acylation of <b>43</b> with <i>p</i>-fluorophenylisocyanate or conversion of <b>43</b> to the corresponding <i>cis</i>-acetal with phenylacetaldehyde produced <b>44</b> and <b>45</b>, respectively, which were inactive. However, the combination of both modifications converted <b>43</b> into a micromolar antagonist (<b>46</b>, IC<sub>50</sub> = 11.17 µM, Table<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Similar modifications of ADP (<b>2</b>), a natural agonist of P2Y<sub>12</sub> receptor, gave a comparable SAR pattern, albeit with a more favorable outcome. The <i>cis</i>-benzyl acetal (<b>40</b>) was found to be a modestly active inhibitor. Likewise, modification of <b>2</b> with a phenylurea moiety (<b>39</b>) also converted the agonist into an antagonist. The incorporation of both of these lipophilic modifications led to <b>41</b>, with potency for inhibition of aggregation of 0.052 µM, comparable to the best of the dinucleoside tetraphosphate series (<b>50</b>). These data are summarized in Table<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_p">On the basis of the results for <b>41</b> and <b>46</b>, we chose to examine similar modifications for <b>1</b> (Scheme<a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Only those acetal substitutions that produced the more potent compounds of the dinucleoside polyphosphate series were prepared and tested for potency. By examining the potency of substituted adenosine diphosphate <b>41</b> and cytidine monophosphate <b>46</b>, it was clear that the purine core is an essential component for maintaining the potency for the inhibition of aggregation. Furthermore, although highly potent antagonists would likely have been found in series based on <b>2</b> (or even <b>3</b>), the chemical instability of the di and triphosphate groups was deemed a significant drug development obstacle.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">Much as was seen for phenylurea analogue <b>39</b>, the reaction of <b>1</b> with phenylisocyanate converted an inactive compound into a modestly active antagonist (<b>51</b>). Similarly, the formation of acetals of <b>1</b> (phenyl, benzyl, styryl, and ethynyl phenyl) also provided analogues that were modestly active (<b>52</b>–<b>55</b>). Preparation of the monophosphate analogue of <b>41</b> (phenylurea and benzyl acetal, <b>56</b>) showed an approximately 3-fold loss in potency (0.052 vs 0.160 µM, respectively), which suggested that truncating the phosphate chain would not lead to an insurmountable loss of potency. Comparison of the phenyl urea moiety in the acetal series benzyl, styryl, and ethynyl phenyl (<b>56</b>, <b>64</b>, and <b>66</b>, respectively) did not reveal any obvious advantage of any of these acetals for increased potency.</div><div class="NLM_p last">A switch to aliphatic ureas led to a breakthrough in potency for the monophosphate series. However, inconsistent trends were found when comparisons were drawn across different acetal series. The ethyl urea derivatives <b>58</b> (<i>cis</i>-benzyl acetal), <b>60</b> (mixture of phenyl acetals), <b>61</b> (mixture of styryl acetals), and <b>62</b> (<i>trans</i>-styryl acetal) were 0–5-fold more potent than diphosphate <b>41</b>, making them the most potent compounds in this study (0.041, 0.013, 0.011, and 0.016 µM, respectively). Preparation of three <i>n</i>-hexyl urea derivatives <b>57</b> (<i>cis</i>-benzyl acetal), <b>63</b> (mixture of styryl acetals), and <b>65</b> (mixture of ethynyl phenyl acetals) led to derivatives with a clear preference for the benzyl acetal (0.053, 0.237, and 0.211 µM, respectively). Comparison of three alkyl ureas in the benzyl acetal series <i>n</i>-hexyl (<b>57</b>), cyclopentyl (<b>59</b>), and ethyl (<b>58</b>) revealed no preference for any of the urea alkyl groups (0.053, 0.036, and 0.041 µM, respectively). On the basis of pharmacological, physicochemical, and synthetic considerations, compound <b>62</b> was nominated as a candidate for further development as an inhibitor of platelet aggregation. A full pharmacological and biochemical characterization of this compound will be reported elsewhere.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> P2Y Receptor Selectivity</h3><div class="NLM_p">Since inhibition of ADP-induced platelet aggregation could result from the blockade of either the P2Y<sub>1</sub> or the P2Y<sub>12</sub> receptors, we ruled out any activity of these compounds at the P2Y<sub>1</sub> receptor by conducting calcium mobilization assays in 1321N1 human astrocytoma cells expressing the recombinant human P2Y<sub>1</sub> receptor (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). None of the compounds that inhibited ADP-induced platelet aggregation had any effect as an antagonist at the P2Y<sub>1</sub> receptor cell line, suggesting that the inhibition of aggregation by ADP was mediated by the antagonism of the P2Y<sub>12</sub> receptor. This observation was consistent with the lack of effect of these compounds on the P2Y<sub>1</sub> receptor-mediated platelet shape change induced by ADP and further confirmed in a selected number of compounds by the inhibition of the P2Y<sub>12</sub> receptor response in C6 rat glioma cells, which express the native P2Y<sub>12</sub> receptor.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p">The diuridine tetraphosphate monoacetals <b>20</b>, <b>22</b>, <b>24</b>, <b>26</b>, <b>28</b>, and <b>30</b> were all P2Y<sub>2</sub> agonists, exhibiting potencies up to 6-fold lower than that of <b>13</b>. Consistent with this trend, the diadenosine tetraphosphate monobenzyl acetal <b>37</b> was slightly less potent as a P2Y<sub>2</sub> agonist than <b>11</b>. Similarly, the cytidine−uridine tetraphosphate monoacetal (C), <b>32</b>, was approximately 10-fold less potent at P2Y<sub>2</sub> than <b>18</b>; however, the cytidine−uridine tetraphosphate monoacetal (U), <b>33</b>, was inactive. Dinucleoside triphosphate monoacetal <b>35</b> showed slightly higher agonist potency at P2Y<sub>6</sub> than <b>19</b> (0.154 vs 0.40 µM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The corresponding diacetal <b>36</b> was not active at this receptor. Likewise, diacetal analogues derived from the three dinucleoside tetraphosphate cores showed a marked reduction in agonist potency toward the P2Y<sub>2</sub> receptor (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). For example, <b>27</b> exhibited a 10-fold loss of agonist potency (EC<sub>50</sub> (P2Y<sub>2</sub>) = 0.350 µM) in a calcium mobilization assay, relative to core <b>13</b>. The other diacetals in this series were even less active at P2Y<sub>2</sub> than <b>27</b> (compounds <b>21</b> and <b>23</b>) or showed little to no activity (compounds <b>25</b> and <b>29</b>). The dibenzyl acetals <b>34</b> and <b>38</b> were also inactive at P2Y<sub>2</sub>. Taken together, these results suggest that increasing lipophilic modification of the hydroxyl groups of dinucleoside polyphosphates leads to both increased potency and selectivity toward the platelet P2Y<sub>12</sub> receptor.</div><div class="NLM_p">In the nucleotide series, monophosphate <b>56</b> showed greater selectivity over the P2Y<sub>1</sub>, P2Y<sub>2</sub>, and P2Y<sub>6</sub> receptors versus its diphosphate counterpart <b>41</b>. In addition, it was not active at the P2Y<sub>4</sub> receptor. This trend held true for compounds <b>51</b>–<b>66</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_p">On the basis of these results, the described modifications of the nucleotides and dinucleoside polyphosphates described herein confer antagonist properties to these analogues and eliminate the P2Y<sub>2</sub> and P2Y<sub>1</sub> activity, achieving selectivity for the inhibition of platelet aggregation toward the P2Y<sub>12</sub> receptor.</div><div class="NLM_p">Dinucleoside polyphosphates and nucleotides modified with acetals and ureas were able to inhibit the aggregation of platelets in a concentration-dependent manner. The inhibitory effects of these compounds have been demonstrated using several platelet preparations, including whole blood, platelet rich plasma (PRP), and washed platelet preparations. The potency of a given compound in these assays varies among the different platelet preparations, mainly because of differences in the protein-binding characteristics of the compound. In general, the apparent potency observed for the compounds of this study was highest in the washed platelet preparation followed by whole blood and PRP. For example, compound <b>62</b> exhibited a potency of 0.016 µM in the washed platelet assay, while the potencies in whole blood and PRP were 0.180 µM and 0.760 µM, respectively. All data shown in this study were obtained with the washed platelet preparation.</div><div class="NLM_p">In order to study the nature of the inhibition of platelet aggregation, we used the diuridine tetraphosphate di-2′,3′-phenylacetaldehyde acetal derivative <b>21</b>. Compound <b>21</b> produced a dose-dependent shift to the right in the platelet aggregation concentration–response curve of the ADP analogue 2-MeS-ADP (Figure<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). The Schild analysis<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> suggested that the antagonism demonstrated by <b>21</b> on platelet aggregation is competitive (Figure<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B), with a K<sub>B</sub> of 0.249 µM and a slope of 0.742. The reversibility of the effects of <b>21</b> on platelet aggregation was studied in a preparation of washed platelets. Platelets were treated with 50 µM <b>21</b> for 3 min at 37 °C in the absence of fibrinogen, then were either stimulated with 2-MeS-ADP and fibrinogen or were washed once by centrifugation before stimulation with 2-MeS-ADP and fibrinogen (Figure<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A and<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). Unlike the thienopyridines <b>9</b> and <b>10</b>, the compounds reported here, as exemplified by compound <b>21</b>, behaved as competitive and reversible antagonists of platelet aggregation mediated by the P2Y<sub>12</sub> receptor.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0009.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compound <b>21</b> on 2-MeS-ADP-promoted platelet aggregation. (A) Platelet aggregation was measured as described in <a class="ref internalNav" href="#sec4_1" aria-label="General Methods">General Methods</a>. Assays were in the presence of the indicated concentrations of 2-MeS-ADP alone or in the presence of 1, 3, 10, 30, or 100 µM compound <b>21</b>. (B) Arunlakshana−Schild plot from the data presented in A. The slope of the plot is 0.7425, and <i>K</i><sub>B</sub> is 0.251 µM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0010.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reversible inhibition of platelet aggregation by compound <b>21</b>. Platelets were incubated in the absence (control) or in the presence of 50 µM of <b>21</b>. In panel A, after a three minute incubation with drug, the indicated concentrations of 2-MeS-ADP and fibrinogen were added, and platelet aggregation was monitored during the following 6–8 min. In panel B, after the three minute incubation with drug, both control and compound <b>21</b>-treated platelets were centrifuged, the supernatant was removed, and the platelets were resuspended in drug-free media. Following this, the indicated concentrations of 2-MeS-ADP and fibrinogen were added, and the aggregation was monitored as described above.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07158" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07158" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">These studies showed that acetal substitution on the 2′,3′-ribose moiety of dinucleoside polyphosphates and nucleotides was an important determinant in conferring antagonist properties toward the P2Y<sub>12</sub> receptor. Indeed, this effect was robust enough that dinucleoside polyphosphates such as <b>13</b> and <b>18</b>, which normally do not interact with the P2Y<sub>12</sub> receptor as either an agonist or antagonist, were converted via these modifications into strong antagonists. Expansion of this concept around dinucleoside polyphosphate <b>13</b> demonstrated that a variety of substituents on the acetal moiety were well tolerated, giving structurally diverse analogues on which a SAR campaign could be based. We found that the number of acetals (lipophilic substitutions) correlated directly with the potency of the molecule to inhibit aggregation, confirming the observations made with initial screening hits, <b>15</b> and <b>16</b>. Furthermore, there was a direct relationship between enhanced P2Y<sub>12</sub> antagonist potency with increasing lipophilic substitution and decrease in agonist potency at several other P2Y receptors, suggesting that both potent and selective compounds might be developed in this series.</div><div class="NLM_p last">We further identified the exocyclic amino group of adenine and cytidine-containing dinucleoside polyphosphates and nucleotides as a second site for lipophilic modification, where ureas in this position greatly enhanced the antagonist potency. In most cases, modification of either a ribose with a 2′,3′-acetal moiety or a base with a urea was enough to generate at least some antagonist behavior. However, these modifications proved to be synergistic, and the disubstituted compounds were the more potent antagonists of platelet aggregation. The compounds reported here are competitive and reversible antagonists of the P2Y<sub>12</sub> receptor. While some of the dinucleoside polyphosphates were potent antagonists of aggregation (compounds <b>42</b> and <b>50</b>), we found that the substituted nucleotide <b>41</b>, used to prepare <b>42</b>, was more potent than its dinucleoside polyphosphate product. Optimization of <b>41</b> led to a series derived from adenosine 5′-monophosphate (<b>1</b>), of which one, <b>62</b>, was selected for in vivo preclinical studies. On the basis of positive results from animal studies, compound <b>62</b> was nominated for further development, where it was subsequently advanced to clinical trials.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> This study provides the basis for further development of potent and selective antagonists of the P2Y<sub>12</sub> receptor that should prove useful for the treatment of cardiovascular diseases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Details</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11545" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11545" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Methods</h3><div class="NLM_p">All reagents were acquired from commercial suppliers and were generally used without further purification. All reactions requiring anhydrous conditions were performed under nitrogen, using anhydrous solvents packaged in septum bottles. <sup>1</sup>H and <sup>31</sup>P NMR spectra were obtained at 300 and 121.5 MHz respectively, using Varian Gemini 2000. Generally, samples run in D<sub>2</sub>O were pretreated with a chelating resin (Chelex 100 Na) in water, followed by lyophilization. This was done to remove paramagnetic ions in an effort to improve the NMR resolution. When resolution was still unsatisfactory, additional experiments were carried out in CD<sub>3</sub>OD or DMSO-<i>d</i><sub>6</sub>.</div><div class="NLM_p">Analytical HPLC chromatograms were obtained on either Waters 600S or Waters Alliance 2795 equipped with diode array detectors. The C<sub>18</sub> columns used (either Waters Xterra RP<sub>18</sub>, 150 × 4.6 mm, 3.5 µm, or Alltech Apollo C<sub>18</sub>) were run employing a linear gradient from 0.02 M KH<sub>2</sub>PO<sub>4</sub>/0.005 M NBu<sub>4</sub><sup>+</sup>HSO<sub>4</sub> (pH adjusted to 5.0 with KOH) to 90% ACN 10% water over 20 min (1 mL/min), a linear gradient from 0.1% TFA to ACN over 20 min (1 mL/min), or a linear gradient from 0.05 M NH<sub>4</sub>OAc (pH 6) to ACN over 20 min (1 mL/min). The former ion pairing system allowed the analysis of unmodified parent dinucleoside polyphosphates to be carried out under reverse-phase conditions. It also was employed to detect the presence or absence of diastereomers arising from the acetal moieties and to quantify the diasteromeric ratios in compounds <b>53</b>–<b>55</b> and <b>60</b>–<b>66</b>. The NH<sub>4</sub>OAc and TFA systems generally did not provide information on diastereomeric ratios but were used to assess the overall purity of the modified nucleotides. Purities of test compounds exceeded 95% and in most cases 98%, as measured in these systems.</div><div class="NLM_p">Unmodified dinucleoside polyphosphates <b>11</b>, <b>13</b>, <b>18</b>, and <b>19</b> were purified using either Waters Delta 600 or Prep LC 2000 with diode array detection, in conjunction with an ion-exchange preparative column (Hamilton PRP X-100 anion exchange column, 20 µm; gradient from water to 1 M ammonium bicarbonate, 100 mL/min). Alternately, these molecules were purified using DEAE Sephadex in a medium pressure mode, utilizing a gradient from water to 1 M ammonium bicarbonate. Dinucleoside polyphosphates and nucleotides modified with lipophilic substituents were generally purified by preparative RPHPLC (Waters PrepLC system, equipped with either two or three 25 × 100 mm or two 40 × 100 mm Waters NovaPak C<sub>18</sub> segments, depending on the scale of the reaction to be purified; gradient from 0.05 M NH<sub>4</sub>OAc to ACN, 20–70 mL/min, diode array detection) and isolated as the ammonium salts. Alternately, products from small-scale reactions were separated on a semipreparative reverse-phase column (Alltech Nucleotide/Nucleoside C<sub>18</sub>, 10–250 mm, 7 µm, gradient from 0.1 M NH<sub>4</sub>OAc to MeOH, 5 mL/min, diode array detector). Irrespective of the preparative RPHPLC purification method, dry products were obtained by partial evaporation, followed by lyophilization.</div><div class="NLM_p last">LR-LCMS were obtained using a Waters Micromass ZQ mass spectrograph (ESI+ and ESI-) coupled to a Waters Alliance 2695 HPLC. For the lipophilic dinucleoside polyphosphate and nucleotides <b>15</b>–<b>42</b> and <b>44</b>–<b>66</b>, a linear gradient from 0.05 M NH<sub>4</sub>OAc (pH 6) to ACN over 20 min (0.5 mL/min) was used.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Platelet Aggregation Assay</h3><div class="NLM_p last">Blood was collected from healthy volunteers into syringes containing 1/6 final blood volume of anticoagulant ACD (65 mM citric acid, 85 mM sodium citrate, and 110 mM dextrose). The blood was centrifuged at 180<i>g</i> for 15 min, and the supernatant (platelet rich plasma) was removed. The platelet rich plasma was centrifuged and the platelet pellet resuspended in a buffer consisting of (mM) NaCl (137), KCl (2.7), CaCl<sub>2</sub> (2) MgCl<sub>2</sub> (1), NaH<sub>2</sub>PO<sub>4</sub> (3), glucose (5), HEPES (10) at pH 7.4, and 0.2% bovine serum albumin. These centrifugations and washes were repeated twice followed by resuspension in the media described above containing 0.25 U apyrase/mL. To prevent platelet activation during the procedure, all platelet resuspensions were conducted in the presence of 5 µM PGI<sub>2</sub>, followed by incubation at 37 °C for 10 min. Platelet suspensions were further supplemented with the same concentration of PGI<sub>2</sub> before each centrifugation. Platelet aggregation was measured using the optical mode of a ChronoLog aggregometer (Havertown, PA). Five hundred microliters of platelet suspension containing 1 mg/mL fibrinogen was warmed to 37 °C and stirred at 1000 rpm. Several concentrations of test compound (usually between 1 nM and 100 µM) were added to the platelet suspension and incubated for two minutes, followed by the addition of a maximally effective concentration of ADP (EC<sub>90</sub>; usually between 1 and 10 µM ADP). The aggregation was recorded for 8 min.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Calcium Mobilization Assay</h3><div class="NLM_p last">For calcium mobilization assays, 1321N1 human astrocytoma cells were loaded with a solution of Fluo-3 AM (2.5 µM final concentration) in an assay buffer consisting of (mM) KCl (10), NaCl (118), CaCl<sub>2</sub> (2.5), MgCl<sub>2</sub> (1), HEPES (20), and glucose (10) at pH 7.4. After a 60-min incubation with Fluo-3 AM at 25 °C, cells were washed and stimulated with the indicated concentrations of P2Y receptor agonists. Intracellular calcium levels were simultaneously monitored in each well by measuring the changes in fluorescence intensity using FLIPR (Molecular Devices Corp., Sunnyvale, CA).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Data Analysis and Statistics</h3><div class="NLM_p last">Data for selected compounds were expressed as the mean ± standard error of the mean (SEM). The potency of inhibitors of platelet aggregation was calculated from the inhibition of ADP-induced aggregation obtained at each concentration of test compound by fitting the data to a four-parameter logistic equation using the GraphPad software package (GraphPad Corp. San Diego, CA). When a broad range of concentrations of P2Y<sub>12</sub> antagonist were tested (usually from 1 nM to 100 µM), an IC<sub>50</sub> value was also obtained. IC<sub>50</sub> values represent the concentration of antagonist needed to inhibit by 50% the aggregation elicited by a given concentration of ADP.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Method for the Preparation of Tributylammonium Salts of Dinucleoside Polyphosphates and Nucleotides</h3><div class="NLM_p">The nucleotides used for the procedures described herein were obtained from commercial sources as the recrystallized free acids [adenosine 5′-monophosphate (<b>1</b>) and cytidine 5′-monophosphate (<b>43</b>)] or as the sodium salts [uridine 5′-monophosphate (<b>4</b>), adenosine 5′-diphosphate (<b>2</b>), uridine 5′-triphosphate (<b>6</b>), and adenosine 5′-triphosphate (<b>3</b>)]. As a prelude to the dinucleoside polyphosphate syntheses, the nucleotide free acids were converted to their tributylammonium salts by treatment with an excess of NBu<sub>3</sub> in aqueous methanol. After stirring for 20 min, the solutions were evaporated to dryness and the residue coevaporated with dry DMF. Solids were obtained with overnight drying on a lyophilizer.</div><div class="NLM_p">The nucleotides purchased as their sodium salts were first converted to their free acid forms by treatment with five weight-equivalents of Dowex 50 H<sup>+</sup> in water. After stirring for 10 min, the strongly acidic solutions were filtered and neutralized with an excess of NBu<sub>3</sub> in MeOH. Once a neutral pH or greater was obtained, the solvents were evaporated to dryness and the residues were coevaporated with dry DMF. The solids were dried to constant weight on a lyophilizer.</div><div class="NLM_p">Tributylamine content in the solids was determined by <sup>1</sup>H NMR, and the molecular weights were adjusted accordingly. When fully dried, nucleoside monophosphates generally had 1 mol equivalent of NBu<sub>3</sub>, 1.33–1.5 mol equivalents of diphosphates, and 2 mol equivalents of triphosphates. When easily handled solids were obtained, they were added as such to the dinucleoside polyphosphate-forming reactions described below; oily tributylammonium salts were dissolved to known concentrations in DMF.</div><div class="NLM_p last">The dinucleoside polyphosphates used as starting materials (<b>11</b>, <b>13</b>, <b>18</b>, and <b>19</b>) were synthesized from the appropriate nucleotide subunits, according to the general methods described in a previous communication.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Briefly, for the synthesis of <b>11</b>, nucleotide <b>3</b> in the ditributylammonium salt form was first activated with dicyclohexylcarbodiimide in DMF at room temperature, which converted the linear nucleoside triphosphate to the known cyclical trimetaphosphate.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Following this, <b>1</b> (as monotributylammonium salt) was added, and the reaction mixture was heated at 35 °C for 72 h. The dinucleoside polyphosphate so obtained (<b>11</b>) was isolated via ion exchange prep HPLC. Similarly, dinucleoside polyphosphates <b>13</b> and <b>18</b> were prepared via the DCC activation of <b>6</b> (2NBu<sub>3</sub> salt), followed by the reaction of the activated species with the appropriate nucleoside monophosphate in the NBu<sub>3</sub> salt form (<b>4</b> for dinucleoside polyphosphate <b>13</b>, and <b>43</b> for <b>18</b>). Dinucleoside triphosphate <b>19</b> was prepared from the reaction between commercially available uridine-5′-monophosphomorpholidate-4-morpholine-<i>N</i>,<i>N</i>′-dicyclohexylcarboxamidine salt and the NBu<sub>3</sub> salt of <b>5</b> in DMF. The typical yields for these procedures ranged from 10 to 40%. Two dinucleoside polyphosphates (<b>11</b> and <b>47</b>) were converted to their free acid forms as a prelude to further synthesis. This was accomplished by treating the NBu<sub>3</sub> salt forms with Dowex 50 H<sup>+</sup> as described above for mononucleotide sodium salts, followed by direct freezing and lyophilization of the resultant dinucleoside free acids. All free acid forms were stored at –20 °C to prevent decomposition.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>P</i><sup>1</sup>-[(2′(3′)-<i>O</i>-2-(Methylamino)benzoyl)uridine-5′-yl]-<i>P</i><sup>4</sup>-[uridine-5′-yl]-tetraphosphate (<b>15</b>) and <i>P</i><sup>1</sup>-[(2′(3′)-<i>O</i>-2-(Methylamino)benzoyl)uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′(3′)-<i>O</i>-2-(methylamino)benzoyl)uridine-5′-yl]-tetraphosphate (<b>16</b>)</h4><div class="NLM_p last">Up4U and 4Na salt (<b>13</b>, 1.0 g, 1.14 mmol) was dissolved in water (3 mL) and DMF (3 mL). To this was added <i>N</i>-methyl isatoicanhydride (303 mg, 1.71 mmol) and the reaction mixture heated at 50 °C for 5 h. The reaction mixture was diluted to 15 mL with water, and the insoluble material was removed by filtration. The products were separated via preparative HPLC. The yield of the mono MANT analogue <b>15</b> was 350 mg (31%), while the yield of the di MANT analogue <b>16</b> was 430 mg (33.5%). <b>15</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.70 (d, 3H), 4.12 (m, 7H), 4.39 (s, 1H), 4.53 (t, 1H), 5.34 (m, 1H), 5.72 (m, 2H), 5.83 (dd, 1H), 6.01 (m, 1H), 6.53 (q, 1H), 6.67 (t, 1H), 7.35 (t, 1H), 7.78 (m, 3H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.84(m, 2P), −10.20 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 921.9 (M − H). <b>16</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.66 (t, 6H), 4.22 (m, 6H), 4.46 (q, 2H), 5.22 (t, 1H), 5.28 (d, 1H), 5.72 (d, 8.1 Hz, 1H), 5.84 (d, 1.5H), 5.93 (m, 1.5H), 6.54 (m, 4H), 7.28 (m, 2H), 7.77 (m, 4H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.76 (m, 2P), −10.16 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 1055.1 (M − H).</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>P</i><sup>1</sup>-[(2′,3′)-di-<i>O</i>-Benzoyl)uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-di-<i>O</i>-benzoyl)uridine-5′-yl]-tetraphosphate (<b>17</b>)</h4><div class="NLM_p last">Compound <b>13</b>, ditributylammonium salt (200 mg, 0.172 mmol), and 4-dimethylaminopyridine (5 mg, 0.04 mmol) were dissolved in pyridine (3.0 mL) and benzoic anhydride (500 mg, 2.21 mmol) added. The reaction mixture was stirred overnight at room temperature, after which the pyridine was removed. The residue was partitioned between ethyl acetate (75 mL) and 0.5 M NaHCO<sub>3</sub> (50 mL). The layers were separated and the aqueous layer containing the products concentrated to 8 mL. The products were separated via preparative HPLC. The isolated yield of the tetra-benzoate (<b>17</b>) was 64 mg (31%). Only minimal quantities of the mono and dibenzoates and a lesser amount of the tribenzoate were produced under the chosen reaction conditions and were not isolated. <b>17</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 4.30 (m, 4H), 5.63 (t, 2H), 5.72 (m, 2H), 5.90 (d, <i>J</i> = 8.1 Hz, 2H), 6.21 (d, <i>J</i> = 5.4 Hz, 2H), 7.27 (m, 8H), 7.41 m, 4H), 7.59 (d, 4H), 7.71 (d, 4H), 7.93 (d, <i>J</i> = 8.1 Hz, 2H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.95 (m, 2P), −10.50 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 1205.3 (M − H).</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(2-Phenylethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[uridine-5′-yl]-tetraphosphate (<b>20</b>) and <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(2-Phenylethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(2-phenylethylidene)uridine-5′-yl]-tetraphosphate (<b>21</b>)</h4><div class="NLM_p last">Compound <b>13</b> and 4Na salt (290 mg, 0.332 mmol) were dissolved in 99% formic acid (3 mL) and phenylacetaldehyde dimethyl acetal (110 μL, 0.664 mmol) added. The reaction was stirred for 48 h and the formic acid removed by evaporation. The residue was partitioned between butyl acetate (15 mL) and 0.7 M NaHCO<sub>3</sub> (15 mL). The layers were separated and the products in the aqueous layer purified via preparative HPLC. The isolated yield of the monoacetal (<b>20</b>) was 88 mg (30%), and of the diacetal (<b>21</b>) 60 mg (18%). <b>20</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.99 (d, 2H), 4.04 (m, 5H), 4.22 (m, 2H), 4.32 (s, 1H), 4.78 (m, 2H),5.30 (t, 1H), 5.36 (d, <i>J</i> = 2.4 Hz, 1H), 5.73 (d, <i>J</i> = 8.1 Hz, 1H), 5.81 (t, 2H), 7.20 (m, 5H), 7.63 (d, <i>J</i> = 8.1 Hz, 1H), 7.79 (d, <i>J</i> = 8.1 Hz, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −22.00 (m, 2P), −10.78 (m, 1P), −10.18 (m, 1P). MS (ES): <i>m</i>/<i>z</i> 890.9 (M − H). <b>21</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.98 (d, <i>J</i> = 3.9 Hz, 4H), 3.98 (s, 4H), 4.27 (s, 2H), 4.74 (m, 4H), 5.28 (t, <i>J</i> = 3.9 Hz, 2H), 5.37 (d, <i>J</i> = 2.7 Hz, 2H), 5.74 (d, <i>J</i> = 8.1 Hz, 2H), 7.21 (m, 10H), 7.61 (d, <i>J</i> = 8.1 Hz, 2H).4 <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.81 (m, 2P), −10.57 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 993.0 (M − H).</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(Phenylmethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[uridine-5′-yl]-tetraphosphate (<b>22</b>) and <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(Phenylmethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(phenylmethylidene)uridine-5′-yl]-tetraphosphate (<b>23</b>)</h4><div class="NLM_p last">Compound <b>13</b> and 4Na salt (500 mg, 0.569 mmol) were dissolved in 99% formic acid (4 mL) and benzaldehyde dimethyl acetal (342 μL, 2.27 mmol) added. The reaction was stirred for 4 h, then the formic acid removed by evaporation. The residue was partitioned between ethyl acetate and 1 M NaHCO<sub>3</sub> and the products in the aqueous layer purified via preparative HPLC. The yield of the monoacetal (<b>22</b>, 48839) was 211 mg (42%), and of the diacetal (<b>23</b>, 48840) 37 mg (6.7%). <b>22</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 4.07 (m, 7H), 4.43 (m, 0.4H), 4.60 (m, 0.6H), 4.97 (d, 2H), 5.73 (m, 3H), 5.86 (d, 1.6H), 6.00 (s, 0.4H), 7.36 (m, 5H), 7.64 (d, 0.4H), 7.72 (t, 1.6H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −22.01 (m, 2P), −10.77 (m, 0.66P), −10.32 (m, 1.33P). MS (ES): <i>m</i>/<i>z</i> 877.2 (M − H). <b>23</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 4.06 (m, 4H), 4.36 (s, 0.7H), 4.54 (s, 1.3H),4.91 (m, 4H), 5.69 (t, 2H), 5.80 (d, 2H), 5.85 (s, 1.3H), 5.93 (s, 0.7H), 7.31 (m, 10H), 7.57 (d, 0.7H), 7.67 (d, 1.3H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.89 (m, 2P), −10.69 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 965.1 (M − H).</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(Phenylethenylmethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[uridine-5′-yl]-tetraphosphate (<b>24</b>) and <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(Phenylethenylmethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(phenylethenylmethylidene)uridine-5′-yl]-tetraphosphate (<b>25</b>)</h4><div class="NLM_p last">Compound <b>13</b> and 4Na salt (1.0 g, 1.14 mmol) were dissolved in trifluoroacetic acid (3 mL) and <i>trans</i>-cinnamaldehyde (2.00 mL, 15.9 mmol) added. The reaction was allowed to proceed at ambient temperature for 1 h. The TFA was removed at <30 °C in vacuo and the residue partitioned between EtOAc and water, along with the addition of sufficient concentrated NH<sub>4</sub>OH to render pH 7–8. The products in the aqueous layer were separated via preparative HPLC. The isolated yield of the monoacetal (<b>24</b>) was 396 mg (38%) and of the diacetal (<b>25</b>) 112 mg (9.7%). <b>24</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 4.13 (m, 4H), 4.22 (m, 3H), 4.44 (s, 0.5H), 4.94 (d, 2H), 5.59 (d, <i>J</i> = 6.6 Hz, 0.4H), 5.73 (d, 6.6 Hz, 0.6H), 5.81 (m, 3H), 6.17 (ddd, 1H), 6.39 (d, 0.3H), 6.85 (dd, 1H), 7.30 (m, 3H), 7.45 (m, 2H), 7.75 (m, 2H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −22.11 (m, 2P), −10.54 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 903.1 (M − H). <b>25</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 4.14 (m, 4H), 4.39 (m, 1H), 4.86 (m, 4H), 5.56 (d, <i>J</i> = 6.6 Hz, 0.8H), 5.65 (t, <i>J</i> = 6.9 Hz, 1.2H), 5.78 (m, 4H), 6.11 (m, 2H), 6.78 (m, 2H), 7.26 (m, 6H), 7.38 (m, 4H), 7.68 (m, 2H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −22.07 (m, 2P), −10.72 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 1017.3 (M − H).</div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(Phenylethynylmethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[uridine-5′-yl]-tetraphosphate (<b>26</b>) and <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(Phenylethynylmethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(phenylethynylmethylidene)uridine-5′-yl]-tetraphosphate (<b>27</b>)</h4><div class="NLM_p last">Compound <b>13</b> and 4Na salt (250 mg, 0.28 mmol) were dissolved in 99% formic acid (2 mL) and phenylpropargyl aldehyde (105 μL, 3.42 mmol) added. The reaction was stirred for 1 h, and the formic acid was removed by evaporation. The residue was partitioned between EtOAc and 1 M NaHCO<sub>3</sub>, and the products in the aqueous layer purified via preparative HPLC. The isolated yield of the monoacetal (<b>26</b>) was 82 mg (32%) and of the diacetal (<b>27</b>) 10 mg (3.5%). <b>26</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 4.13 (m, 5H), 4.24 (m, 2H), 4.49 (s, 0.5H), 5.03 (d, 2H), 5.82 (m, 3.5H), 6.00 (s, 0.5H), 6.13 (s, 1H), 7.31 (m, 3H), 7.44 (m, 2H), 7.76 (m, 2H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −22.13 (m, 2P), −10.49 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 901.2 (M − H). <b>27</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 4.15 (m, 4H), 4.42 (m, 2H), 5.04 (m, 4H), 5.70 (t, 1H), 5.78 (m, 2H), 5.95 (s, 0.5H), 5.98 (s, 0.5H), 6.01 (s, 0.5H), 6.08 (s, 0.8H), 6.13 (d, 0.6H), 7.29 (m, 5H), 7.40 (m, 5H), 7.67 (m, 2H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −22.07 (m, 2P), −10.72 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 1013.2 (M − H).</div></div><div id="sec4_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(Propylmethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[uridine-5′-yl]-tetraphosphate (<b>28</b>) and <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(Propylmethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(propylmethylidene)uridine-5′-yl]-tetraphosphate (<b>29</b>)</h4><div class="NLM_p last">Compound <b>13</b> and 4Na salt (1.0 g, 1.14 mmol) was dissolved in 99% formic acid (4 mL) and butyraldehyde (304 μL, 3.42 mmol) added. The reaction was stirred for 16 h, and the formic acid was removed by evaporation. The residue was partitioned between EtOAc and 1 M NaHCO<sub>3</sub>, and the products in the aqueous layer purified via preparative HPLC. The yield of the monoacetal (<b>28</b>) was 227 mg (23%) and of the diacetal (<b>29</b>) 309 mg (30%). <b>28</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 0.80 (t, 3H), 1.28 (m, 2H), 1.61 (m, 2H), 4.08 (m, 5H), 4.22 (m, 2H), 4.48 (s, 1H), 4.79 (m, 2H), 5.06 (t, 1H), 5.77 (m, 4H), 7.70 (d, 1H), 7.80 (d, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.95 (m, 2P), −10.68 (m, 1P), −10.23 (m 1P). MS (ES): <i>m</i>/<i>z</i> 843.3 (M − H). <b>29</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 0.80 (t, 6H), 1.29 (m, 4H), 1.62 (m, 4H), 4.06 (m, 4H), 4.47 (s, 2H), 4.79 (m, 4H), 5.06 (t, 2H), 5.76 (m, 4H), 7.70 (d, 2H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.92 (m, 2P), −10.63 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 897.2 (M − H).</div></div><div id="sec4_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(Heptylmethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[uridine-5′-yl]-tetraphosphate (<b>30</b>) and <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(Heptylmethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(heptylmethylidene)uridine-5′-yl]-tetraphosphate (<b>31</b>)</h4><div class="NLM_p last">Compound <b>13</b> and 4Na salt (1.0 g, 1.14 mmol) were dissolved in 99% formic acid (4 mL) and butyraldehyde (533 μL, 3.42 mmol) added. The reaction was stirred for 2.25 h, then the formic acid was removed by evaporation. The residue was partitioned between EtOAc and 1 M NaHCO<sub>3</sub> and the products in the aqueous layer purified via preparative HPLC. The yield of the monoacetal (<b>30</b>) was 253 mg (25%) and of the diacetal (<b>31</b>) 375 mg (32%). <b>30</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 0.67 (t, 3H), 1.18 (m, 10H), 1.61 (m, 2H), 4.06 (m, 5H), 4.21 (m, 2H), 4.48 (s, 1H), 4.78 (m, 2H), 5.04 (t, 1H), 5.77 (m, 4H), 7.69 (d, 1H), 7.79 (d, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.93 (m, 2P), −10.65 (m, 1P), −10.22 (m 1P). MS (ES): <i>m</i>/<i>z</i> 899.3 (M − H). <b>31</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 0.69 (t, 6H), 1.20 (m, 20H), 1.61 (m, 4H), 4.05 (m, 4H), 4.47 (s, 2H), 4.78 (m, 4H), 5.04 (t, 2H), 5.76 (m, 4H), 7.71 (d, 2H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.92 (m, 2P), −10.63 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 1009.6 (M − H).</div></div><div id="sec4_6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(2-Phenylethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[cytidine-5′-yl]-tetraphosphate (<b>33</b>), <i>P</i><sup>1</sup>-[Uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(2-phenylethylidene)cytidine-5′-yl]-tetraphosphate (<b>32</b>), and <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(2-Phenylethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(2-phenylethylidene)cytidine-5′-yl]-tetraphosphate (<b>34</b>)</h4><div class="NLM_p last">Compound <b>18</b> and 4Na salt (100 mg, 0.114 mmol) were dissolved in 99% formic acid (1 mL) and phenylacetaldehyde dimethyl acetal (57 μL, 0.342 mmol) added. The reaction was stirred for 16 h, then the formic acid removed by evaporation. The residue was partitioned between EtOAc and 1 M NaHCO<sub>3</sub> and the products in the aqueous layer purified via preparative HPLC. The yield of U-side monoacetal (<b>33</b>) was 26 mg (25%), the C-side monoacetal (<b>32</b>) was 20 mg (20%), and the diacetal (<b>34</b>) was 21 mg (19%). <b>33</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.95 (d, 2H), 4.09 (m, 7H), 4.28 (m, 1H), 4.64 (m, 1H), 4.73 (m, 1H), 5.28 (t, 1H), 5.32 (d, 1H), 5.71 (m, 2H), 6.08 (d, 1H), 7.17 (m, 5H), 7.57 (d, 1H), 7.95 (d, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −22.07 (m, 2P), −10.85 (m, 1P), −10.17 (m, 1P). MS (ES): <i>m</i>/<i>z</i> 890.3 (M − H). <b>32</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.95 (d, 2H), 4.07 (m, 7H), 4.42 (m, 1H), 4.69 (m, 2H), 5.23 (d, 2H), 5.75 (m, 2H), 6.04 (d, 1H), 7.15 (m, 5H), 7.73 (dd, 2H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −22.05 (m, 2P), −11.02 (m, 1P), −10.28 (m, 1P). MS (ES): <i>m</i>/<i>z</i> 890.3 (M − H). <b>34</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.93 (d, 4H), 3.94 (m, 4H), 4.24 (s, 1H), 4.35 (s, 1H), 4.69 (m, 4H), 5.22 (m, 3H), 5.32 (d, 1H), 5.68 (d, 1H), 6.01 (d, 1H), 7.17 (m, 10H), 7.56 (d, 1H), 7.67 (d, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −22.11 (m, 2P), −10.88 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 992.4 (M − H).</div></div><div id="sec4_6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(2-Phenylethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[uridine-5′-yl]-triphosphate (<b>35</b>) and <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(2-Phenylethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(2-phenylethylidene)uridine-5′-yl]-triphosphate (<b>36</b>)</h4><div class="NLM_p last">Compound <b>19</b> and 3Na salt (100 mg, 0.129 mmol) were dissolved in 99% formic acid (1 mL) and phenylacetaldehyde dimethyl acetal (64 μL, 0.386 mmol) added. The reaction was stirred for 16 h, and the formic acid then removed by evaporation. The residue was partitioned between EtOAc and 0.5 M NaHCO<sub>3</sub> and the products in the aqueous layer purified via preparative HPLC. The yield of the monoacetal (<b>35</b>) was 40 mg (38%) and of the diacetal (<b>36</b>) 24 mg (20%). <b>35</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.93 (d, 2H), 3.98 (d, 5H), 4.16 (d, 3H), 4.67 (m, 2H), 5.23 (t, 1H), 5.31 (s, 1H), 5.67 (d, 1H), 5.74 (m, 2H), 7.16 (m, 5H), 7.55 (d, 1H), 7.73 (d, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.99 (m, 1P), −10.80 (m, 1P) 10.30 (m, 1P). MS (ES): <i>m</i>/<i>z</i> 811.6 (M − H). <b>36</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.91 (d, 4H), 3.89 (s, 4H), 4.13 (s, 2H), 4.63 (m, 2H), 5.21 (t, 2H), 5.32 (d, 2H), 5.65 (d, 2H), 7.15 (m, 10H), 7.49 (d, 2H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.99 (m, 1P), −10.62 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 913.3 (M − H).</div></div><div id="sec4_6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(2-Phenylethylidene)adenosine-5′-yl]-<i>P</i><sup>4</sup>-[adenosine-5′-yl]-tetraphosphate (<b>37</b>) and <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(2-Phenylethylidene)adenosine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(2-phenylethylidene)adenosine-5′-yl]-tetraphosphate (<b>38</b>)</h4><div class="NLM_p last">The free acid of <b>11</b> (500 mg, 0.598 mmol) was dissolved in 99% formic acid (5 mL) and phenylacetaldehyde dimethyl acetal (297 μL, 1.79 mmol) added. The reaction was stirred for 21 h, then the formic acid removed by evaporation. The residue was partitioned between EtOAc and 1 M NaHCO<sub>3</sub> and the products in the aqueous layer purified via preparative HPLC. The yield of monoacetal (<b>37</b>, 48506) was 155 mg (27.6%) and of the diacetal (<b>38</b>, 48808) 38 mg (6.1%). <b>37</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 3.02 (d, 2H), 4.05 (m, 2H), 4.14 (m, 2H), 4.22 (m, 1H), 4.40 (m, 2H), 4.55 (t, 1H), 4.92 (m, 1H), 5.04 (m, 1H), 5.34 (t, 1H), 5.68 (d, 1H), 5.87 (d, 1H), 7.24 (m, 5H), 8.03 (d, 1H), 8.19 (s, 1H), 8.31 (s, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.74 (m, 2P), −10.35 (m, 1P), −9.98 (m, 1P). MS (ES): <i>m</i>/<i>z</i> 937.5 (M − H). <b>38</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.95 (d, 4H), 4.01 (m, 4H), 4.30 (m, 2H), 4.87 (m, 2H), 4.96 (m, 2H), 5.23 (t, 2H), 5.61 (d, 2H), 7.15 (m, 10H), 7.92 (s, 2H), 8.18 (s, 2H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.84 (m, 2P), −10.40 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 1039.8 (M − H).</div></div><div id="sec4_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2-benzyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-trihydrogen Diphosphate (<b>40</b>)</h4><div class="NLM_p last">Compound <b>2</b> and 1Na salt (800 mg, 1.78 mmol) were dissolved in 99% formic acid (5 mL), and phenylacetaldehyde dimethyl acetal (589 μL, 3.56 mmol) was added. The mixture was stirred overnight at 35 °C and evaporated to dryness. The residue was partitioned between EtOAc and 1 M NaHCO<sub>3</sub>. The resultant partial emulsion was centrifuged (4000 rpm) and the layers separated. The aqueous layer containing the product was concentrated to 20 mL and the product purified by reverse-phase preparative HPLC. The yield of the title compound (<b>40</b>) was 252 mg (27%). <b>40</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 3.03 (d, 2H), 3.94 (d, 2H), 4.40 (s, 1H), 4.92 (d, 1H), 5.14 (m, 1H), 5.33 (t, 1H), 5.73 (d, 1H), 7.20 (m, 5H), 8.08 (s, 1H), 8.20 (s, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −10.31 (d, 1P), −9.52 (d, 1P). MS (ES): <i>m</i>/<i>z</i> 528.1 (M − H).</div></div><div id="sec4_6_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> ((2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4-Dihydroxy-5-(6-(3-phenylureido)-9<i>H</i>-purin-9-yl)tetrahydrofuran-2-yl)methyl-trihydrogen Diphosphate (<b>39</b>)</h4><div class="NLM_p last">Compound <b>2</b> and 1NBu<sub>3</sub> salt (<b>2</b>, 1.0g, 1.63 mmol) were dissolved in dry DMF (15 mL) and phenylisocyanate (540 μL, 4.9 mmol) added. The reaction was heated for 1 h at 45 °C. The solvent was removed and the residue partitioned between EtOAc and 0.25 M NaHCO<sub>3</sub> (5 mL). The layers were separated and the product in the aqueous layer isolated by reverse-phase preparative HPLC. The yield of <b>39</b> was 431 mg (48%). <b>39</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 4.09 (m, 2H), 4.21 (m, 1H), 4.36 (t, 1H), 4.48 (t, 1H), 5.78 (d, 1H), 6.54 (t, 1H), 6.77 (m, 4H), 8.18 (s, 1H), 8.25 (s, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −10.08 (d, 1P), −8.76 (d, 1P). MS (ES): <i>m</i>/<i>z</i> 545.1 (M − H).</div></div><div id="sec4_6_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-2-Benzyl-6-(6-(3-phenylureido)-9<i>H</i>-purin-9-yl)tetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-trihydrogen Diphosphate (<b>41</b>)</h4><div class="NLM_p last">Compound <b>40</b>, 1NH<sub>4</sub> salt (200 mg, 0.355 mmol), and tributylamine (200 μL, 0.841 mmol) were dissolved in dry DMF (3 mL). Phenylisocyanate (194 μL, 1.78 mmol) was added and the reaction mixture heated for 60 h at 30 °C. The solvent was removed and the residue partitioned between EtOAc and 0.2 M NaHCO<sub>3</sub> (3 mL). The product in the aqueous layer was isolated by reverse-phase preparative HPLC. The yield of the title compound (<b>41</b>) was 31 mg (13.5%). Compound <b>41</b> proved to be somewhat unstable, slowly degrading to the corresponding monophosphate (<b>56</b>). Consequently, heating was avoided during the isolation of this molecule, and it was stored at −80 °C immediately after the lyophilization step. When handled appropriately, the typical content of compound <b>56</b> was 3–5%. <b>41</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 3.06 (d, 2H), 3.94 (m, 2H), 4.44 (s, 1H), 4.97 (d,1H), 5.13 (m, 1H), 5.35 (t, 1H), 5.71 (d, <i>J</i> = 3.3 Hz, 1H), 6.89 (t, 1H), 7.10 (t, 2H), 7.21 (m, 7H), 8.31 (s, 1H), 8.44 (s, 1H).). <sup>1</sup>H NMR (300 MHz, MeOD + D<sub>2</sub>O) δ 3.14 (d, 2H), 4.16 (m, 2H), 4.54 (s, 1H), 5.15 (d, 1H), 5.33 (m, 2H), 6.17 (d, <i>J</i> = 3.3 Hz, 1H), 7.12 (t, 1H), 7.31 (m, 7H), 7.61 (d, 2H), 8.70 (s, 1H), 8.73 (s, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −10.44 (d, 1P), −9.52 (d, 1P). MS (ES): <i>m</i>/<i>z</i> 648.8 (M − H).</div></div><div id="sec4_6_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(2-Phenylethylidene)-6-(3-phenylureido)adenosine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(2-phenylethylidene)-6-(3-phenylureido)adenosine-5′-yl]-tetraphosphate (<b>42</b>)</h4><div class="NLM_p last">Compound <b>41</b> (60 mg, 0.092 mmol) was dissolved in dry DMF (1.0 mL) and NBu<sub>3</sub> (100 μL, 0.42 mmol). 1,1′-Carbonyldiimidazole (20 mg, 0.123 mmol) was added and the reaction mixture allowed to stir overnight at ambient temperature. The reaction was quenched with water (1 mL) and 1 M NaHCO<sub>3</sub> (1 mL). The desired product was isolated by reverse-phase preparative HPLC. The yield of the title compound (<b>42</b>) was 9 mg (16%). <b>42</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O + acetonitrile d3) δ 3.04 (t, 4H), 4.01 (s, 4H), 4.41 (s, 2H), 4.87 (d, 2H), 4.99 (t, 2H), 5.22 (t, 2H), 5.95 (d, 2H), 7.08 (t, 2H), 7.26 (m, 14H), 7.51 (d, 4H), 8.39 (s, 2H), 8.44 (s, 2H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.31 (m, 2P), −10.13 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 1279.9 (M − H).</div></div><div id="sec4_6_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> ((2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-5-(4-(3-(4-Fluorophenyl)ureido)-2-oxopyrimidin-1(2<i>H</i>)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl-dihydrogen Phosphate (<b>44</b>)</h4><div class="NLM_p last">Compound <b>43</b> and 1 NBu<sub>3</sub> salt (51 mg, 0.1 mmol) were dissolved in dry DMF (0.5 mL) and <i>p</i>-fluorophenylisocyanate (34 μL, 0.3 mmol) added. The reaction was heated at 60 °C for 5 min, then at 30 °C for 1 h. The solvent was removed by evaporation under vacuum and the residue partitioned between EtOAc (10 mL) and 0.5 M NaHCO<sub>3</sub>. The product in the aqueous layer was isolated by reverse-phase preparative HPLC. The yield of the title compound (<b>44</b>) was 51 mg (80%). <b>44</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 4.05 (m, 5H), 5.78 (d, 1H), 6.24 (d, 1H), 6.97 (t, 2H), 7.28 (m, 2H), 8.14 (d, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 1.39 (s). MS (ES): <i>m</i>/<i>z</i> 461.4 (M − H).</div></div><div id="sec4_6_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-6-(4-Amino-2-oxopyrimidin-1(2<i>H</i>)-yl)-2-benzyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>45</b>)</h4><div class="NLM_p last">Compound <b>43</b> (1.0g, 3.09 mmol), in the free acid form, was dissolved in 99% formic acid (7.5 mL) and phenylacetaldehyde dimethyl acetal (1.03 mL, 6.2 mmol) added. The reaction was stirred overnight at ambient temperature, after which the volatiles were removed under vacuum. The residue was partitioned between EtOAc and 1 M NaHCO<sub>3</sub>, and the product in the aqueous layer was isolated by reverse-phase preparative HPLC. The yield of the title compound (<b>45</b>) was 650 mg (49%). <b>45</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.98 (d, 2H), 3.77 (m, 2H, 4.17 (s, 1H), 4.71 (m, 2H), 5.28 (t, 1H), 5.52 (d, 1H), 5.86 (d, 1H), 7.20 (m, 5H), 7.63 (d, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 2.87 (s). MS (ES): <i>m</i>/<i>z</i> 424.2 (M − H).</div></div><div id="sec4_6_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-2-Benzyl-6-(4-(3-(4-fluorophenyl)ureido)-2-oxopyrimidin-1(2<i>H</i>)-yl)tetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-hydrogen Phosphate (<b>46</b>)</h4><div class="NLM_p last">Compound <b>45</b> (100 mg, 0.218 mmol) and NBu<sub>3</sub> (104 μL, 0.436 mmol) were dissolved in dry DMF (2 mL). 4-Fluorophenylisocyanate (99 μL, 0.871 mmol) was added and the reaction stirred at room temperature. At 1 h, an additional portion of 4-fluorophenylisocyanate (99 μL, 0.871 mmol) was added. After 3 h, the solvent was removed and the residue partitioned between EtOAc and 1 M NaHCO<sub>3</sub>. The product in the aqueous layer was isolated by reverse-phase preparative HPLC. The yield of the title compound (<b>46</b>) was 102 mg (83%). <b>46</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 3.00 (d, 2H), 3.81 (m, 2H), 4.34 (m, 1H), 4.72 (m, 2H), 5.28 (t, 1H), 5.44 (d, 1H), 6.20 (d, 1H), 6.99 (t, 2H), 7.27 (m, 2H), 7.92 (d, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 2.39 (s). MS (ES): <i>m</i>/<i>z</i> 563.2 (M − H).</div></div><div id="sec4_6_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>P</i><sup>1</sup>-[Uridine-5′-yl]-<i>P</i><sup>4</sup>-[4-(3-(4-fluorophenyl)ureido)cytidine-5′-yl]-tetraphosphate (<b>47</b>)</h4><div class="NLM_p last">Compound <b>6</b> and 2NBu<sub>3</sub> salt (8.93 g, 10.5 mmol) were dissolved in dry DMF (total solution volume 50 mL) and DCC (2.04 g, 9.9 mmol) added. The reaction was stirred for 1.25 h at 30 °C, during which time it became heterogeneous because of precipitated dicyclohexylurea. <sup>31</sup>P NMR showed complete conversion to the cyclic trimeta phosphate. A solution of CMP 6-(<i>p</i>-fluoro)phenylurea and 1NBu<sub>3</sub> salt (<b>44</b>, 3.38 g, 5.25 mmol) in dry DMF (50 mL) was added, and the solution was kept at 30 °C for 3 days. Water (10 mL) was added, and the reaction mixture was stirred for 30 min, after which the solvent was removed by evaporation. The residue was dissolved in water (100 mL), and the precipitated dicyclohexylurea was removed by filtration. The filtrate was concentrated and the product isolated by reverse-phase preparative HPLC. The yield of the title compound (<b>47</b>) was 2.12 g (41%, based on <b>44</b>). <b>47</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 4.11 (m, 10H), 5.74 (m, 3H), 6.30 (d, 1H), 6.97 (t, 2H), 7.29 (m, 2H), 7.71 (d, 1H), 8.15 (d, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.67 (m, 2P), −10.32 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 925.4 (M − H).</div></div><div id="sec4_6_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(2-Phenylethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[4-(3-(4-fluorophenyl)ureido)cytidine-5′-yl]-tetraphosphate (<b>48</b>), <i>P</i><sup>1</sup>-[Uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(2-phenylethylidene)-4-(3-(4-fluorophenyl)ureido)cytidine-5′-yl]-tetraphosphate (<b>49</b>), and <i>P</i><sup>1</sup>-[(2′,3′)-<i>O</i>-(2-Phenylethylidene)uridine-5′-yl]-<i>P</i><sup>4</sup>-[(2′,3′)-<i>O</i>-(2-phenylethylidene)-4-(3-(4-fluorophenyl)ureido)cytidine-5′-yl]-tetraphosphate (<b>50</b>)</h4><div class="NLM_p last">Compound <b>47</b> (100 mg, 0.108 mmol), in the free acid form, was dissolved in 99% formic acid (2 mL) and phenylacetaldehyde dimethyl acetal (107 μL, 0.65 mmol) added. The reaction was heated at 30 °C for 45 min, after which the formic acid was removed at ambient temperature. The residue was partitioned between EtOAc and 0.8 M NaHCO<sub>3</sub>. The products in the aqueous layer were purified by reverse-phase preparative HPLC. In addition to the recovered starting material (<b>47</b>, 38 mg), the yields were 39 mg of the uridine-side monoacetal (<b>48</b>, 32%), 14 mg of the cytidine-side monoacetal (<b>49</b>, 12%), and 15 mg of the diacetal (<b>50</b>, 12%). <b>48</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.86 (d, 2H), 4.10 (m, 8H), 4.66 (m, 2H), 5.19 (t, 1H), 5.31 (d, 1H), 5.69 (d, 1H), 5.78 (d, 1H), 6.30 (d, 1H), 6.97 (t, 2H), 7.13 (m, 5H), 7.30 (m, 2H), 7.54 (d, 1H), 8.16 (d, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.71 (m, 2P), −10.62 (m, 1P), −9.92 (m, 1P). MS (ES): <i>m</i>/<i>z</i> 1027.2 (M − H). <b>49</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.98 (d, 2H), 4.19 (m, 7H), 4.42 (m, 1H), 4.68 (m, 2H), 5.26 (t, 1H), 5.37 (d, 1H), 5.66 (d, 1H), 5.75 (d, 1H), 6.24 (d, 1H), 6.96 (t, 2H), 7.21 (m, 5H), 7.30 (d, 2H), 7.61 (d, 1H), 7.88 (d, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.62 (m, 2P), −10.60 (m, 1P), −10.19 (m, 1P). MS (ES): <i>m</i>/<i>z</i> 1027.2 (M − H). <b>50</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.88 (d, 2H), 3.00 (d, 2H), 4.00 (m, 4H), 4.18 (m, 1H), 4.36 (m, 1H), 4.68 (m, 4H), 5.17 (t, 1H), 5.28 (t, 1H), 5.35 (d, 1H), 5.41 (d, 1H), 5.68 (d, 1H), 6.24 (d, 1H), 6.98 (t, 2H), 7.18 (m, 10H), 7.31 (m, 2H), 7.53 (d, 1H), 7.90 (d, 1H).). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ −21.57 (m, 2P), −10.62 (m, 2P). MS (ES): <i>m</i>/<i>z</i> 1129.7 (M − H).</div></div><div id="sec4_6_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2-benzyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>52</b>)</h4><div class="NLM_p last">The free acid of <b>1</b> (10.0g, 28.8 mmol) was dissolved in trifluoroacetic acid (50 mL) and cooled to 0–5 °C followed by the addition of phenylacetaldehyde dimethyl acetal (13.5 mL, 88.5 mmol). Three additional portions of phenylacetaldehyde dimethyl acetal (2.5 mL, 15mmol) were added at 2 h, 2.75 h, and 3.5 h. The reaction was stirred for a total of 7 h, and the volatiles were removed in vacuo at <40 °C. The residue was partitioned between EtOAc and 0.75 M NaHCO<sub>3</sub>. The aqueous layer was back extracted with EtOAc, and the product in the aqueous layer was isolated by reverse-phase preparative HPLC. The yield of the title compound (<b>52</b>) was 7.5g (59%). <b>52</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.99 (d, 2H), 3.80(m, 2H), 4.32 (s, 1H), 4.82 (d, 1H), 5.07 (m, 1H), 5.28 (t, 1H), 5.72 (d, 1H), 7.17 (m, 5H), 7.99 (s, 1H), 8.09 (s, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 1.45 (s). MS (ES): <i>m</i>/<i>z</i> 448.3 (M − H). HPLC retention time (C<sub>18</sub>, ion pairing): 10.64 min (100%).</div></div><div id="sec4_6_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2-phenyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>53</b>)</h4><div class="NLM_p last">Compound <b>53</b> was prepared from <b>1</b> (free acid) according to the method for the synthesis of <b>52</b>, substituting benzaldehyde (3 equiv) for phenylacetaldehyde dimethyacetal. The yield of the title compound (<b>53</b>) was 92%, following reverse-phase preparative HPLC purification. The product consisted of a 50:50 ratio of acetal diastereomers, as determined by HPLC and NMR (MeOD). <b>53</b>: <sup>1</sup>H NMR (300 MHz, MeOD) δ 4.07 (m, 2H), 4.56 (m, 0.5H), 4.66 (m, 0.5H), 5.24 (m, 1H), 5.46 (m, 1H),6.00 (s, 0.5H), 6.24 (s, 0.5H), 6.36 (d, <i>J</i> = 3.0 Hz, 0.5H), 6.39 (d, <i>J</i> = 3.3 Hz, 0.5H), 7.39 (m, 3H), 7.52 (m, 1H), 7.58 (m, 1H), 8.20 (d, 1H), 8.49 (s, 0.5H), 8.56 (s, 0.5H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 1.58 (s 0.5P), 1.70 (s, 0.5P). MS (ES): <i>m</i>/<i>z</i> 434.5 (M − H). HPLC retention times (C<sub>18</sub>, ion pairing): 9.99 min (50%), 10.17 (50%).</div></div><div id="sec4_6_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-6-(6-Amino-9H-purin-9-yl)-2-styryltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>54</b>)</h4><div class="NLM_p last">Compound <b>54</b> was prepared from <b>1</b> (free acid) according to the method for the synthesis of <b>52</b>, substituting <i>trans</i>-cinnamaldehyde (2 equiv) for phenylacetaldehyde dimethyl acetal. Following overnight stirring at 0–5 °C, further portions of <i>trans</i>-cinnamaldehyde (4 × 0.9 equiv) were added over a 2 h period, to enhance the conversion to product. The yield of the title compound (<b>54</b>) was 51%, following preparative HPLC purification. The product consisted of a 66:33 ratio of acetal diastereomers, as determined by HPLC and NMR (MeOD). <b>54</b>: <sup>1</sup>H NMR (300 MHz, MeOD) δ 4.08 (m, 2H), 4.50 (m, 0.66H), 4.62 (m, 0.33H), 5.11 (dd, 0.33H), 5.18 (dd, 0.66H), 5.37 (m, 1H), 5.65 (d, <i>J</i> = 6.9 Hz, 0.33H), 5.89 (d, <i>J</i> = 6.3 Hz, 0.66H), 6.29 (m, 2H), 6.87 (d, <i>J</i> = 15.9 Hz, 1H), 7.33 (d, 3H), 7.47 (m, 2H), 8.22 (s, 1H), 8.49 (s, 0.66H), 8.56 (s, 0.33H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 1.17 (s 0.33P), 1.28 (s, 0.66P). MS (ES): <i>m</i>/<i>z</i> 460.6 (M − H) HPLC retention times (C<sub>18</sub>, ion pairing): 10.96 min (66%), 11.11 (33%).</div></div><div id="sec4_6_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-6-(6-Amino-9<i>H</i>-purin-9-yl)-2-(phenylethynyl)tetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>55</b>)</h4><div class="NLM_p last">Compound <b>55</b> was prepared from <b>1</b> (free acid) according to the method for the synthesis of <b>52</b>, substituting phenylpropargyl aldehyde (3 equiv) for phenylacetaldehyde dimethyl acetal. The reaction was stirred for three days at RT, giving a 36% yield of the title compound (<b>55</b>) following preparative HPLC purification. The product consisted of a 35:65 ratio of acetal diastereomers, as determined by HPLC and NMR (MeOD). <b>55</b>: <sup>1</sup>H NMR (300 MHz, MeOD) δ 4.09 (m, 2H), 4.56 (m, 0.33H), 4.76 (m, 0.66H), 5.19 (dd, 0.66H), 5.30 (dd, 0.33H), 5.42 (dd, 0.65H), 5.51 (dd, 0.35H), 6.08 (s, 0.65H), 6.29 (d, <i>J</i> = 3.3 Hz, 0.33H), 6.31 (s, 0.35H), 6.55 (d, <i>J</i> = 3.0 Hz, 0.66H), 7.38 (m, 4H), 7.54 (m, 1H), 8.22 (d, 1H), 8.51 (d, 1H) <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 1.35 (s). (MS (ES): <i>m</i>/<i>z</i> 458.4 (M − H) HPLC retention times (C<sub>18</sub>, ion pairing): 10.89 min (35%), 11.09 (65%).</div></div><div id="sec4_6_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> ((2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4-Dihydroxy-5-(6-(3-phenylureido)-9<i>H</i>-purin-9-yl)tetrahydrofuran-2-yl)methyl-dihydrogen Phosphate (<b>51</b>)</h4><div class="NLM_p last">Compound <b>51</b> was synthesized from <b>1</b> (NBu<sub>3</sub> salt) according to the method for the synthesis of <b>39</b>, using phenyl isocyanate (5 equiv). The yield of the title compound was 17%. The low yield of <b>51</b> was attributable to byproducts arising from the competitive acylation of the hydroxyl groups. <b>51</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 3.99 (, 3H), 4.23 (s, 1H), 4.34 (t, 1H), 4.58 (t, 1H), 5.97 (d, <i>J</i> = 5.4 Hz, 1H), 6.90 (t, 1H), 7.10 (t, 2H), 7.18 (d, 2H), 8.40 (s, 1H), 8.42 (s, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 1.65 (s).</div></div><div id="sec4_6_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-2-Benzyl-6-(6-(3-phenylureido)-9<i>H</i>-purin-9-yl)tetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>56</b>)</h4><div class="NLM_p last">Compound <b>52</b> and 1 NH<sub>4</sub> salt (5.0g, 10.7 mmol) were dissolved in DMF (20 mL) and tributylamine (5.11 mL, 21.4 mmol) added, stirred for 5 min, and then evaporated to an oil. This oil was dissolved in DMF (35 mL), and phenyl isocyanate (3.51 mL. 32.2 mmol) was added and the reaction heated to 30–35 °C overnight. The volatiles were evaporated, and the residue was partitioned between BuOAc (100 mL), toluene (200 mL), and water (300 mL). The aqueous layer was separated, concentrated, and the product purified by reverse-phase preparative HPLC. The purified yield of the title compound <b>56</b> following lyophilization was 3.3g (54%). <b>56</b>: <sup>1</sup>H NMR (300 MHz, MeOD) δ 3.14 (d, <i>J</i> = 4.5 Hz, 2H), 4.01 (m, 2H), 4.53 (s, 1H), 5.07 (d, 1H), 5.31 (m, 2H), 6.19 (d, <i>J</i> = 3.3 Hz, 1H), 7.11 (t, 1H), 7.29 (m, 7H), 7.61 (d, 2H), 8.69 (s, 1H), 8.81 (s, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 3.15 (s). MS (ES): <i>m</i>/<i>z</i> 567.2 (M − H). HPLC retention time (C<sub>18</sub>, ion pairing): 13.48 min (100%).</div></div><div id="sec4_6_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-2-Benzyl-6-(6-(3-hexylureido)-9<i>H</i>-purin-9-yl)tetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>57</b>)</h4><div class="NLM_p last">Compound <b>52</b> and 1 NH<sub>4</sub> salt (8.0g, 17.2 mmol) were dissolved in DMF (50 mL) and tributylamine (8.17 mL, 34.3 mmol) and the solution was concentrated to approximately one-half volume under vacuum to remove ammonia. Further DMF (25 mL) was added, after which <i>n</i>-hexylisocyanate (7.0 mL, 48.3 mmol) was added over 2 h, with vigorous stirring and at such a rate as to avoid solidification of the reaction mixture. The reaction was heated for 3 days at 35 °C and was concentrated to an oil. This residue was reconstituted in 1 M NaHCO<sub>3</sub> (20 mL) and water (300 mL), and the resulting suspension heated for 10 min at 50 °C in order to cleave any acylphosphate intermediates. The mixture was cooled, water (100 mL) and ether (200 mL) were added, and the layers were separated. The product containing the aqueous layer was concentrated to around 100 mL and an equal volume of acetonitrile added as an aid to solubility. The product was isolated by reverse-phase preparative HPLC. The yield of <b>57</b> was 5.2 g (52%). <b>57</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 0.76 (t, 3H), 1.17 (s, 6H), 1.38 (m, 2H), 2.94 (d, 2H), 3.09 (t, 2H), 3.80 (m, 2H), 4.38 (s, 1H), 4.85 (d, 1H), 5.07 (t, 1H), 5.25 (t, 1H), 5.82 (d, 1H), 7.12 (m, 5H), 8.26 (s, 1H), 8.44 (s, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 5.12 (s). MS (ES): <i>m</i>/<i>z</i> 575.3 (M − H). HPLC retention time (C<sub>18</sub>, ion pairing): 14.90 min (100%).</div></div><div id="sec4_6_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-2-Benzyl-6-(6-(3-ethylureido)-9<i>H</i>-purin-9-yl)tetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>58</b>)</h4><div class="NLM_p last">Compound <b>58</b> was prepared from <b>52</b> according to the method for the synthesis of <b>57</b>, substituting ethylisocyanate (6.5 equiv) for <i>n</i>-hexylisocyanate. The reaction was heated for a total of 3 days at 50 °C, then concentrated to an oil. Following alkaline treatment to cleave the transient acylphosphate species, the residue was partitioned between aqueous NaHCO<sub>3</sub> and ether. The products in the aqueous layer were separated by reverse-phase preparative HPLC, giving <b>58</b> in 47% yield. <b>58</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 1.06 (t, 3H), 2.98 (d, 2H), 3.20 (q, 2H), 3.83 (d, 2H), 4.36 (s, 1H), 4.84 (d, 1H), 5.10 (s, 1H), 5.28 (t, 1H), 5.74 (s, 1H), 7.17 (s, 5H), 8.19 (s, 1H), 8.28 (s, 1H).<sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 1.21 (s). MS (ES): <i>m</i>/<i>z</i> 519.2 (M − H). HPLC retention time (C<sub>18</sub>, ion pairing): 12.00 min (100%).</div></div><div id="sec4_6_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-2-Benzyl-6-(6-(3-cyclopentylureido)-9<i>H</i>-purin-9-yl)tetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>59</b>)</h4><div class="NLM_p last">Compound <b>59</b> was prepared from <b>52</b> according of the method for the synthesis of <b>57</b>, substituting cyclopentylisocyanate (12 equiv) for <i>n</i>-hexylisocyanate. The isocyanate was added in 4 equal portions, with heating at 50 °C over 6 days. The reaction was concentrated to an oil and treated with 1 M NaHCO<sub>3</sub> to cleave the transient acylphosphate species. This solution was partitioned between aqueous NaHCO<sub>3</sub> and ether, and the products in the aqueous layer were separated by reverse-phase preparative HPLC. The yield of <b>59</b> was 10%. <b>59</b>: <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) 1.54 (m, 4H), 1.67 (m, 2H), 1.88 (m, 2H), 3.04 (d, 2H), 3.75 (m, 2H), 4.06 (m, 1H), 4.38 (s, 1H), 4.96 (d, 1H), 5.24 (m, 2H), 6.15 (d, 1H), 7.23 (m, 5H), 8.53 (s, 1H), 8.74 (s, 1H), 9.4 (d, 1H), 9.60 (broad s, 1H). δ <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 1.49 (s). MS (ES): <i>m</i>/<i>z</i> 559.3 (M − H). HPLC retention time (C<sub>18</sub>, ion pairing): 13.50 min (100%).</div></div><div id="sec4_6_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-6-(6-(3-Ethylureido)-9<i>H</i>-purin-9-yl)-2-phenyltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>60</b>)</h4><div class="NLM_p last">Compound <b>60</b> was prepared from <b>53</b> according to the method for the synthesis of <b>57</b>, substituting ethylisocyanate (6 equiv) for <i>n</i>-hexylisocyanate. The reaction was heated at 35–40 °C for 4 days, with daily additions of the isocyanate (1.5 equiv × 4) over this time. The conversion by this time was around 92%. Following alkaline treatment to cleave the transient acylphosphate species, workup (aqueous NaHCO<sub>3</sub>/ether), and preparative HPLC, the yield of <b>60</b> was 86%. The product consisted of an approximately 60:40 ratio of acetal diastereomers (60:40 by NMR (MeOD); 56:44 by HPLC). <b>60</b>: <sup>1</sup>H NMR (300 MHz, MeOD) δ 1.26 (t, 3H), 3.41 (q, 2H), 4.06 (m, 2H), 4.61 (m, 0.6H), 4.70 (s, 0.4H), 5.28 (m, 1H), 5.51 (m, 1H), 6.02 (s, 0.4H), 6.27 (s, 0.6H), 6.47 (t, 1H), 7.40 (m, 3H), 7.52 (m, 1H), 7.59 (m, 1H), 8.56 (d, 1H), 8.72 (s, 0.6H), 8.81 (s, 0.4H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 1.39 (s, 0.5P), 1.54 (s, 0.5P). MS (ES): <i>m</i>/<i>z</i> 505.2 (M − H). HPLC retention time (C<sub>18</sub>, ion pairing): 11.58 min (56%), 11.95 min 44%).</div></div><div id="sec4_6_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-6-(6-(3-Ethylureido)-9<i>H</i>-purin-9-yl)-2-styryltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>61</b>)</h4><div class="NLM_p last">Compound <b>61</b> was prepared from <b>54</b> according to the method for the synthesis of <b>57</b>, substituting ethylisocyanate (7 equiv) for <i>n</i>-hexylisocyanate. The isocyanate was added in daily portions (1 equiv × 7), with heating at 30–35 °C over 7 days. The conversion by this time was around 65%. Following alkaline treatment to cleave the transient acylphosphate species, workup (aqueous NaHCO<sub>3</sub>/ether), and preparative HPLC, the yield of <b>61</b> was 50%. The product consisted of an approximately 66:33 ratio of acetal diastereomers (65:35 by NMR (MeOD); 66:33 by HPLC). <b>61</b>: <sup>1</sup>H NMR (300 MHz, MeOD) δ 1.26 (t, 3H), 3.41 (q, 2H), 4.07 (m, 2H), 4.54 (m, 0.65H), 4.65 (s, 0.35H), 5.14 (dd, 0.35H), 5.21 (dd, 0.65H), 5.38 (m, 1H), 5.65 (d, <i>J</i> = 6.6 Hz, 0.35H), 5.90 (d, <i>J</i> = 6.3 Hz, 0.65H), 6.21 (dd, <i>J</i> = 6.3 Hz, 0.65H), 6.39 (m, 1.35H), 6.89 (dd, 1H), 7.31 (m, 3H), 7.48 (m, 2H), 8.57 (d, 1H), 8.69 (s, 0.6H), 8.77 (s, 0.4H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 1.90 (s, 0.33P), 1.98 (s, 0.66P). MS (ES): <i>m</i>/<i>z</i> 531.2 (M − H). HPLC retention times (C<sub>18</sub>, ion pairing): 12.06 min (66%), 12.39 (33%).</div></div><div id="sec4_6_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> ((2<i>S</i>,3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-6-(6-(3-Ethylureido)-9<i>H</i>-purin-9-yl)-2-styryltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>62</b>)</h4><div class="NLM_p last">Compound <b>61</b> (50 mg; a 66% trans:33% cis mixture of diastereomers) was dissolved in 25% aqueous acetic acid (2 mL) and was warmed at 35 °C for 1.5 h. Ion pairing HPLC (see <a class="ref internalNav" href="#sec4_1" aria-label="General Methods">General Methods</a>) indicated that the less stable <i>cis</i>-acetal isomer was completely cleaved by this time, leaving a mixture of the trans diastereomer, the 2′,3′-diol arising from the cleavage of the cis diastereomer, and cinnamaldehyde. The products were separated and purified via preparative HPLC. Following lyophilization, the yield of title compound <b>62</b> was 23 mg (69.7%). <b>62</b>: <sup>1</sup>H NMR (300 MHz, MeOD) δ 1.26 (t, 3H), 3.41 (q, 2H), 4.03 (m, 2H), 4.56 (s, 1H), 5.24 (dd, 1H), 5.45 (dd, 1H), 5.91 (d, <i>J</i> = 6.0 Hz, 1H), 6.22 (dd, <i>J</i> = 6.0 Hz, <i>J</i> = 15.9 Hz, 1H), 6.40 (d, <i>J</i> = 3.3 Hz, 1H), 6.87 (d, <i>J</i> = 16.2 Hz, 1H), 7.29 (m, 3H), 7.46 (d, 2H), 8.56 (s, 1H), 8.92 (s, 1H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 1.29 (s). MS (ES): <i>m</i>/<i>z</i> 531.2 (M − H). HPLC retention time (C<sub>18</sub>, ion pairing): 12.12 min (100%).</div></div><div id="sec4_6_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-6-(6-(3-Hexylureido)-9<i>H</i>-purin-9-yl)-2-styryltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>63</b>)</h4><div class="NLM_p last">Compound <b>63</b> was prepared from <b>54</b> according to the method for the synthesis of <b>57</b>. <i>n</i>-Hexylisocyanate (4.3 equiv) was added and the reaction heated at 35 °C overnight. A further portion of <i>n</i>-hexylisocyanate (2.2 equiv) was added, and the reaction heated an additional 3 days. Following alkaline treatment, workup (aqueous NaHCO<sub>3</sub>/ether), and preparative HPLC, the yield of <b>63</b> was 38%. The product consisted of an approximately 75:25 ratio of acetal diastereomers (80:20 by NMR (D<sub>2</sub>O); 75:25 by HPLC). <b>63</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 0.69 (t, 3H), 1.19 (m, 6H), 1.44 (t, 2H), 3.18 (t, 2H), 3.85 (s, 2H), 4.46 (d, 1H), 5.05 (m, 1H), 5.25 (m, 0.2H), 5.30 (m, 0.8H), 5.60 (d, 0.2H), 5.80 (d, 0.8H), 6.07 (dd, 0.8H)), 6.22 (m, 1.2H), 6.76 (t, 1H), 7.20 (m, 3H), 7.29 (m, 2H), 8.37 (s, 1H), 8.48 (s, 0.8H), 8.57 (s, 0.2H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 4.99(s, 0.2P), 5.05 (s, 0.8P). MS (ES): <i>m</i>/<i>z</i> 587.4 (M − H). HPLC retention time (C<sub>18</sub>, ion pairing): 15.43 min (75%), 16.37 (25%).</div></div><div id="sec4_6_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-6-(6-(3-Phenylureido)-9<i>H</i>-purin-9-yl)-2-styryltetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>64</b>)</h4><div class="NLM_p last">Compound <b>64</b> was prepared from <b>54</b> according to the method for the synthesis of <b>56</b>. The reaction was allowed to stir at 40 °C for 2 days. Following workup and preparative HPLC, the yield of the title compound was 22%. The product consisted of an approximately 65:35 ratio of acetal diastereomers (66:33 by NMR (D<sub>2</sub>O); 65:35 by HPLC). <b>64</b>: <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 3.88 (m, 2H), 4.47 (d, 1H), 5.07 (m, 1H), 5.28 (m, 1H), 5.63 (d, <i>J</i> = 6.6 Hz, 0.33H), 5.81 (d, <i>J</i> =6.3 Hz, 0.66H), 6.19 (m, 2H), 6.78 (dd, 1H), 7.01 (t, 1H), 7.26 (m, 9H), 8.44 (s, 0.33H), 8.46 (s, 0.66H), 8.49 (s, 0.66H), 8.59 (s, 0.33H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 4.86 (s, 0.35P), 4.89 (s, 0.65P). MS (ES): <i>m</i>/<i>z</i> 579.3 (M − H). HPLC retention time (C<sub>18</sub>, ion pairing): 13.62 min (65%), 14.19 (35%).</div></div><div id="sec4_6_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-6-(6-(3-Hexylureido)-9<i>H</i>-purin-9-yl)-2-(phenylethynyl)tetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>65</b>)</h4><div class="NLM_p last">Compound <b>65</b> was prepared from <b>55</b> according to the method for the synthesis of <b>57</b>. <i>n</i>-Hexylisocyanate (4 equiv) was added in a single portion and the reaction heated at 80–85 °C overnight. Following alkaline treatment, workup (aqueous NaHCO<sub>3</sub>/ether), and preparative HPLC, the yield of <b>65</b> was 22%. The product consisted of an approximately 48:52 ratio of acetal diastereomers (45:55 by NMR (MeOD); 48:52 by HPLC). <b>65</b>: <sup>1</sup>H NMR (300 MHz, MeOD) δ 0.92 (t, 3H),1.37 (m, 6H), 1.64 (m, 2H), 3.38 (t, 2H), 4.07 (m, 2H), 4.60 (m, 0.45H),4.76 (m, 0.55H), 5.22 (dd, 0.55H), 5.34 (dd, 0.45H), 5.46 (dd, 0.55H), 5.56 (dd, 0.45H), 6.07 (s, 0.55H), 6.32 (s, 0.45H), 6.35 (d, <i>J</i> = 3.3 Hz, 0.45H), 6.65 (d, <i>J</i> = 3.3 Hz, 0.55H), 7.40 (m, 4H), 7.56 (m, 1H), 8.56 (d, 1H), 8.76 (s, 0.45H), 8.79 (s, 0.55H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 1.99 (s, 0.51P), 2.05 (s, 0.49P). MS (ES): <i>m</i>/<i>z</i> 585.4 (M − H). HPLC retention times (C<sub>18</sub>, ion pairing): 14.80 min (48%), 15.97 (52%).</div></div><div id="sec4_6_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> ((3a<i>S</i>,4<i>R</i>,6<i>R</i>,6a<i>S</i>)-2-(Phenylethynyl)-6-(6-(3-phenylureido)-9<i>H</i>-purin-9-yl)tetrahydrofuro[3,4-<i>d</i>][1,3]dioxol-4-yl)methyl-dihydrogen Phosphate (<b>66</b>)</h4><div class="NLM_p last">Compound <b>66</b> was prepared from <b>55</b> according to the method for the synthesis of <b>56</b>, using phenyl isocyanate (5 equiv). The reaction was heated overnight at 30–35 °C. Following workup and preparative HPLC, the yield of the title compound was 61%. The product consisted of a 50:50 ratio of acetal diastereomers (47:53 by NMR (MeOD); 49:51 by HPLC). <b>66</b>: <sup>1</sup>H NMR (300 MHz, MeOD) δ 4.05 (m, 2H), 4.64 (s, 0.47H), 4.76 (s, 0.53H), 5.25 (d, 0.52H), 5.39 (d, 0.48H), 5.48 (m, 0.52H), 5.58 (m, 0.48H), 6.04 (s, 0.53H), 6.33 (s, 0.47H), 6.39 (d, <i>J</i> = 3.3 Hz, 0.49H), 6.70 (d, <i>J</i> = 3.3 Hz, 0.51H), 7.11 (t, 1H), 7.40 (m, 6H), 7.59 (m, 3H), 8.67 (s, 1H), 9.02 (s, 0.47H), 9.05 (s, 0.53H). <sup>31</sup>P NMR (121.47 MHz, D<sub>2</sub>O) δ 5.07 (0.5P), 5.08 (0.5P). MS (ES): <i>m</i>/<i>z</i> 577.3 (M − H). HPLC retention times (C<sub>18</sub>, ion pairing): 13.59 min (49%), 14.42 (51%).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60"><a href="/doi/suppl/10.1021/jm701348d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12672" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12672" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last"><sup>1</sup>H NMR (D<sub>2</sub>O, 300 MHz) for compounds <b>11</b>, <b>13</b>, <b>18</b>, <b>21</b>, <b>53</b>−<b>56</b>, <b>59</b>–<b>62</b>, <b>65</b>, and <b>66</b>. NOE (D<sub>2</sub>O, 300 MHz) correlations for compounds <b>21</b>, <b>31</b>, <b>38</b>, <b>45</b>, <b>58</b>, and <b>62</b>. This material is available free of charge via the Internet at http://pubs.acs.org.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701348d/suppl_file/jm701348d-file003.pdf">jm701348d-file003.pdf (194.02 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm701348d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78578" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78578" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James G. Douglass</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#513b353e24363d30222211383f2221382334213930233c7f323e3c"><span class="__cf_email__" data-cfemail="b8d2dcd7cddfd4d9cbcbf8d1d6cbc8d1caddc8d0d9cad596dbd7d5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roshni I. Patel</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin R. Yerxa</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sammy R. Shaver</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul S. Watson</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Krzysztof Bednarski</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Plourde</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine C. Redick</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kurt Brubaker</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arthur C. Jones</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José L. Boyer</span> - <span class="hlFld-Affiliation affiliation">Departments of Chemistry and Molecular Pharmacology, Inspire Pharmaceuticals, Inc., 4222 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8466</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47700" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47700" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Aris Ragouzeos for performing the NOE experiments described in this article and for helpful discussions surrounding the data. We would also like to acknowledge Sanjoy Mahanty and Anna Morgan for performing some of the platelet aggregation studies.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 51 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Burnstock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">P2 purinergic receptors: modulation of cell function and therapeutic potential</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">869</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11082418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=862-869&author=G.+Burnstockauthor=M.+Williams&title=P2+purinergic+receptors%3A+modulation+of+cell+function+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">P2 purinergic receptors: modulation of cell function and therapeutic potential</span></div><div class="casAuthors">Burnstock, Geoffrey; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">862-869</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with 57 refs.  In addn. to its key role in cellular metab. where it acts as a ubiquitous enzyme cofactor and as the key source of cellular energy unique to phosphate bond Testing, the purine nucleotide ATP also functions as a potent extracellular messenger in producing its effects via the activation of a family of distinct cell surface receptors, the P2 receptor family.  The pyrimidine nucleotide UTP as well as the dinucleotides ADP and UDP also modulate cell function via P2 receptor activation and thus, ATP, UTP, ADP and UDP play key roles in a diversity of tissue functions that include fast excitatory neurotransmission, developmental processing, pulmonary function, nociception, auditory and ocular function, the apoptotic cascade, astroglial cell function, metastasis formation, bone and cartilage disease, and platelet aggregation/homeostasis.  Advances in mol. biol. of the P2 receptor family are now being used concurrently to identify novel ligand that have the potency, selectivity, and bioavailability to characterize P2 responses in animals and intact tissues and to better understand the role of this receptor family in tissue function and disease.  It will be important as new approaches to human therapeutics target P2 receptors that the multiplicity of actions assocd. with ATP-esp. in regard to mol. targets distinct form the P2 receptor family-are factored the functional responses obsd. in model systems with ATP and its analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0VUaEB6gAjbVg90H21EOLACvtfcHk0lh9JF4z0OGZDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKju7s%253D&md5=628b0969220bc9f2dbd2ea86f3441f14</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DP2%2520purinergic%2520receptors%253A%2520modulation%2520of%2520cell%2520function%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D862%26epage%3D869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">Purine and pyrimidine (P2) receptors as drug targets</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4057</span><span class="NLM_x">–</span> <span class="NLM_lpage">4093</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020046y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4057-4093&author=K.+A.+Jacobsonauthor=M.+F.+Jarvisauthor=M.+Williams&title=Purine+and+pyrimidine+%28P2%29+receptors+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm020046y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020046y%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJarvis%26aufirst%3DM.%2BF.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DPurine%2520and%2520pyrimidine%2520%2528P2%2529%2520receptors%2520as%2520drug%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4057%26epage%3D4093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Burnstock, G.</span><span> </span><span class="NLM_article-title">Potential therapeutic targets in the rapidly expanding field of purinergic signaling</span> <span class="citation_source-journal">Clin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1007%2Fs102380200006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11871639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A280%3ADC%252BD387js1yguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=45-53&author=G.+Burnstock&title=Potential+therapeutic+targets+in+the+rapidly+expanding+field+of+purinergic+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Potential therapeutic targets in the rapidly expanding field of purinergic signalling</span></div><div class="casAuthors">Burnstock G</div><div class="citationInfo"><span class="NLM_cas:title">Clinical medicine (London, England)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-53</span>
        ISSN:<span class="NLM_cas:issn">1470-2118</span>.
    </div><div class="casAbstract">The concept of a purinergic signalling system, using purine nucleotides and nucleosides as extracellular messengers, was first proposed over 30 years ago.  After a brief historical review and update of purinoceptor subtypes, this article focuses on the diverse physiological roles of adenosine triphosphate, adenosine diphosphate, uridine triphosphate and adenosine.  These molecules mediate short-term (acute) signalling functions in neurotransmission, secretion and vasodilation, and long-term (chronic) signalling functions in development, regeneration, proliferation and cell death.  Plasticity of purinoceptor expression in pathological conditions is frequently observed, including an increase in the purinergic component of parasympathetic nervous control of the human bladder in interstitial cystitis and outflow obstruction, and in sympathetic cotransmitter control of blood vessels in hypertensive rats.  The antithrombotic action of clopidogrel (Plavix), a P2Y12 receptor antagonist, has been shown to be particularly promising in the prevention of recurrent strokes and heart attacks in recent clinical trials (CAPRIE and CURE).  The role of P2X3 receptors in nociception and a new hypothesis concerning purinergic mechanosensory transduction in visceral pain will be considered, as will the therapeutic potential of purinergic agonists or antagonists for the treatment of supraventricular tachycardia, cancer, dry eye, bladder hyperactivity, erectile dysfunction, osteoporosis, diabetes, gut motility and vascular disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdks502CPyLPIW7hznt0zpfW6udTcc2eY-3XiT_5Ak5Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387js1yguw%253D%253D&md5=65c059c551faa73fccf0d946ef56a0aa</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs102380200006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs102380200006%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26atitle%3DPotential%2520therapeutic%2520targets%2520in%2520the%2520rapidly%2520expanding%2520field%2520of%2520purinergic%2520signaling%26jtitle%3DClin.%2520Med.%26date%3D2002%26volume%3D2%26spage%3D45%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Abbracchio, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnstock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeynaems, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnard, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumagalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisman, G. A.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1124%2Fpr.58.3.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=16968944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=281-341&author=M.+P.+Abbracchioauthor=G.+Burnstockauthor=J.+M.+Boeynaemsauthor=E.+A.+Barnardauthor=J.+L.+Boyerauthor=C.+Kennedyauthor=G.+E.+Knightauthor=M.+Fumagalliauthor=C.+Gachetauthor=K.+A.+Jacobsonauthor=G.+A.+Weisman&title=International+Union+of+Pharmacology+LVIII%3A+update+on+the+P2Y+G+protein-coupled+nucleotide+receptors%3A+from+molecular+mechanisms+and+pathophysiology+to+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy</span></div><div class="casAuthors">Abbracchio, Maria P.; Burnstock, Geoffrey; Boeynaems, Jean-Marie; Barnard, Eric A.; Boyer, Jose L.; Kennedy, Charles; Knight, Gillian E.; Fumagalli, Marta; Gachet, Christian; Jacobson, Kenneth A.; Weisman, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-341</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  There have been many advances in our knowledge about different aspects of P2Y receptor signaling since the last review published by our International Union of Pharmacol. subcommittee.  More receptor subtypes have been cloned and characterized and most orphan receptors deorphanized, so that it is now possible to provide a basis for a future subdivision of P2Y receptor subtypes.  More is known about the functional elements of the P2Y receptor mols. and the signaling pathways involved, including interactions with ion channels.  There have been substantial developments in the design of selective agonists and antagonists to some of the P2Y receptor subtypes.  There are new findings about the mechanisms underlying nucleotide release and ectoenzymic nucleotide breakdown.  Interactions between P2Y receptors and receptors to other signaling mols. have been explored as well as P2Y-mediated control of gene transcription.  The distribution and roles of P2Y receptor subtypes in many different cell types are better understood and P2Y receptor-related compds. are being explored for therapeutic purposes.  These and other advances are discussed in the present review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3-m5Cf-JzaLVg90H21EOLACvtfcHk0lg55vrxqLUBSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLbF&md5=b302ee34857a5f45d740e4f2e962ed42</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.3%26sid%3Dliteratum%253Aachs%26aulast%3DAbbracchio%26aufirst%3DM.%2BP.%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DBoeynaems%26aufirst%3DJ.%2BM.%26aulast%3DBarnard%26aufirst%3DE.%2BA.%26aulast%3DBoyer%26aufirst%3DJ.%2BL.%26aulast%3DKennedy%26aufirst%3DC.%26aulast%3DKnight%26aufirst%3DG.%2BE.%26aulast%3DFumagalli%26aufirst%3DM.%26aulast%3DGachet%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DWeisman%26aufirst%3DG.%2BA.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology%2520LVIII%253A%2520update%2520on%2520the%2520P2Y%2520G%2520protein-coupled%2520nucleotide%2520receptors%253A%2520from%2520molecular%2520mechanisms%2520and%2520pathophysiology%2520to%2520therapy%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D281%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Nichols, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yerxa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellerman, D. J.</span><span> </span><span class="NLM_article-title">Diquafosol tetrasodium: a novel dry eye therapy</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1517%2F13543784.13.1.47" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=14680452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVequ7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=47-54&author=K.+K.+Nicholsauthor=B.+Yerxaauthor=D.+J.+Kellerman&title=Diquafosol+tetrasodium%3A+a+novel+dry+eye+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Diquafosol tetrasodium: a novel dry eye therapy</span></div><div class="casAuthors">Nichols, Kelly K.; Yerxa, Ben; Kellerman, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-54</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The ophthalmic formulation of diquafosol tetrasodium (INS365), a P2Y2 receptor agonist, is targeted to treat dry eye disease through rehydration of the ocular surface.  Existing pharmacol. therapies for dry eye disease are limited, therefore, approval of this medication is anticipated.  This review summarizes key findings during development and in clin. trials including clin. effectiveness and safety.  The relevance of P2Y2 receptor technol. to dry eye disease and the disease process is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZv98y57kHe7Vg90H21EOLACvtfcHk0lgQq6bJcpVgiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVequ7k%253D&md5=e55e928b3e9fdefb96ff0e1237f867e2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543784.13.1.47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.13.1.47%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DK.%2BK.%26aulast%3DYerxa%26aufirst%3DB.%26aulast%3DKellerman%26aufirst%3DD.%2BJ.%26atitle%3DDiquafosol%2520tetrasodium%253A%2520a%2520novel%2520dry%2520eye%2520therapy%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D13%26spage%3D47%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Yerxa, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabater, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutts, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang-Furr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowlen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, R. C.</span><span> </span><span class="NLM_article-title">Pharmacology of INS37217 [P(1)-(uridine 5′)-P(4)- (2′-deoxycytidine 5′)tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">880</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1124%2Fjpet.102.035485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=12183642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsF2hs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2002&pages=871-880&author=B.+R.+Yerxaauthor=J.+R.+Sabaterauthor=C.+W.+Davisauthor=M.+J.+Stuttsauthor=M.+Lang-Furrauthor=M.+Picherauthor=A.+C.+Jonesauthor=M.+Cowlenauthor=R.+Doughertyauthor=J.+Boyerauthor=W.+M.+Abrahamauthor=R.+C.+Boucher&title=Pharmacology+of+INS37217+%5BP%281%29-%28uridine+5%E2%80%B2%29-P%284%29-+%282%E2%80%B2-deoxycytidine+5%E2%80%B2%29tetraphosphate%2C+tetrasodium+salt%5D%2C+a+next-generation+P2Y%282%29+receptor+agonist+for+the+treatment+of+cystic+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of INS37217 [P1-(uridine 5')-P4-(2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y2 receptor agonist for the treatment of cystic fibrosis</span></div><div class="casAuthors">Yerxa, B. R.; Sabater, J. R.; Davis, C. W.; Stutts, M. J.; Lang-Furr, M.; Picher, M.; Jones, A. C.; Cowlen, M.; Dougherty, R.; Boyer, J.; Abraham, W. M.; Boucher, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">871-880</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">INS37217 [P1-(uridine 5')-P4-(2'-deoxycytidine 5')tetraphosphate, tetrasodium salt] is a deoxycytidine-uridine dinucleotide with agonist activity at the P2Y2 receptor.  In primate lung tissues, the P2Y2 receptor mRNA was located by in situ hybridization predominantly in epithelial cells and not in smooth muscle or stromal tissue.  The pharmacol. profile of INS37217 parallels that of UTP, leading to increased chloride and water secretion, increased cilia beat frequency, and increased mucin release.  The combined effect of these actions was confirmed in an animal model of tracheal mucus velocity that showed that a single administration of INS37217 significantly enhanced mucus transport for at least 8 h after dosing.  This extended duration of action is consistent with the ability of INS37217 to resist metab. by airway cells and sputum enzymes.  The enhanced metabolic stability and resultant increased duration of improved mucociliary clearance may confer significant advantages to INS37217 over other P2Y2 agonists in the treatment of diseases such as cystic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-amp_4RhjqbVg90H21EOLACvtfcHk0lgQq6bJcpVgiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsF2hs7Y%253D&md5=c3730118238defb16024eeb0c29bab21</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.035485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.035485%26sid%3Dliteratum%253Aachs%26aulast%3DYerxa%26aufirst%3DB.%2BR.%26aulast%3DSabater%26aufirst%3DJ.%2BR.%26aulast%3DDavis%26aufirst%3DC.%2BW.%26aulast%3DStutts%26aufirst%3DM.%2BJ.%26aulast%3DLang-Furr%26aufirst%3DM.%26aulast%3DPicher%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DA.%2BC.%26aulast%3DCowlen%26aufirst%3DM.%26aulast%3DDougherty%26aufirst%3DR.%26aulast%3DBoyer%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DW.%2BM.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26atitle%3DPharmacology%2520of%2520INS37217%2520%255BP%25281%2529-%2528uridine%25205%25E2%2580%25B2%2529-P%25284%2529-%2520%25282%25E2%2580%25B2-deoxycytidine%25205%25E2%2580%25B2%2529tetraphosphate%252C%2520tetrasodium%2520salt%255D%252C%2520a%2520next-generation%2520P2Y%25282%2529%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520cystic%2520fibrosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D302%26spage%3D871%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hechler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenain, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchese, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vial, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazenave, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachet, C.</span><span> </span><span class="NLM_article-title">A role of the fast ATP-gated P2X<sub>1</sub> cation channel in thrombosis of small arteries in vivo</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">198</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1084%2Fjem.20030144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=12913094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1WisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2003&pages=661-667&author=B.+Hechlerauthor=N.+Lenainauthor=P.+Marcheseauthor=C.+Vialauthor=V.+Heimauthor=M.+Freundauthor=J.+P.+Cazenaveauthor=M.+Cattaneoauthor=Z.+M.+Ruggeriauthor=R.+Evansauthor=C.+Gachet&title=A+role+of+the+fast+ATP-gated+P2X1+cation+channel+in+thrombosis+of+small+arteries+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo</span></div><div class="casAuthors">Hechler, Beatrice; Lenain, Nadege; Marchese, Patrizia; Vial, Catherine; Heim, Veronique; Freund, Monique; Cazenave, Jean-Pierre; Cattaneo, Marco; Ruggeri, Zaverio M.; Evans, Richard; Gachet, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">661-667</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The P2X1 receptor is a fast ATP-gated cation channel expressed in blood platelets, where its role has been difficult to assess due to its rapid desensitization and the lack of pharmacol. tools.  In this paper, we have used P2X1-/- and wild-type mouse platelets, treated with apyrase to prevent desensitization, to demonstrate the function of P2X1 in the response to thrombogenic stimuli.  In vitro, the collagen-induced aggregation and secretion of P2X1-deficient platelets was decreased, as was adhesion and thrombus growth on a collagen-coated surface, particularly when the wall shear rate was elevated.  In vivo, the functional role of P2X1 could be demonstrated using two models of platelet-dependent thrombotic occlusion of small arteries, in which blood flow is characterized by a high shear rate.  The mortality of P2X1-/- mice in a model of systemic thromboembolism was reduced and the size of mural thrombi formed after a laser-induced vessel wall injury was decreased as compared with normal mice, whereas the time for complete thrombus removal was shortened.  Overall, the P2X1 receptor appears to contribute to the formation of platelet thrombi, particularly in arteries in which shear forces are high.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHh7SuXMrv7LVg90H21EOLACvtfcHk0lgQq6bJcpVgiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1WisLc%253D&md5=f71b408b4adee16a3f09f8f2b2daa65d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1084%2Fjem.20030144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20030144%26sid%3Dliteratum%253Aachs%26aulast%3DHechler%26aufirst%3DB.%26aulast%3DLenain%26aufirst%3DN.%26aulast%3DMarchese%26aufirst%3DP.%26aulast%3DVial%26aufirst%3DC.%26aulast%3DHeim%26aufirst%3DV.%26aulast%3DFreund%26aufirst%3DM.%26aulast%3DCazenave%26aufirst%3DJ.%2BP.%26aulast%3DCattaneo%26aufirst%3DM.%26aulast%3DRuggeri%26aufirst%3DZ.%2BM.%26aulast%3DEvans%26aufirst%3DR.%26aulast%3DGachet%26aufirst%3DC.%26atitle%3DA%2520role%2520of%2520the%2520fast%2520ATP-gated%2520P2X1%2520cation%2520channel%2520in%2520thrombosis%2520of%2520small%2520arteries%2520in%2520vivo%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2003%26volume%3D198%26spage%3D661%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Cattaneo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachet, C.</span><span> </span><span class="NLM_article-title">ADP receptors and clinical bleeding disorders</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2281</span><span class="NLM_x">–</span> <span class="NLM_lpage">2285</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=10521355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFGitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=2281-2285&author=M.+Cattaneoauthor=C.+Gachet&title=ADP+receptors+and+clinical+bleeding+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">ADP receptors and clinical bleeding disorders</span></div><div class="casAuthors">Cattaneo, Marco; Gachet, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2281-2285</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  ADP plays a key role in hemostasis and thrombosis.  Despite its early identification in 1961 as the first known aggregating agent, the mol. basis of ADP-induced platelet activation is only beginning to be understood.  The present review proposes a model of 3 purinergic receptors contributing sep. to the complex process of ADP-induced platelet aggregation: the P2X1 ionotropic receptor, responsible for rapid influx of ionized calcium into the cytosol; the P2Y1 metabotropic receptor, responsible for mobilization of ionized calcium from internal stores, which initiates aggregation; and an as-yet-unidentified P2Y receptor coupled to Gαi2, which is essential for the full aggregation response to ADP.  It is probable that this as-yet-unidentified receptor is the mol. target of the ADP-selective antiaggregating drugs ticlopidine and clopidogrel.  In addn., it is probably defective in patients with a bleeding diathesis that is characterized by selective impairment of platelet responses to ADP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhpn3cL0czd7Vg90H21EOLACvtfcHk0lgRMue6A_bJTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFGitrk%253D&md5=129bef84c60274c44fd8024b68fec686</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCattaneo%26aufirst%3DM.%26aulast%3DGachet%26aufirst%3DC.%26atitle%3DADP%2520receptors%2520and%2520clinical%2520bleeding%2520disorders%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D1999%26volume%3D19%26spage%3D2281%26epage%3D2285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hollopeter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantzen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishnan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurden, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conley, P. B.</span><span> </span><span class="NLM_article-title">Identification of the platelet ADP receptor targeted by antithrombotic drugs</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">409</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1038%2F35051599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11196645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFSktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=409&publication_year=2001&pages=202-207&author=G.+Hollopeterauthor=H.+M.+Jantzenauthor=D.+Vincentauthor=G.+Liauthor=L.+Englandauthor=V.+Ramakrishnanauthor=R.+B.+Yanauthor=A.+Nurdenauthor=D.+Juliusauthor=P.+B.+Conley&title=Identification+of+the+platelet+ADP+receptor+targeted+by+antithrombotic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the platelet ADP receptor targeted by antithrombotic drugs</span></div><div class="casAuthors">Hollopeter, Gunther; Jantzen, Hans-Michiel; Vincent, Diana; Li, Georgia; England, Laura; Ramakrishnan, Vanitha; Yang, Ruey-Bing; Nurden, Paquita; Nurden, Alan; Julius, David; Conley, Pamela B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">409</span>
        (<span class="NLM_cas:issue">6817</span>),
    <span class="NLM_cas:pages">202-207</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Platelets have a crucial role in the maintenance of normal hemostasis, and perturbations of this system can lead to pathol. thrombus formation and vascular occlusion, resulting in stroke; myocardial infarction and unstable angina.  ADP released from damaged vessels and red blood cells induces platelet aggregation through activation of the integrin GPIIb-IIIa and subsequent binding of fibrinogen.  ADP is also secreted from platelets on activation, providing pos. feedback that potentiates the actions of many platelet activators.  ADP mediates platelet aggregation through its action on two G-protein-coupled receptor subtypes.  The P2Y1 receptor couples to Gq and. mobilizes intracellular calcium ions to mediate platelet shape change and aggregation.  The second ADP receptor required for aggregation (variously called P2YADP, P2YAC, P2Ycyc or P2TAC) is coupled to the inhibition of adenylyl cyclase through Gi.  The mol. identity of the Gi-linked receptor is still elusive, even though it is the target of efficacious antithrombotic agents, such as ticlopidine and clopidogrel and AR-C66096. Here the authors describe the cloning of this receptor, designated P2Y12, and provide evidence that a patient with a bleeding disorder has a defect in this gene.  Cloning of the P2Y12 receptor should facilitate the development- of better antiplatelet agents to treat cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbNuDi2tNS7bVg90H21EOLACvtfcHk0lgRMue6A_bJTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFSktQ%253D%253D&md5=fe30017f0d3bd9aacb4ad3bd6189c5d9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F35051599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35051599%26sid%3Dliteratum%253Aachs%26aulast%3DHollopeter%26aufirst%3DG.%26aulast%3DJantzen%26aufirst%3DH.%2BM.%26aulast%3DVincent%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DEngland%26aufirst%3DL.%26aulast%3DRamakrishnan%26aufirst%3DV.%26aulast%3DYan%26aufirst%3DR.%2BB.%26aulast%3DNurden%26aufirst%3DA.%26aulast%3DJulius%26aufirst%3DD.%26aulast%3DConley%26aufirst%3DP.%2BB.%26atitle%3DIdentification%2520of%2520the%2520platelet%2520ADP%2520receptor%2520targeted%2520by%2520antithrombotic%2520drugs%26jtitle%3DNature%26date%3D2001%26volume%3D409%26spage%3D202%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gachet, C.</span><span> </span><span class="NLM_article-title">Identification, characterization, and inhibition of the platelet ADP receptors</span> <span class="citation_source-journal">Int. J. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11794691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVCktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2001&pages=375-381&author=C.+Gachet&title=Identification%2C+characterization%2C+and+inhibition+of+the+platelet+ADP+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Identification, characterization, and inhibition of the platelet ADP receptors</span></div><div class="casAuthors">Gachet, Christian</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Hematology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">IJHEEY</span>;
        ISSN:<span class="NLM_cas:issn">0925-5710</span>.
    
            (<span class="NLM_cas:orgname">Carden Jennings Publishing</span>)
        </div><div class="casAbstract">A review.  ADP (ADP) plays a crucial role in hemostasis and thrombosis, and its receptors are potential targets for antithrombotic drugs.  Two G-protein-coupled P2 receptors contribute to platelet aggregation: the P2Y1 receptor initiates aggregation through mobilization of calcium stores, whereas the P2Y12 receptor coupled to adenylyl cyclase inhibition is essential for a full aggregation response to ADP and the stabilization of aggregates.  The latter is defective in certain patients with a selective congenital deficiency of aggregation to ADP.  It is also the target of the antithrombotic drug clopidogrel and of ATP analogs and other compds. currently under evaluation.  In addn., the P2X1 ionotropic receptor is present in platelets, but its role is not yet completely known.  Studies in P2Y1-knockout mice and exptl. thrombosis models using selective P2Y1 antagonists have shown that the P2Y1 receptor, like the P2Y12 receptor, is a potential target for new antithrombotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVFgMG2VsVULVg90H21EOLACvtfcHk0lgRMue6A_bJTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVCktw%253D%253D&md5=c6cb4320d104c9bc181b7cd1803c5c90</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGachet%26aufirst%3DC.%26atitle%3DIdentification%252C%2520characterization%252C%2520and%2520inhibition%2520of%2520the%2520platelet%2520ADP%2520receptors%26jtitle%3DInt.%2520J.%2520Hematol.%26date%3D2001%26volume%3D74%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Dogne, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leval, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benoit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, J. L.</span><span> </span><span class="NLM_article-title">Recent advances in antiplatelet agents</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.2174%2F0929867024606948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11945125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD38XislGmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=577-589&author=J.+M.+Dogneauthor=X.+de+Levalauthor=P.+Benoitauthor=J.+Delargeauthor=B.+Masereelauthor=J.+L.+David&title=Recent+advances+in+antiplatelet+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in antiplatelet agents</span></div><div class="casAuthors">Dogne, Jean-Michel; De Leval, Xavier; Benoit, Patricia; Delarge, Jacques; Masereel, Bernard; David, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">577-589</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Platelet aggregation plays a key role in the pathogenesis of thromboembolic diseases such as myocardial infarction, stroke, unstable angina and peripheral artery disease.  Until recently, aspirin was the only antiplatelet agent available to prevent or treat these events.  Over the past several years, there has been a substantial expansion in the antiplatelet armamentarium as well as in the understanding of the clin. importance of antiplatelet therapy in limiting the complications of thrombosis.  Aspirin was one of the first agents to be adopted and it remains as the std. therapy with the higher amt. of available clin. information.  Following aspirin, ADP receptor antagonists like ticlopidine and clopidogrel as well as phosphodiesterase inhibitors dipyridamole and cilostazol have been introduced.  Glycoprotein (GP) IIb/IIIa receptor antagonists like eptifibatide, tirofiban and abciximab are the newer antiplatelet agents which act at the end of the common pathway of platelet aggregation.  Although results of clin. studies with the first oral GPIIb/IIIa antagonists were disappointing, agents of the new generation might expand the potential application of GPIIb/IIIa targeted therapy.  This review will highlight recent advances in the development of aspirin, phosphodiesterase inhibitors, ADP receptor antagonists and the platelet glycoprotein IIb/IIIa inhibitors.  The emphasis of this paper has been placed on the chem. aspects of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiRrsDrA0l5bVg90H21EOLACvtfcHk0ljrBjcgO8qgiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislGmt7s%253D&md5=87aa6ec800724fef1c385969d75cc407</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F0929867024606948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867024606948%26sid%3Dliteratum%253Aachs%26aulast%3DDogne%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BLeval%26aufirst%3DX.%26aulast%3DBenoit%26aufirst%3DP.%26aulast%3DDelarge%26aufirst%3DJ.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DDavid%26aufirst%3DJ.%2BL.%26atitle%3DRecent%2520advances%2520in%2520antiplatelet%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26spage%3D577%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ingall, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInally, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindon, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teobald, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clegg, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, W.</span><span> </span><span class="NLM_article-title">Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm981072s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFartg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=213-220&author=A.+H.+Ingallauthor=J.+Dixonauthor=A.+Baileyauthor=M.+E.+Coombsauthor=D.+Coxauthor=J.+I.+McInallyauthor=S.+F.+Huntauthor=N.+D.+Kindonauthor=B.+J.+Teobaldauthor=P.+A.+Willisauthor=R.+G.+Humphriesauthor=P.+Leffauthor=J.+A.+Cleggauthor=J.+A.+Smithauthor=W.+Tomlinson&title=Antagonists+of+the+platelet+P2T+receptor%3A+a+novel+approach+to+antithrombotic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonists of the Platelet P2T Receptor: A Novel Approach to Antithrombotic Therapy</span></div><div class="casAuthors">Ingall, Anthony H.; Dixon, John; Bailey, Andrew; Coombs, Mandy E.; Cox, David; McInally, Judith I.; Hunt, Simon F.; Kindon, Nicholas D.; Teobald, Barry J.; Willis, Paul A.; Humphries, Robert G.; Leff, Paul; Clegg, Jane A.; Smith, James A.; Tomlinson, Wendy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-220</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The platelet P2T receptor plays a major role in platelet aggregation, and its antagonists are predicted to have significant therapeutic potential as antithrombotic agents.  We have explored analogs of ATP, which is a weak, nonselective but competitive P2T receptor antagonist.  Modification of the polyphosphate side chain to prevent breakdown to the agonist ADP and substitution of the adenine moiety to enhance affinity and selectivity for the P2T receptor led to the identification of compd. AR-C67085MX, having an IC50 of 2.5 nM against ADP-induced aggregation of human platelets.  This compd. was the first very potent antagonist of the P2T receptor, with a selectivity for that subtype of the P2 receptor family of >1000-fold.  Further modification of the structure produced compd. AR-C69931MX having an IC50 of 0.4 nM.  In vivo, at maximally effective antithrombotic doses, there is little prolongation of bleeding time (1.4-fold), which is in marked contrast to the 5-6-fold found with GPIIb/IIIa antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMgNOWrXPnEbVg90H21EOLACvtfcHk0ljrBjcgO8qgiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFartg%253D%253D&md5=82328b71981a7200181f7719b74248f8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm981072s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm981072s%26sid%3Dliteratum%253Aachs%26aulast%3DIngall%26aufirst%3DA.%2BH.%26aulast%3DDixon%26aufirst%3DJ.%26aulast%3DBailey%26aufirst%3DA.%26aulast%3DCoombs%26aufirst%3DM.%2BE.%26aulast%3DCox%26aufirst%3DD.%26aulast%3DMcInally%26aufirst%3DJ.%2BI.%26aulast%3DHunt%26aufirst%3DS.%2BF.%26aulast%3DKindon%26aufirst%3DN.%2BD.%26aulast%3DTeobald%26aufirst%3DB.%2BJ.%26aulast%3DWillis%26aufirst%3DP.%2BA.%26aulast%3DHumphries%26aufirst%3DR.%2BG.%26aulast%3DLeff%26aufirst%3DP.%26aulast%3DClegg%26aufirst%3DJ.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DTomlinson%26aufirst%3DW.%26atitle%3DAntagonists%2520of%2520the%2520platelet%2520P2T%2520receptor%253A%2520a%2520novel%2520approach%2520to%2520antithrombotic%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D213%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Leon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hechler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vial, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazenave, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachet, C.</span><span> </span><span class="NLM_article-title">The P2Y<sub>1</sub> receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">403</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=1997&pages=26-30&author=C.+Leonauthor=B.+Hechlerauthor=C.+Vialauthor=C.+Lerayauthor=J.+P.+Cazenaveauthor=C.+Gachet&title=The+P2Y1+receptor+is+an+ADP+receptor+antagonized+by+ATP+and+expressed+in+platelets+and+megakaryoblastic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeon%26aufirst%3DC.%26aulast%3DHechler%26aufirst%3DB.%26aulast%3DVial%26aufirst%3DC.%26aulast%3DLeray%26aufirst%3DC.%26aulast%3DCazenave%26aufirst%3DJ.%2BP.%26aulast%3DGachet%26aufirst%3DC.%26atitle%3DThe%2520P2Y1%2520receptor%2520is%2520an%2520ADP%2520receptor%2520antagonized%2520by%2520ATP%2520and%2520expressed%2520in%2520platelets%2520and%2520megakaryoblastic%2520cells%26jtitle%3DFEBS%2520Lett.%26date%3D1997%26volume%3D403%26spage%3D26%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kauffenstein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hechler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazenave, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachet, C.</span><span> </span><span class="NLM_article-title">Adenine triphosphate nucleotides are antagonists at the P2Y receptor</span> <span class="citation_source-journal">Thromb. Haemost.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1980</span><span class="NLM_x">–</span> <span class="NLM_lpage">1988</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1111%2Fj.1538-7836.2004.00926.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFagsL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=1980-1988&author=G.+Kauffensteinauthor=B.+Hechlerauthor=J.+P.+Cazenaveauthor=C.+Gachet&title=Adenine+triphosphate+nucleotides+are+antagonists+at+the+P2Y+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Adenine triphosphate nucleotides are antagonists at the P2Y12 receptor</span></div><div class="casAuthors">Kauffenstein, G.; Hechler, B.; Cazenave, J.-P.; Gachet, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1980-1988</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The aim of the present study was to characterize the pharmacol. profile of the P2Y12 receptor for several adenine triphosphate nucleotides in view of their possible roles as partial agonists or true antagonists.  Two distinct cellular systems were used: P2Y1 receptor deficient mouse platelets (P2Y-/-1 platelets) previously shown to express a native and functional P2Y12 receptor and 1321 N1 astrocytoma cells stably expressing the human P2Y12 receptor (1321 N1 P2Y12).  ADP and its structural analogs inhibited cAMP accumulation in a dose-dependent manner in both P2Y-/-1 platelets and 1321 N1 P2Y12 cells with a similar rank order of potency, 2 methylthio-ADP (2MeSADP) > > ADP-Adenosine 5'-(βthio) diphosphate (ADPβS).  Com. ATP, 2 chloro-ATP (2ClATP) and 2 methylthio-ATP (2MeSATP) also inhibited cAMP accumulation in both cell systems.  In contrast, after creatine phosphate (CP)/creatine phosphokinase (CPK) regeneration, adenine triphosphate nucleotides lost their agonistic effect on P2Y-/-1 platelets and behaved as antagonists of ADP (0.5 μM)-induced adenylyl cyclase inhibition with IC50 of 13.5±4.8, 838±610, 1280±1246 μM for 2MeSATP, ATP and 2ClATP, resp.  In 1321 N1 P2Y12 cells, CP/CPK regenerated ATP and 2ClATP lost their agonistic effect only when CP/CPK was maintained during the cAMP assay.  The stable ATP analog ATPγS antagonized ADPβS-induced inhibition of cAMP accumulation in both P2Y-/-1 platelets and 1321 N1 P2Y12 cells.  Thus, ATP and its triphosphate analogs are not agonists but rather antagonists at the P2Y12 receptor expressed in platelets or transfected cells, provided care is taken to remove diphosphate contaminants and to prevent the generation of diphosphate nucleotide derivs. by cell Ectonucleotidases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI_kgO7RQAP7Vg90H21EOLACvtfcHk0lhBrPcrL_m6dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFagsL3N&md5=9e468ae6832bb040db72eb0985ac0d69</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2004.00926.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2004.00926.x%26sid%3Dliteratum%253Aachs%26aulast%3DKauffenstein%26aufirst%3DG.%26aulast%3DHechler%26aufirst%3DB.%26aulast%3DCazenave%26aufirst%3DJ.%2BP.%26aulast%3DGachet%26aufirst%3DC.%26atitle%3DAdenine%2520triphosphate%2520nucleotides%2520are%2520antagonists%2520at%2520the%2520P2Y%2520receptor%26jtitle%3DThromb.%2520Haemost.%26date%3D2004%26volume%3D2%26spage%3D1980%26epage%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Humphries, R. G.</span><span> </span><span class="NLM_article-title">Pharmacology of AR-C69931MX and related compounds: from pharmacological tools to clinical trials</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=66-72&author=R.+G.+Humphries&title=Pharmacology+of+AR-C69931MX+and+related+compounds%3A+from+pharmacological+tools+to+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHumphries%26aufirst%3DR.%2BG.%26atitle%3DPharmacology%2520of%2520AR-C69931MX%2520and%2520related%2520compounds%253A%2520from%2520pharmacological%2520tools%2520to%2520clinical%2520trials%26jtitle%3DHaematologica%26date%3D2000%26volume%3D85%26spage%3D66%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Greenbaum, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grines, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kereiakes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilchrist, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clegg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stankowski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grogan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuelsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, W. D.</span><span> </span><span class="NLM_article-title">Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: result from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial</span> <span class="citation_source-journal">Am. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">689e1</span><span class="NLM_x">–</span> <span class="NLM_lpage">689e10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2006&pages=689e1-689e10&author=A.+B.+Greenbaumauthor=C.+L.+Grinesauthor=J.+A.+Bittlauthor=R.+C.+Beckerauthor=D.+J.+Kereiakesauthor=I.+C.+Gilchristauthor=J.+Cleggauthor=J.+E.+Stankowskiauthor=D.+R.+Groganauthor=R.+A.+Harringtonauthor=H.+Emanuelssonauthor=W.+D.+Weaver&title=Initial+experience+with+an+intravenous+P2Y12+platelet+receptor+antagonist+in+patients+undergoing+percutaneous+coronary+intervention%3A+result+from+a+2-part%2C+phase+II%2C+multicenter%2C+randomized%2C+placebo-+and+active-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreenbaum%26aufirst%3DA.%2BB.%26aulast%3DGrines%26aufirst%3DC.%2BL.%26aulast%3DBittl%26aufirst%3DJ.%2BA.%26aulast%3DBecker%26aufirst%3DR.%2BC.%26aulast%3DKereiakes%26aufirst%3DD.%2BJ.%26aulast%3DGilchrist%26aufirst%3DI.%2BC.%26aulast%3DClegg%26aufirst%3DJ.%26aulast%3DStankowski%26aufirst%3DJ.%2BE.%26aulast%3DGrogan%26aufirst%3DD.%2BR.%26aulast%3DHarrington%26aufirst%3DR.%2BA.%26aulast%3DEmanuelsson%26aufirst%3DH.%26aulast%3DWeaver%26aufirst%3DW.%2BD.%26atitle%3DInitial%2520experience%2520with%2520an%2520intravenous%2520P2Y12%2520platelet%2520receptor%2520antagonist%2520in%2520patients%2520undergoing%2520percutaneous%2520coronary%2520intervention%253A%2520result%2520from%2520a%25202-part%252C%2520phase%2520II%252C%2520multicenter%252C%2520randomized%252C%2520placebo-%2520and%2520active-controlled%2520trial%26jtitle%3DAm.%2520Heart%2520J.%26date%3D2006%26volume%3D151%26spage%3D689e1%26epage%3D689e10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Husted, S.; Emanuelsson, H.; Heptinstall, S.; Clark, S.; Peters, G.</span> Greater and Less Variable Inhibition of Platelet Aggregation (IPA) with AZD6140, the First Oral Reversible ADP Receptor Antagonist, Compared with Clopidogrel in Patients with Atherosclerosis (The DISPERSE Study). Presented at European Society of Cardiology (ESC), Stockholm, Sweden, 7th September,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Husted%2C+S.%3B+Emanuelsson%2C+H.%3B+Heptinstall%2C+S.%3B+Clark%2C+S.%3B+Peters%2C+G.+Greater+and+Less+Variable+Inhibition+of+Platelet+Aggregation+%28IPA%29+with+AZD6140%2C+the+First+Oral+Reversible+ADP+Receptor+Antagonist%2C+Compared+with+Clopidogrel+in+Patients+with+Atherosclerosis+%28The+DISPERSE+Study%29.+Presented+at+European+Society+of+Cardiology+%28ESC%29%2C+Stockholm%2C+Sweden%2C+7th+September%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHusted%26aufirst%3DS.%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Scarborough, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laibelman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clizbe, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretto, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conley, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedlock, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantzen, H.</span><span> </span><span class="NLM_article-title">Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y(12))</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1805</span><span class="NLM_x">–</span> <span class="NLM_lpage">1808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1805-1808&author=R.+M.+Scarboroughauthor=A.+M.+Laibelmanauthor=L.+A.+Clizbeauthor=L.+J.+Frettoauthor=P.+B.+Conleyauthor=E.+E.+Reynoldsauthor=D.+M.+Sedlockauthor=H.+Jantzen&title=Novel+tricyclic+benzothiazolo%5B2%2C3-c%5Dthiadiazine+antagonists+of+the+platelet+ADP+receptor+%28P2Y%2812%29%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26aulast%3DLaibelman%26aufirst%3DA.%2BM.%26aulast%3DClizbe%26aufirst%3DL.%2BA.%26aulast%3DFretto%26aufirst%3DL.%2BJ.%26aulast%3DConley%26aufirst%3DP.%2BB.%26aulast%3DReynolds%26aufirst%3DE.%2BE.%26aulast%3DSedlock%26aufirst%3DD.%2BM.%26aulast%3DJantzen%26aufirst%3DH.%26atitle%3DNovel%2520tricyclic%2520benzothiazolo%255B2%252C3-c%255Dthiadiazine%2520antagonists%2520of%2520the%2520platelet%2520ADP%2520receptor%2520%2528P2Y%252812%2529%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1805%26epage%3D1808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Scarborough, R. W.; Grant, C. M.; Zhang, X.; Cannon, H.; Huang, W.; Mehrotra, M.</span> 4-(6-Halo-7-substituted-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl-5-chloro-thiophen-2-yl-sulfonylureas and Forms and Methods Related Thereto. PCT Intl. Pat. Appl. 2007/056219 May 18,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Scarborough%2C+R.+W.%3B+Grant%2C+C.+M.%3B+Zhang%2C+X.%3B+Cannon%2C+H.%3B+Huang%2C+W.%3B+Mehrotra%2C+M.+4-%286-Halo-7-substituted-2%2C4-dioxo-1%2C4-dihydro-2H-quinazolin-3-yl%29-phenyl-5-chloro-thiophen-2-yl-sulfonylureas+and+Forms+and+Methods+Related+Thereto.+PCT+Intl.+Pat.+Appl.+2007%2F056219+May+18%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DScarborough%26aufirst%3DR.%2BW.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Wang, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincelette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Cunha, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-McNulty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckman, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergona, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dole, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J.</span><span> </span><span class="NLM_article-title">A novel P2Y<sub>12</sub> adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models</span> <span class="citation_source-journal">Thromb. Haemost.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=17479197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvVGrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2007&pages=847-55&author=Y.+X.+Wangauthor=J.+Vinceletteauthor=V.+da+Cunhaauthor=B.+Martin-McNultyauthor=C.+Mallariauthor=R.+M.+Fitchauthor=S.+Alexanderauthor=I.+Islamauthor=B.+O.+Buckmanauthor=S.+Yuanauthor=J.+M.+Postauthor=B.+Subramanyamauthor=R.+Vergonaauthor=M.+E.+Sullivanauthor=W.+P.+Doleauthor=J.+Morserauthor=J.+Bryant&title=A+novel+P2Y12+adenosine+diphosphate+receptor+antagonist+that+inhibits+platelet+aggregation+and+thrombus+formation+in+rat+and+dog+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A novel P2Y12 adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models</span></div><div class="casAuthors">Wang, Yi-Xin; Vincelette, Jon; da Cunha, Valdeci; Martin-McNulty, Baby; Mallari, Cornell; Fitch, Richard M.; Alexander, Serene; Islam, Imadul; Buckman, Brad O.; Yuan, Shendong; Post, Joseph M.; Subramanyam, Babu; Vergona, Ronald; Sullivan, Mark E.; Dole, William P.; Morser, John; Bryant, Judi</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">847-855</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Irreversible platelet inhibitors, such as aspirin and clopidogrel, have limited antithrombotic efficacy in the clinic due to their bleeding risk.  We have developed an orally active reversible P2Y12 receptor antagonist, BX 667.  The aim of this study was to det. if the reversible antagonist BX 667 had a greater therapeutic index than the irreversible P2Y12 receptor antagonist clopidogrel.  Since BX 667 is rapidly converted to its active metabolite BX 048 in rats, we first injected BX 048 i.v. in a rat arterial venous (A-V) shunt model of thrombosis.  BX 048 dose- and concn.-dependently attenuated thrombosis.  When administered orally, BX 667 and clopidogrel had similar efficacy, but BX 667 caused less bleeding than clopidogrel.  In a rat model of a platelet-rich thrombus induced by vessel injury with FeCl2, both BX 667 and clopidogrel exhibited higher levels of thrombus inhibition after oral administration compared to their potency in the A-V shunt model.  Again, BX 667 caused less bleeding than clopidogrel.  In a dog cyclic flow model, i.v. injection of either BX 667 or clopidogrel dose-dependently reduced thrombus formation with lower bleeding for BX 667 than clopidogrel.  Inhibition of thrombosis was highly correlated with inhibition of ADP-induced platelet aggregation in these animal models.  In dogs pre-treated with aspirin, BX 667 maintained its wider therapeutic index, measured by inhibition of platelet aggregation over bleeding, compared to the aspirin-clopidogrel combination.  These data demonstrate that the reversible P2Y12 receptor antagonist, BX 667, has a wider therapeutic index than clopidogrel in exptl. models of thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA0dlxE8Vj3LVg90H21EOLACvtfcHk0lhySbljWcMbjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvVGrtb4%253D&md5=96a72e2264df899f95bbf91ee6a8a0a6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BX.%26aulast%3DVincelette%26aufirst%3DJ.%26aulast%3Dda%2BCunha%26aufirst%3DV.%26aulast%3DMartin-McNulty%26aufirst%3DB.%26aulast%3DMallari%26aufirst%3DC.%26aulast%3DFitch%26aufirst%3DR.%2BM.%26aulast%3DAlexander%26aufirst%3DS.%26aulast%3DIslam%26aufirst%3DI.%26aulast%3DBuckman%26aufirst%3DB.%2BO.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DPost%26aufirst%3DJ.%2BM.%26aulast%3DSubramanyam%26aufirst%3DB.%26aulast%3DVergona%26aufirst%3DR.%26aulast%3DSullivan%26aufirst%3DM.%2BE.%26aulast%3DDole%26aufirst%3DW.%2BP.%26aulast%3DMorser%26aufirst%3DJ.%26aulast%3DBryant%26aufirst%3DJ.%26atitle%3DA%2520novel%2520P2Y12%2520adenosine%2520diphosphate%2520receptor%2520antagonist%2520that%2520inhibits%2520platelet%2520aggregation%2520and%2520thrombus%2520formation%2520in%2520rat%2520and%2520dog%2520models%26jtitle%3DThromb.%2520Haemost.%26date%3D2007%26volume%3D97%26spage%3D847%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Harker, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boissel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilgrim, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gent, M.</span><span> </span><span class="NLM_article-title">Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events</span> <span class="citation_source-journal">Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.2165%2F00002018-199921040-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=10514023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADyaK1MXmslGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=325-335&author=L.+A.+Harkerauthor=J.+P.+Boisselauthor=A.+J.+Pilgrimauthor=M.+Gent&title=Comparative+safety+and+tolerability+of+clopidogrel+and+aspirin%3A+results+from+CAPRIE.+CAPRIE+Steering+Committee+and+Investigators.+Clopidogrel+versus+aspirin+in+patients+at+risk+of+ischaemic+events"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE</span></div><div class="casAuthors">Harker, Laurence A.; Boissel, Jean-Pierre; Pilgrim, Alison J.; Gent, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">325-335</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">The objective of this study was to provide a comprehensive comparison of the long term safety and tolerability of clopidogrel, a new ADP receptor antagonist that inhibits platelet activation induced by ADP, and aspirin (acetylsalicylic acid).  The study population comprised 19 185 patients with symptomatic atherosclerosis manifested as recent ischemic stroke, recent myocardial infarction or symptomatic peripheral arterial disease.  Patients were randomized to receive clopidogrel 75 mg/day or aspirin 325 mg/day for a min. of 1 yr and a max. of 3 yr.  Compared with aspirin, clopidogrel reduced the combined risk of ischemic stroke, myocardial infarction or vascular death by 8.7% (p = 0.043).  The incidence of early permanent discontinuations of the study drug due to adverse events was almost identical in both treatment groups (11.94% for clopidogrel vs. 11.92% for aspirin).  Reported neutropenia was similar in the clopidogrel and aspirin groups (0.10 vs. 0.17%, resp.) with corresponding rates (0.05 vs. 0.04%, resp.) for severe neutropenia.  Thrombocytopenia was identical in the clopidogrel and aspirin groups (0.26%), with the rates of severe thrombocytopenia being 0.19 vs. 0.10%, resp.  None of these obsd. differences was statistically significant.  The overall incidence of hemorrhagic events did not differ statistically significantly between treatment groups (9.27% for clopidogrel vs. 9.28% for aspirin; p = 0.98).  There was a trend towards a lower incidence of intracranial hemorrhage in the clopidogrel group (0.31%) compared with the aspirin group (0.42%).  Any reported gastrointestinal hemorrhage was significantly less frequent with clopidogrel (1.99%) than with aspirin (2.66%) [p < 0.002].  The corresponding data for severe gastrointestinal bleeding were 0.49 vs. 0.71%; p < 0.05.  Overall, there were significantly fewer gastrointestinal adverse events with clopidogrel than with aspirin (27.1 vs. 29.8%; p < 0.001), with less abdominal pain, dyspepsia, constipation, or peptic, gastric, or duodenal ulceration with clopidogrel.  Diarrhea was significantly more common in the clopidogrel group (4.46 vs. 3.36%; p<0.001), although the incidence of severe diarrhea (0.23 vs. 0.11%) was low and was not significantly different between groups.  There were significantly more patients with rash in the clopidogrel group (6.0%) compared with the aspirin group (4.6%) [p < 0.001].  However, these events were generally mild and transient in nature.  Given the favorable benefit/risk ratio, clopidogrel represents a clin. important advance in the treatment of patients with manifest atherosclerotic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWxjl3EauDS7Vg90H21EOLACvtfcHk0lhySbljWcMbjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslGhs7s%253D&md5=926618bb12abe8d13fcd6cb5cf9adb31</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2165%2F00002018-199921040-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-199921040-00007%26sid%3Dliteratum%253Aachs%26aulast%3DHarker%26aufirst%3DL.%2BA.%26aulast%3DBoissel%26aufirst%3DJ.%2BP.%26aulast%3DPilgrim%26aufirst%3DA.%2BJ.%26aulast%3DGent%26aufirst%3DM.%26atitle%3DComparative%2520safety%2520and%2520tolerability%2520of%2520clopidogrel%2520and%2520aspirin%253A%2520results%2520from%2520CAPRIE.%2520CAPRIE%2520Steering%2520Committee%2520and%2520Investigators.%2520Clopidogrel%2520versus%2520aspirin%2520in%2520patients%2520at%2520risk%2520of%2520ischaemic%2520events%26jtitle%3DDrug%2520Saf.%26date%3D1999%26volume%3D21%26spage%3D325%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Gent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easton, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hachinski, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbison, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicurella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turpie, A. G.</span><span> </span><span class="NLM_article-title">The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1215</span><span class="NLM_x">–</span> <span class="NLM_lpage">1220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1989&pages=1215-1220&author=M.+Gentauthor=J.+A.+Blakelyauthor=J.+D.+Eastonauthor=D.+J.+Ellisauthor=V.+C.+Hachinskiauthor=J.+W.+Harbisonauthor=E.+Panakauthor=R.+S.+Robertsauthor=J.+Sicurellaauthor=A.+G.+Turpie&title=The+Canadian+American+Ticlopidine+Study+%28CATS%29+in+thromboembolic+stroke"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGent%26aufirst%3DM.%26aulast%3DBlakely%26aufirst%3DJ.%2BA.%26aulast%3DEaston%26aufirst%3DJ.%2BD.%26aulast%3DEllis%26aufirst%3DD.%2BJ.%26aulast%3DHachinski%26aufirst%3DV.%2BC.%26aulast%3DHarbison%26aufirst%3DJ.%2BW.%26aulast%3DPanak%26aufirst%3DE.%26aulast%3DRoberts%26aufirst%3DR.%2BS.%26aulast%3DSicurella%26aufirst%3DJ.%26aulast%3DTurpie%26aufirst%3DA.%2BG.%26atitle%3DThe%2520Canadian%2520American%2520Ticlopidine%2520Study%2520%2528CATS%2529%2520in%2520thromboembolic%2520stroke%26jtitle%3DLancet%26date%3D1989%26volume%3D1%26spage%3D1215%26epage%3D1220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Bertrand, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershlick, A. H.</span><span> </span><span class="NLM_article-title">Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS)</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=624-629&author=M.+E.+Bertrandauthor=H.+J.+Rupprechtauthor=P.+Urbanauthor=A.+H.+Gershlick&title=Double-blind+study+of+the+safety+of+clopidogrel+with+and+without+a+loading+dose+in+combination+with+aspirin+compared+with+ticlopidine+in+combination+with+aspirin+after+coronary+stenting%3A+the+clopidogrel+aspirin+stent+international+cooperative+study+%28CLASSICS%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DM.%2BE.%26aulast%3DRupprecht%26aufirst%3DH.%2BJ.%26aulast%3DUrban%26aufirst%3DP.%26aulast%3DGershlick%26aufirst%3DA.%2BH.%26atitle%3DDouble-blind%2520study%2520of%2520the%2520safety%2520of%2520clopidogrel%2520with%2520and%2520without%2520a%2520loading%2520dose%2520in%2520combination%2520with%2520aspirin%2520compared%2520with%2520ticlopidine%2520in%2520combination%2520with%2520aspirin%2520after%2520coronary%2520stenting%253A%2520the%2520clopidogrel%2520aspirin%2520stent%2520international%2520cooperative%2520study%2520%2528CLASSICS%2529%26jtitle%3DCirculation%26date%3D2000%26volume%3D102%26spage%3D624%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Savi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereillo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzabiaga, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combalbert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffrand, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, J. M.</span><span> </span><span class="NLM_article-title">Identification and biological activity of the active metabolite of clopidogrel</span> <span class="citation_source-journal">Thromb. Haemost.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1055%2Fs-0037-1614133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11127873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFCjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2000&pages=891-896&author=P.+Saviauthor=J.+M.+Pereilloauthor=M.+F.+Uzabiagaauthor=J.+Combalbertauthor=C.+Picardauthor=J.+P.+Maffrandauthor=M.+Pascalauthor=J.+M.+Herbert&title=Identification+and+biological+activity+of+the+active+metabolite+of+clopidogrel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and biological activity of the active metabolite of clopidogrel</span></div><div class="casAuthors">Savi, P.; Pereillo, J. M.; Uzabiaga, M. F.; Combalbert, J.; Picard, C.; Maffrand, J. P.; Pascal, M.; Herbert, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">891-896</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">F. K. Schattauer Verlagsgesellschaft mbH</span>)
        </div><div class="casAbstract">Like ticlopidine, the ADP receptor antagonist clopidogrel is inactive in vitro and must be administered i.v. or orally to exhibit antiaggregatory and antithrombotic activities.  We have previously shown that hepatic metab. is necessary for activity.  This study demonstrates that an active metabolite can be generated from human liver microsomes incubated with clopidogrel.  Using several anal. methodologies (LC/MS, NMR, chiral supercrit. fluid chromatog.), we have identified its structure.  In vitro, this highly unstable compd., different from that formed from ticlopidine, exhibited all the biol. activities of clopidogrel obsd. ex vivo: Irreversible inhibition of the binding of 33P-2MeS-ADP to washed human platelets (IC50 = 0.53 μM), selective inhibition of ADP-induced platelet aggregation (IC50 = 1.8 μM) and ADP-induced adenylyl cyclase down-regulation.  The irreversible modification of the ADP-receptor site which is responsible for the biol. activity could be explained by the formation of a disulfide bridge between the reactive thiol group of the active metabolite and a cysteine residue of the platelet ADP receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp6q3TXPondbVg90H21EOLACvtfcHk0lgdTF5Ku3tJng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFCjsbs%253D&md5=822a367258ccea5111da1ad6e94847ca</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1055%2Fs-0037-1614133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0037-1614133%26sid%3Dliteratum%253Aachs%26aulast%3DSavi%26aufirst%3DP.%26aulast%3DPereillo%26aufirst%3DJ.%2BM.%26aulast%3DUzabiaga%26aufirst%3DM.%2BF.%26aulast%3DCombalbert%26aufirst%3DJ.%26aulast%3DPicard%26aufirst%3DC.%26aulast%3DMaffrand%26aufirst%3DJ.%2BP.%26aulast%3DPascal%26aufirst%3DM.%26aulast%3DHerbert%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520and%2520biological%2520activity%2520of%2520the%2520active%2520metabolite%2520of%2520clopidogrel%26jtitle%3DThromb.%2520Haemost.%26date%3D2000%26volume%3D84%26spage%3D891%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Nguyen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diodati, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pharand, C.</span><span> </span><span class="NLM_article-title">Resistance to clopidogrel: a review of the evidence</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1016%2Fj.jacc.2005.01.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=15837243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlagsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=1157-1164&author=T.+A.+Nguyenauthor=J.+G.+Diodatiauthor=C.+Pharand&title=Resistance+to+clopidogrel%3A+a+review+of+the+evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to clopidogrel: A review of the evidence</span></div><div class="casAuthors">Nguyen, Thuy Anh; Diodati, Jean G.; Pharand, Chantal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1157-1164</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Current available data show that about 4% to 30% of patients treated with conventional doses of clopidogrel do not display adequate antiplatelet response.  Clopidogrel resistance is a widely used term that remains to be clearly defined.  So far, it has been used to reflect failure of clopidogrel to achieve its antiaggregatory effect.  The interpatient variability in clopidogrel response is multifactorial.  It can be due to extrinsic or intrinsic mechanisms.  Among extrinsic mechanisms are the possibility of clopidogrel underdosing in patients undergoing stenting or with acute coronary syndrome, and drug-drug interactions involving CYP3A4.  Intrinsic mechanisms include genetic polymorphisms of the P2Y12 receptor and of the CYP3As, accrued release of ADP, or up-regulation of other platelet activation pathways.  Presently, there is no definite demonstration of an assocn. between low responsiveness to clopidogrel and thrombotic events.  The optimal level of clopidogrel-induced platelet inhibition, which will correlate quant. with clopidogrel's ability to prevent atherothrombotic events is still lacking.  Furthermore, because there is no single and validated platelet function assay to measure clopidogrel's antiplatelet effect, it is not justified to routinely look for clopidogrel resistance in the clin. setting.  This review discusses currently available evidence surrounding the variability in the antiplatelet response to clopidogrel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQhwpm4v6DQrVg90H21EOLACvtfcHk0lgdTF5Ku3tJng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlagsb8%253D&md5=83a7a7999b192cf3be07a1489719c755</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2005.01.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2005.01.034%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BA.%26aulast%3DDiodati%26aufirst%3DJ.%2BG.%26aulast%3DPharand%26aufirst%3DC.%26atitle%3DResistance%2520to%2520clopidogrel%253A%2520a%2520review%2520of%2520the%2520evidence%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2005%26volume%3D45%26spage%3D1157%26epage%3D1164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bennett, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carwile, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moake, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarantolo, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarode, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatfield, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, H. M.</span><span> </span><span class="NLM_article-title">Thrombotic thrombocytopenic purpura associated with clopidogrel</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">1773</span><span class="NLM_x">–</span> <span class="NLM_lpage">1777</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1056%2FNEJM200006153422402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=10852999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A280%3ADC%252BD3c3psVOqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2000&pages=1773-1777&author=C.+L.+Bennettauthor=J.+M.+Connorsauthor=J.+M.+Carwileauthor=J.+L.+Moakeauthor=W.+R.+Bellauthor=S.+R.+Tarantoloauthor=L.+J.+McCarthyauthor=R.+Sarodeauthor=A.+J.+Hatfieldauthor=M.+D.+Feldmanauthor=C.+J.+Davidsonauthor=H.+M.+Tsai&title=Thrombotic+thrombocytopenic+purpura+associated+with+clopidogrel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombotic thrombocytopenic purpura associated with clopidogrel</span></div><div class="casAuthors">Bennett C L; Connors J M; Carwile J M; Moake J L; Bell W R; Tarantolo S R; McCarthy L J; Sarode R; Hatfield A J; Feldman M D; Davidson C J; Tsai H M</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">1773-7</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  The antiplatelet drug clopidogrel is a new thienopyridine derivative whose mechanism of action and chemical structure are similar to those of ticlopidine.  The estimated incidence of ticlopidine-associated thrombotic thrombocytopenic purpura is 1 per 1600 to 5000 patients treated, whereas no clopidogrel-associated cases were observed among 20,000 closely monitored patients treated in phase 3 clinical trials and cohort studies.  Because of the association between ticlopidine use and thrombotic thrombocytopenic purpura and other adverse effects, clopidogrel has largely replaced ticlopidine in clinical practice.  More than 3 million patients have received clopidogrel.  We report the clinical and laboratory findings in 11 patients in whom thrombotic thrombocytopenic purpura developed during or soon after treatment with clopidogrel.  METHODS:  The 11 patients were identified by active surveillance by the medical directors of blood banks (3 patients), hematologists (6), and the manufacturer of clopidogrel (2).  RESULTS:  Ten of the 11 patients received clopidogrel for 14 days or less before the onset of thrombotic thrombocytopenic purpura.  Although 10 of the 11 patients had a response to plasma exchange, 2 required 20 or more exchanges before clinical improvement occurred, and 2 had relapses while not receiving clopidogrel.  One patient died despite undergoing plasma exchange soon after diagnosis.  CONCLUSIONS:  Thrombotic thrombocytopenic purpura can occur after the initiation of clopidogrel therapy, often within the first two weeks of treatment.  Physicians should be aware of the possibility of this syndrome when initiating clopidogrel treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXveYHTxkPEGhHGZei4OW9fW6udTcc2eZFPvfJA6JHjrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3psVOqsg%253D%253D&md5=f37c00b9885e7ad857224952340546b8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1056%2FNEJM200006153422402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200006153422402%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DC.%2BL.%26aulast%3DConnors%26aufirst%3DJ.%2BM.%26aulast%3DCarwile%26aufirst%3DJ.%2BM.%26aulast%3DMoake%26aufirst%3DJ.%2BL.%26aulast%3DBell%26aufirst%3DW.%2BR.%26aulast%3DTarantolo%26aufirst%3DS.%2BR.%26aulast%3DMcCarthy%26aufirst%3DL.%2BJ.%26aulast%3DSarode%26aufirst%3DR.%26aulast%3DHatfield%26aufirst%3DA.%2BJ.%26aulast%3DFeldman%26aufirst%3DM.%2BD.%26aulast%3DDavidson%26aufirst%3DC.%2BJ.%26aulast%3DTsai%26aufirst%3DH.%2BM.%26atitle%3DThrombotic%2520thrombocytopenic%2520purpura%2520associated%2520with%2520clopidogrel%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2000%26volume%3D342%26spage%3D1773%26epage%3D1777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Weerakkody, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naganuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, K. J.</span><span> </span><span class="NLM_article-title">Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: an integrated analysis</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1177%2F1074248407304731" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=205-12&author=G.+J.+Weerakkodyauthor=J.+A.+Jakubowskiauthor=J.+T.+Brandtauthor=C.+D.+Payneauthor=H.+Naganumaauthor=K.+J.+Winters&title=Greater+inhibition+of+platelet+aggregation+and+reduced+response+variability+with+prasugrel+versus+clopidogrel%3A+an+integrated+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1177%2F1074248407304731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1074248407304731%26sid%3Dliteratum%253Aachs%26aulast%3DWeerakkody%26aufirst%3DG.%2BJ.%26aulast%3DJakubowski%26aufirst%3DJ.%2BA.%26aulast%3DBrandt%26aufirst%3DJ.%2BT.%26aulast%3DPayne%26aufirst%3DC.%2BD.%26aulast%3DNaganuma%26aufirst%3DH.%26aulast%3DWinters%26aufirst%3DK.%2BJ.%26atitle%3DGreater%2520inhibition%2520of%2520platelet%2520aggregation%2520and%2520reduced%2520response%2520variability%2520with%2520prasugrel%2520versus%2520clopidogrel%253A%2520an%2520integrated%2520analysis%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%2520Ther.%26date%3D2007%26volume%3D3%26spage%3D205%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Tantry, U. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliden, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurbel, P. A.</span><span> </span><span class="NLM_article-title">Prasugrel</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=1627-33&author=U.+S.+Tantryauthor=K.+P.+Blidenauthor=P.+A.+Gurbel&title=Prasugrel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTantry%26aufirst%3DU.%2BS.%26aulast%3DBliden%26aufirst%3DK.%2BP.%26aulast%3DGurbel%26aufirst%3DP.%2BA.%26atitle%3DPrasugrel%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D15%26spage%3D1627%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Zamecnik, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeway, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randerath, K.</span><span> </span><span class="NLM_article-title">Enzymatic synthesis of diadenosine tetraphosphate and diadenosine triphosphat with a purified lysyl-sRNA synthetase</span> <span class="citation_source-journal">Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1016%2F0006-291X%2866%2990415-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=5338216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADyaF28XksV2jtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1966&pages=91-97&author=P.+C.+Zamecnikauthor=M.+L.+Stephensonauthor=C.+M.+Janewayauthor=K.+Randerath&title=Enzymatic+synthesis+of+diadenosine+tetraphosphate+and+diadenosine+triphosphat+with+a+purified+lysyl-sRNA+synthetase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymic synthesis of diadenosine tetraphosphate and diadenosine triphosphate with a purified lysyl-sRNA synthetase</span></div><div class="casAuthors">Zamecnik, Paul C.; Stephenson, Mary L.; Janeway, Claude M.; Randerath, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-7</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">An optical rotatory dispersion study was employed to det. a possible change in conformation of L-lysine:sRNA (sol. RNA) ligase which is involved in L-lysine (I) activation for protein synthesis.  During I activation, the Cotton effect developed during a 30 min. incubation at 37°.  The appearance of this Cotton effect was dependent on the presence of lysyl-sRNA synthetase, I, ATP, and Mg2+.  The Cotton effect increased by increasing ATP concn. and by addn. of pyrophosphatase.  The material which was responsible for causing the Cotton effect was dialyzed, purified by thin-layer chromatography on poly(ethylenimine)-cellulose, and identified as P1,P4-di-51-adenosine-tetraphosphate (II).  A smaller amt. of P1,P3-di-51-adenosine triphosphate was also found.  II could be formed in small amts. from ATP in the presence of a purified (but not homogeneous) prepn. of Escherichia coli lysyl-sRNA synthetase.  It was maximally formed when a small amt. of E. coli sRNA (unfractionated) was added to an incubation medium contg. I, Tris buffer (pH 7.8), Mg2+, and ATP.  Under these conditions, the formation of II was strictly dependent on I  The reaction for the synthesis of II was reversible.  A possible involvement and the mechanism of formation of II during I activation for protein synthesis is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIJm2AcuUyYbVg90H21EOLACvtfcHk0liFb_Yj6IUJhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28XksV2jtbs%253D&md5=f23fa079eb11e222b82a96afb2783b0b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2866%2990415-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252866%252990415-3%26sid%3Dliteratum%253Aachs%26aulast%3DZamecnik%26aufirst%3DP.%2BC.%26aulast%3DStephenson%26aufirst%3DM.%2BL.%26aulast%3DJaneway%26aufirst%3DC.%2BM.%26aulast%3DRanderath%26aufirst%3DK.%26atitle%3DEnzymatic%2520synthesis%2520of%2520diadenosine%2520tetraphosphate%2520and%2520diadenosine%2520triphosphat%2520with%2520a%2520purified%2520lysyl-sRNA%2520synthetase%26jtitle%3DBiophys.%2520Res.%2520Commun.%26date%3D1966%26volume%3D24%26spage%3D91%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Pintor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotllan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miras-Portugal, M. T.</span><span> </span><span class="NLM_article-title">Characterization and quantification of diadenosine hexaphosphate in chromaffin cells: granular storage and secretagogue-induced release</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">200</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=1992&pages=296-300&author=J.+Pintorauthor=P.+Rotllanauthor=M.+Torresauthor=M.+T.+Miras-Portugal&title=Characterization+and+quantification+of+diadenosine+hexaphosphate+in+chromaffin+cells%3A+granular+storage+and+secretagogue-induced+release"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPintor%26aufirst%3DJ.%26aulast%3DRotllan%26aufirst%3DP.%26aulast%3DTorres%26aufirst%3DM.%26aulast%3DMiras-Portugal%26aufirst%3DM.%2BT.%26atitle%3DCharacterization%2520and%2520quantification%2520of%2520diadenosine%2520hexaphosphate%2520in%2520chromaffin%2520cells%253A%2520granular%2520storage%2520and%2520secretagogue-induced%2520release%26jtitle%3DAnal.%2520Biochem.%26date%3D1992%26volume%3D200%26spage%3D296%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Rotllan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miras-Portugal, M. T.</span><span> </span><span class="NLM_article-title">Adenosine kinase from bovine adrenal medulla</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1111%2Fj.1432-1033.1985.tb09110.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=2992963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADyaL2MXltlOmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1985&pages=365-71&author=P.+Rotllanauthor=M.+T.+Miras-Portugal&title=Adenosine+kinase+from+bovine+adrenal+medulla"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine kinase from bovine adrenal medulla</span></div><div class="casAuthors">Rotllan, Pedro; Miras Portugal, Maria Teresa</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">365-71</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Adenosine kinase from bovine adrenal medulla was purified 1600-fold by using (NH4)2SO4 pptn., gel filtration, and affinity chromatog.  Gel filtration yielded a mol. wt. of ∼42,000 and Km values of 0.2 μM for adenosine and 20 μM for MgATP.  The enzyme showed a broad specificity for purine nucleoside triphosphates as phosphate donors.  Both free Mg2+ and ATP were inhibitors.  AMP was a competitive inhibitor with regard to adenosine and a noncompetitive inhibitor vs. MgATP, whereas ADP was a uncompetitive inhibitor with regard to adenosine and a noncompetitive inhibitor vs. MgATP.  Adenosine kinase was strongly inhibited by the bis(adenylyl)polyphosphates, Ap4A and Ap5A.  These compds. inhibited the enzyme competitively vs. MgATP (Ki = 0.06 μM for Ap4A and 0.4 μM for Ap5A) and uncompetitively with regard to adenosine.  The results of the kinetic anal. suggest an ordered bi-bi mechanism, with adenosine being the 1st substrate.  The phosphorylation of adenosine was unaffected by the presence of vanadate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopWGivyTmseLVg90H21EOLACvtfcHk0ljMW7AamaV2SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXltlOmtro%253D&md5=a1a8586c4cf55ce577bdf3dffa7e7c77</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1985.tb09110.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1985.tb09110.x%26sid%3Dliteratum%253Aachs%26aulast%3DRotllan%26aufirst%3DP.%26aulast%3DMiras-Portugal%26aufirst%3DM.%2BT.%26atitle%3DAdenosine%2520kinase%2520from%2520bovine%2520adrenal%2520medulla%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1985%26volume%3D151%26spage%3D365%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Hilderman, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, E. F.</span><span> </span><span class="NLM_article-title">P1,P4-diadenosine 5′ tetraphosphate induces nitric oxide release from bovine aortic endothelial cells</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=1998&pages=320-324&author=R.+H.+Hildermanauthor=E.+F.+Christensen&title=P1%2CP4-diadenosine+5%E2%80%B2+tetraphosphate+induces+nitric+oxide+release+from+bovine+aortic+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHilderman%26aufirst%3DR.%2BH.%26aulast%3DChristensen%26aufirst%3DE.%2BF.%26atitle%3DP1%252CP4-diadenosine%25205%25E2%2580%25B2%2520tetraphosphate%2520induces%2520nitric%2520oxide%2520release%2520from%2520bovine%2520aortic%2520endothelial%2520cells%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D427%26spage%3D320%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Pintor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Hernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualix, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Villafuertes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernando, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miras-Portugal, M. T.</span><span> </span><span class="NLM_article-title">Diadenosine polyphosphate receptors. from rat and guinea-pig brain to human nervous system</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1016%2FS0163-7258%2800%2900049-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11007994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslOjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2000&pages=103-115&author=J.+Pintorauthor=M.+Diaz-Hernandezauthor=J.+Gualixauthor=R.+Gomez-Villafuertesauthor=F.+Hernandoauthor=M.+T.+Miras-Portugal&title=Diadenosine+polyphosphate+receptors.+from+rat+and+guinea-pig+brain+to+human+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Diadenosine polyphosphate receptors from rat and guinea-pig brain to human nervous system</span></div><div class="casAuthors">Pintor, J.; Diaz-Hernandez, M.; Gualix, J.; Gomez-Villafuertes, R.; Hernando, F.; Miras-Portugal, M. T.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">103-115</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with ∼87 refs.  Diadenosine polyphosphates are a family of naturally occurring nucleotidic compds. present in secretory vesicles together with other chem. messengers.  The exocytotic release of these compds. permits them to stimulate receptors termed "purinoceptors" or "ATP receptors.  " Purinoceptors for nucleotides are named P2 in contrast with those sensitive to nucleosides (P1).  P2 receptors are further subdivided into metabotropic P2Y receptors, further divided into 5 subtypes, and ionotropic P2X receptors, with 7 different subtypes.  Diadenosine polyphosphates can activate recombinant P2Y1, P2Y2, and P2Y4 and recombinant homomeric P2X1, P2X2, P2X3, P2X4, and P2X6.  Heteromeric P2X receptors change their sensitivity to diadenosine polyphosphates when co-assembly between different subunits occurs.  Diadenosine polyphosphates can activate specific receptors termed dinucleotide receptors or P4 receptors, which are insensitive to other nucleosides or nucleotides.  The P4 receptor is a receptor-operated Ca2+ channel present in rat brain synaptic terminals, stimulated by diadenosine pentaphosphate and diadenosine tetraphosphate.  This receptor is strongly modulated by protein kinases A and C and protein phosphatases.  The dinucleotide receptor is present in different brain areas, such as midbrain (in rat and guinea pig), cerebellum (in guinea pig), and cortex (in human).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppyWJKgXiysLVg90H21EOLACvtfcHk0ljMW7AamaV2SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslOjtb4%253D&md5=23d6f1bef8f4a9b0de122be16c2a2743</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2800%2900049-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252800%252900049-8%26sid%3Dliteratum%253Aachs%26aulast%3DPintor%26aufirst%3DJ.%26aulast%3DDiaz-Hernandez%26aufirst%3DM.%26aulast%3DGualix%26aufirst%3DJ.%26aulast%3DGomez-Villafuertes%26aufirst%3DR.%26aulast%3DHernando%26aufirst%3DF.%26aulast%3DMiras-Portugal%26aufirst%3DM.%2BT.%26atitle%3DDiadenosine%2520polyphosphate%2520receptors.%2520from%2520rat%2520and%2520guinea-pig%2520brain%2520to%2520human%2520nervous%2520system%26jtitle%3DPharmacol.%2520Ther.%26date%3D2000%26volume%3D87%26spage%3D103%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Harrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brossmer, R.</span><span> </span><span class="NLM_article-title">Inhibition of platelet aggregation and the platelet release reaction by alpha, omega diadenosine polyphosphates</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1975&pages=57-60&author=M.+J.+Harrisonauthor=R.+Brossmer&title=Inhibition+of+platelet+aggregation+and+the+platelet+release+reaction+by+alpha%2C+omega+diadenosine+polyphosphates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DM.%2BJ.%26aulast%3DBrossmer%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520platelet%2520aggregation%2520and%2520the%2520platelet%2520release%2520reaction%2520by%2520alpha%252C%2520omega%2520diadenosine%2520polyphosphates%26jtitle%3DFEBS%2520Lett.%26date%3D1975%26volume%3D54%26spage%3D57%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Rapaport, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamecnik, P. C.</span><span> </span><span class="NLM_article-title">Presence of diadenosine 5′,5′′′-P1, P4-tetraphosphate (Ap4A) in mamalian cells in levels varying widely with proliferative activity of the tissue: a possible positive “pleiotypic activator”</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">3984</span><span class="NLM_x">–</span> <span class="NLM_lpage">3988</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1976&pages=3984-3988&author=E.+Rapaportauthor=P.+C.+Zamecnik&title=Presence+of+diadenosine+5%E2%80%B2%2C5%E2%80%B2%E2%80%B2%E2%80%B2-P1%2C+P4-tetraphosphate+%28Ap4A%29+in+mamalian+cells+in+levels+varying+widely+with+proliferative+activity+of+the+tissue%3A+a+possible+positive+%E2%80%9Cpleiotypic+activator%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRapaport%26aufirst%3DE.%26aulast%3DZamecnik%26aufirst%3DP.%2BC.%26atitle%3DPresence%2520of%2520diadenosine%25205%25E2%2580%25B2%252C5%25E2%2580%25B2%25E2%2580%25B2%25E2%2580%25B2-P1%252C%2520P4-tetraphosphate%2520%2528Ap4A%2529%2520in%2520mamalian%2520cells%2520in%2520levels%2520varying%2520widely%2520with%2520proliferative%2520activity%2520of%2520the%2520tissue%253A%2520a%2520possible%2520positive%2520%25E2%2580%259Cpleiotypic%2520activator%25E2%2580%259D%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1976%26volume%3D73%26spage%3D3984%26epage%3D3988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Chan, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamecnik, P. C.</span><span> </span><span class="NLM_article-title">P1,P4-dithio-P2,P3-monochloromethylene diadenosine 5′,5′′′-P1,P4-tetraphosphate: a novel antiplatelet agent</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">4034</span><span class="NLM_x">–</span> <span class="NLM_lpage">4039</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=4034-4039&author=S.+W.+Chanauthor=S.+J.+Galloauthor=B.+K.+Kimauthor=M.+J.+Guoauthor=G.+M.+Blackburnauthor=P.+C.+Zamecnik&title=P1%2CP4-dithio-P2%2CP3-monochloromethylene+diadenosine+5%E2%80%B2%2C5%E2%80%B2%E2%80%B2%E2%80%B2-P1%2CP4-tetraphosphate%3A+a+novel+antiplatelet+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DS.%2BW.%26aulast%3DGallo%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DB.%2BK.%26aulast%3DGuo%26aufirst%3DM.%2BJ.%26aulast%3DBlackburn%26aufirst%3DG.%2BM.%26aulast%3DZamecnik%26aufirst%3DP.%2BC.%26atitle%3DP1%252CP4-dithio-P2%252CP3-monochloromethylene%2520diadenosine%25205%25E2%2580%25B2%252C5%25E2%2580%25B2%25E2%2580%25B2%25E2%2580%25B2-P1%252CP4-tetraphosphate%253A%2520a%2520novel%2520antiplatelet%2520agent%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D4034%26epage%3D4039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Bhattacharyya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerzmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feig, A. L.</span><span> </span><span class="NLM_article-title">Fluorescent analogs of UDP-glucose and their use in characterizing substrate binding by toxin A from Clostridium difficile</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">3425</span><span class="NLM_x">–</span> <span class="NLM_lpage">3432</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1046%2Fj.1432-1033.2002.03013.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=12135481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtF2hurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=2002&pages=3425-3432&author=S.+Bhattacharyyaauthor=A.+Kerzmannauthor=A.+L.+Feig&title=Fluorescent+analogs+of+UDP-glucose+and+their+use+in+characterizing+substrate+binding+by+toxin+A+from+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent analogs of UDP-glucose and their use in characterizing substrate binding by toxin A from Clostridium difficile</span></div><div class="casAuthors">Bhattacharyya, Sudeep; Kerzmann, Amy; Feig, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3425-3432</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Uridine-5'-diphospho-1-α-D-glucose (UDP-Glc) is a common substrate used by glucosyltransferases, including certain bacterial toxins such as Toxins A and B from Clostridium difficile.  Fluorescent analogs of UDP-Glc have been prepd. for use in our studies of the clostridial toxins.  These compds. are related to the methylanthraniloyl-ATP compds. commonly used to probe the chem. of ATP-dependent enzymes.  The reaction of excess methylisatoic anhydride with UDP-Glc in aq. soln. yields primarily the 2' and 3' isomers of methylanthraniloyl-UDP-Glc (MUG).  As the 2' and 3' isomers readily interconvert, this isomeric mixt. was copurified by HPLC away from the other isomeric products, and was characterized by a combination of NMR, fluorescence and mass spectrometric methods.  TcdA binds MUG competitively with respect to UDP-Glc with an affinity of 15±2 μM in the absence of Mg2+.  There is currently no evidence that the fluorescent substrate analog is turned over by the toxin in either glucosyltransferase or glucosylhydrolase reactions.  Using a competition assay, the affinity of UDP-Glc was detd. to be 45±10 μM in the absence of Mg2+.  The binding of UDP-Glc and Mg2+ are highly coupled with Mg2+ affinities in the range of 90-600 μM, depending on the exptl. conditions.  These results imply that one of the significant roles of the metal ion might be to stabilize the enzyme-substrate complex prior to initiation of the transferase chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPjQGC0fnLxLVg90H21EOLACvtfcHk0ljprCUwdWRMmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtF2hurY%253D&md5=f7f66c12c22054acc767b9713c5e672f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1033.2002.03013.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1033.2002.03013.x%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharyya%26aufirst%3DS.%26aulast%3DKerzmann%26aufirst%3DA.%26aulast%3DFeig%26aufirst%3DA.%2BL.%26atitle%3DFluorescent%2520analogs%2520of%2520UDP-glucose%2520and%2520their%2520use%2520in%2520characterizing%2520substrate%2520binding%2520by%2520toxin%2520A%2520from%2520Clostridium%2520difficile%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2002%26volume%3D269%26spage%3D3425%26epage%3D3432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Martin, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gero, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusack, N. J.</span><span> </span><span class="NLM_article-title">Structure-activity studies of analogs of β, γ-methylene-ATP at P2x-purinoreceptors in the rabbit ear central artery</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=153-165&author=P.+L.+Martinauthor=T.+W.+Geroauthor=A.+A.+Pottsauthor=N.+J.+Cusack&title=Structure-activity+studies+of+analogs+of+%CE%B2%2C+%CE%B3-methylene-ATP+at+P2x-purinoreceptors+in+the+rabbit+ear+central+artery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DP.%2BL.%26aulast%3DGero%26aufirst%3DT.%2BW.%26aulast%3DPotts%26aufirst%3DA.%2BA.%26aulast%3DCusack%26aufirst%3DN.%2BJ.%26atitle%3DStructure-activity%2520studies%2520of%2520analogs%2520of%2520%25CE%25B2%252C%2520%25CE%25B3-methylene-ATP%2520at%2520P2x-purinoreceptors%2520in%2520the%2520rabbit%2520ear%2520central%2520artery%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1995%26volume%3D36%26spage%3D153%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda de Las Infantas, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.; Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of a new series of N<sup>6</sup>-arylcarbamoyl, 2-(Ar)alkynyl-N<sup>6</sup>-arylcarbamoyl, and N<sup>6</sup>-carboxamido derivatives of adenosine 5′-N-ethyluronamide as A<sub>1</sub> and A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">3174</span><span class="NLM_x">–</span> <span class="NLM_lpage">3185</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980147p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=3174-3185&author=P.+G.+Baraldiauthor=B.+Cacciariauthor=M.+J.+Pineda+de+Las+Infantasauthor=G.+Romagnoli%2C+R.%3B+Spallutoauthor=R.+Volpiniauthor=S.+Costanziauthor=S.+Vittoriauthor=G.+Cristalliauthor=N.+Melmanauthor=K.+S.+Parkauthor=X.+Jiauthor=K.+A.+Jacobson&title=Synthesis+and+biological+activity+of+a+new+series+of+N6-arylcarbamoyl%2C+2-%28Ar%29alkynyl-N6-arylcarbamoyl%2C+and+N6-carboxamido+derivatives+of+adenosine+5%E2%80%B2-N-ethyluronamide+as+A1+and+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm980147p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980147p%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DPineda%2Bde%2BLas%2BInfantas%26aufirst%3DM.%2BJ.%26aulast%3DRomagnoli%252C%2BR.%253B%2BSpalluto%26aufirst%3DG.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DPark%26aufirst%3DK.%2BS.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520a%2520new%2520series%2520of%2520N6-arylcarbamoyl%252C%25202-%2528Ar%2529alkynyl-N6-arylcarbamoyl%252C%2520and%2520N6-carboxamido%2520derivatives%2520of%2520adenosine%25205%25E2%2580%25B2-N-ethyluronamide%2520as%2520A1%2520and%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D3174%26epage%3D3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Knorre, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurbatov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samukov, V. V.</span><span> </span><span class="NLM_article-title">General method for the synthesis of ATP gamma-derivatives</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1976&pages=105-108&author=D.+G.+Knorreauthor=V.+A.+Kurbatovauthor=V.+V.+Samukov&title=General+method+for+the+synthesis+of+ATP+gamma-derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnorre%26aufirst%3DD.%2BG.%26aulast%3DKurbatov%26aufirst%3DV.%2BA.%26aulast%3DSamukov%26aufirst%3DV.%2BV.%26atitle%3DGeneral%2520method%2520for%2520the%2520synthesis%2520of%2520ATP%2520gamma-derivatives%26jtitle%3DFEBS%2520Lett.%26date%3D1976%26volume%3D70%26spage%3D105%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Wakuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, J.</span><span> </span><span class="NLM_article-title">Conformational Analysis of 2′,3′-<i>O</i>-Alkylideneadenosines</span> <span class="citation_source-journal">Nippon Kagaku Kaishi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1998&pages=40-44&author=H.+Wakudaauthor=M.+Ideauthor=Y.+Maedaauthor=J.+Kimura&title=Conformational+Analysis+of+2%E2%80%B2%2C3%E2%80%B2-O-Alkylideneadenosines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWakuda%26aufirst%3DH.%26aulast%3DIde%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DJ.%26atitle%3DConformational%2520Analysis%2520of%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-O-Alkylideneadenosines%26jtitle%3DNippon%2520Kagaku%2520Kaishi%26date%3D1998%26volume%3D1%26spage%3D40%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Bakthavachalam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee-Gin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherian, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarnik, A. W.</span><span> </span><span class="NLM_article-title">Synthesis, stereochemistry, intramolecular cyclization, and rates of hydrolysis of adenosine 2′,3′-acetals</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=1987&pages=124-135&author=V.+Bakthavachalamauthor=L.+Lee-Ginauthor=X.+M.+Cherianauthor=A.+W.+Czarnik&title=Synthesis%2C+stereochemistry%2C+intramolecular+cyclization%2C+and+rates+of+hydrolysis+of+adenosine+2%E2%80%B2%2C3%E2%80%B2-acetals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBakthavachalam%26aufirst%3DV.%26aulast%3DLee-Gin%26aufirst%3DL.%26aulast%3DCherian%26aufirst%3DX.%2BM.%26aulast%3DCzarnik%26aufirst%3DA.%2BW.%26atitle%3DSynthesis%252C%2520stereochemistry%252C%2520intramolecular%2520cyclization%252C%2520and%2520rates%2520of%2520hydrolysis%2520of%2520adenosine%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-acetals%26jtitle%3DCarbohydr.%2520Res.%26date%3D1987%26volume%3D170%26spage%3D124%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><div class="note"><p class="first last">Further proof of structure for compounds <b>21</b>, <b>31</b>, <b>38</b>, <b>45</b>, <b>58</b>, and <b>62</b> may be found in the Supporting Information</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Further+proof+of+structure+for+compounds+21%2C+31%2C+38%2C+45%2C+58%2C+and+62+may+be+found+in+the+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="note"><p class="first last">One plausible explanation to describe the selectivity of the acetal ring-forming reactions can be illustrated by examining the following transition states (<b>A</b>−<b>D</b>). The final ring closure could be described as a 5-endo trig cyclization of a free 2′ or 3′ hydroxyl group of the ribose ring on to the oxonium ion derived from the complementary hydroxyl group. The transition states are drawn using the 2′-hydroxyl as a nucleophile and the 3′-oxonium ion as an electrophile for illustrative purposes only. To minimize steric congestion, the conformation of the ribose ring places the base and the side chain in pseudo equatorial positions. Transition states <b>A</b> and <b>B</b>, which place the pivotal forming stereogenic center of the new ring in a pseudo exo-orientation relative to the ribose ring, should govern formation of kinetically favored products. Transition states <b>C</b> and <b>D</b>, which place the pivotal forming stereogenic center of the new ring in a pseudo endo-orientation, should be less favored. Therefore, the kinetically favored product would be derived from transition state <b>A</b>, which places the substituent in a pseudo equatorial position. Kinetic products (products derived from aldehydes that generate very unstable oxonium ions) should give predominantly the cis-product. In circumstances where the formation of products is under thermodynamic control, acetals derived from aldehydes that can generate stable oxonium ions (cinnamaldehyde, benzaldehyde, and ethynyl phenyl aldehyde), the favored product (whether derived from an open or closed oxonium ion intermediate), would result from the substituent being in the energetically more favored exo-face of the 5,5-bicyclic acetal. Thermodynamic products should give predominantly the trans-product. <span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0001.tif.gif" alt="" /></img></span></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Shaver, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rideout, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendergas, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglass, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redick, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yerxa, B. R.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of dinucleotides: Potent and selective agonists of P2Y receptors</span> <span class="citation_source-journal">Purinergic Signal</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=183-191&author=S.+R.+Shaverauthor=J.+L.+Rideoutauthor=W.+Pendergasauthor=J.+G.+Douglassauthor=E.+G.+Brownauthor=J.+L.+Boyerauthor=R.+I.+Patelauthor=C.+C.+Redickauthor=A.+C.+Jonesauthor=M.+Picherauthor=B.+R.+Yerxa&title=Structure-activity+relationships+of+dinucleotides%3A+Potent+and+selective+agonists+of+P2Y+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaver%26aufirst%3DS.%2BR.%26aulast%3DRideout%26aufirst%3DJ.%2BL.%26aulast%3DPendergas%26aufirst%3DW.%26aulast%3DDouglass%26aufirst%3DJ.%2BG.%26aulast%3DBrown%26aufirst%3DE.%2BG.%26aulast%3DBoyer%26aufirst%3DJ.%2BL.%26aulast%3DPatel%26aufirst%3DR.%2BI.%26aulast%3DRedick%26aufirst%3DC.%2BC.%26aulast%3DJones%26aufirst%3DA.%2BC.%26aulast%3DPicher%26aufirst%3DM.%26aulast%3DYerxa%26aufirst%3DB.%2BR.%26atitle%3DStructure-activity%2520relationships%2520of%2520dinucleotides%253A%2520Potent%2520and%2520selective%2520agonists%2520of%2520P2Y%2520receptors%26jtitle%3DPurinergic%2520Signal%26date%3D2005%26volume%3D1%26spage%3D183%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Hiratsuka, T.</span><span> </span><span class="NLM_article-title">New ribose-modified fluorescent analogs of adenine and guanine nucleotides available as substrates for various enzymes</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">742</span><span class="NLM_x">, </span> <span class="NLM_fpage">496</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=742&publication_year=1983&pages=496-508&author=T.+Hiratsuka&title=New+ribose-modified+fluorescent+analogs+of+adenine+and+guanine+nucleotides+available+as+substrates+for+various+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHiratsuka%26aufirst%3DT.%26atitle%3DNew%2520ribose-modified%2520fluorescent%2520analogs%2520of%2520adenine%2520and%2520guanine%2520nucleotides%2520available%2520as%2520substrates%2520for%2520various%2520enzymes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1983%26volume%3D742%26spage%3D496%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Wright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. D.</span><span> </span><span class="NLM_article-title">Synthesis of novel fluorescent-labeled dinucleoside polyphosphates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2813</span><span class="NLM_x">–</span> <span class="NLM_lpage">2816</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2813-2816&author=M.+Wrightauthor=A.+D.+Miller&title=Synthesis+of+novel+fluorescent-labeled+dinucleoside+polyphosphates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DA.%2BD.%26atitle%3DSynthesis%2520of%2520novel%2520fluorescent-labeled%2520dinucleoside%2520polyphosphates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2813%26epage%3D2816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="note"><p class="first last">In addition to the aforementioned regiochemistry problems, the ribose esters were also less stable as solids and in solution than acetals. At room temperature and a pH of greater than 7, which would be the typical physiological situation, compounds <b>15</b>–<b>17</b> showed significant decomposition after a few days. The acetal compounds were stable in solution under these conditions. Solid ester compounds typically were stored at −80 °C in their ammonium salt forms to avoid decomposition over the long term, whereas solid acetals (in their sodium or ammonium salt forms) could be stored on the benchtop for many months without ill effect. The general trend for stability of the aromatic acetals under acidic conditions was styryl < phenyl < benzyl.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="note"><p class="first last">In general, the rank order of hydrolytic stability of the phosphates that we observed was dinucleoside polyphosphates > nucleoside monophosphates > nucleoside diphosphates > nucleoside triphosphates. Dinucleoside polyphosphates and nucleoside monophosphates modified with the lipophilic moieties described in this article could be stored in their salt forms (sodium, ammonium, or tributylammonium) at ambient temperature for months without significant decomposition. As noted in the preparation of <b>41</b>, it was nearly impossible to avoid some degradation of the nucleoside diphosphate to the monophosphate (<b>56</b>), even with optimal handling. The corresponding triphosphate analogue to <b>41</b>and<b>56</b>(not included in this article) proved to be much more troublesome and was not pursued.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span>These data have been partially reported in poster format at the 4th International Symposium of Nucleosides and Nucleotides, Chapel Hill, North Carolina, June, 2004. <span class="NLM_contrib-group">Douglass, J. G.; Patel, R. I.; Redick, C. C.; Jones, A. C.; Shave, S. R.; Boyer, J. L.</span> (Poster 70W) Lipophilic Adenine Nucleotides as Reversible Inhibitors of P2Y<sub>12</sub>-Mediated Platelet Aggregation. 4th International Symposium of Nucleosides and Nucleotides, Chapel Hill, North Carolina, June,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=These+data+have+been+partially+reported+in+poster+format+at+the+4th+International+Symposium+of+Nucleosides+and+Nucleotides%2C+Chapel+Hill%2C+North+Carolina%2C+June%2C+2004.+Douglass%2C+J.+G.%3B+Patel%2C+R.+I.%3B+Redick%2C+C.+C.%3B+Jones%2C+A.+C.%3B+Shave%2C+S.+R.%3B+Boyer%2C+J.+L.+%28Poster+70W%29+Lipophilic+Adenine+Nucleotides+as+Reversible+Inhibitors+of+P2Y12-Mediated+Platelet+Aggregation.+4th+International+Symposium+of+Nucleosides+and+Nucleotides%2C+Chapel+Hill%2C+North+Carolina%2C+June%2C+2004."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DDouglass%26aufirst%3DJ.%2BG.%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Arunlakshana, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schild, H. O.</span><span> </span><span class="NLM_article-title">Some quantitative uses of drug antagonists</span> <span class="citation_source-journal">Br. J. Pharmacol. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1959&pages=48-58&author=O.+Arunlakshanaauthor=H.+O.+Schild&title=Some+quantitative+uses+of+drug+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArunlakshana%26aufirst%3DO.%26aulast%3DSchild%26aufirst%3DH.%2BO.%26atitle%3DSome%2520quantitative%2520uses%2520of%2520drug%2520antagonists%26jtitle%3DBr.%2520J.%2520Pharmacol.%2520Chemother.%26date%3D1959%26volume%3D1%26spage%3D48%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Johnson, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crean, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamoorthy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellerman, D. J.</span><span> </span><span class="NLM_article-title">Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589</span> <span class="citation_source-journal">Platelets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=346-356&author=F.+L.+Johnsonauthor=J.+L.+Boyerauthor=P.+T.+Leeseauthor=C.+Creanauthor=R.+Krishnamoorthyauthor=T.+Durhamauthor=A.+W.+Foxauthor=D.+J.+Kellerman&title=Rapid+and+reversible+modulation+of+platelet+function+in+man+by+a+novel+P2Y%2812%29+ADP-receptor+antagonist%2C+INS50589"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DF.%2BL.%26aulast%3DBoyer%26aufirst%3DJ.%2BL.%26aulast%3DLeese%26aufirst%3DP.%2BT.%26aulast%3DCrean%26aufirst%3DC.%26aulast%3DKrishnamoorthy%26aufirst%3DR.%26aulast%3DDurham%26aufirst%3DT.%26aulast%3DFox%26aufirst%3DA.%2BW.%26aulast%3DKellerman%26aufirst%3DD.%2BJ.%26atitle%3DRapid%2520and%2520reversible%2520modulation%2520of%2520platelet%2520function%2520in%2520man%2520by%2520a%2520novel%2520P2Y%252812%2529%2520ADP-receptor%2520antagonist%252C%2520INS50589%26jtitle%3DPlatelets%26date%3D2007%26volume%3D18%26spage%3D346%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':[],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':[],'ref48':[],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 33 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Béatrice  Roy</span>, <span class="hlFld-ContribAuthor ">Anaïs  Depaix</span>, <span class="hlFld-ContribAuthor ">Christian  Périgaud</span>, and <span class="hlFld-ContribAuthor ">Suzanne  Peyrottes</span>  . </span><span class="cited-content_cbyCitation_article-title">Recent Trends in Nucleotide Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (14)
                                     , 7854-7897. <a href="https://doi.org/10.1021/acs.chemrev.6b00174" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00174%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DRecent%252BTrends%252Bin%252BNucleotide%252BSynthesis%26aulast%3DRoy%26aufirst%3DB%25C3%25A9atrice%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14032016%26date%3D20062016%26date%3D27072016%26volume%3D116%26issue%3D14%26spage%3D7854%26epage%3D7897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Bach</span>, <span class="hlFld-ContribAuthor ">Thomas  Antonsson</span>, <span class="hlFld-ContribAuthor ">Ruth  Bylund</span>, <span class="hlFld-ContribAuthor ">Jan-Arne  Björkman</span>, <span class="hlFld-ContribAuthor ">Krister  Österlund</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Giordanetto</span>, <span class="hlFld-ContribAuthor ">J. J. J.  van Giezen</span>, <span class="hlFld-ContribAuthor ">Søren M.  Andersen</span>, <span class="hlFld-ContribAuthor ">Helen  Zachrisson</span>, and <span class="hlFld-ContribAuthor ">Fredrik  Zetterberg</span>  . </span><span class="cited-content_cbyCitation_article-title">Lead Optimization of Ethyl 6-Aminonicotinate Acyl Sulfonamides as Antagonists of the P2Y12 Receptor. Separation of the Antithrombotic Effect and Bleeding for Candidate Drug AZD1283. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (17)
                                     , 7015-7024. <a href="https://doi.org/10.1021/jm400820m" title="DOI URL">https://doi.org/10.1021/jm400820m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400820m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400820m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLead%252BOptimization%252Bof%252BEthyl%252B6-Aminonicotinate%252BAcyl%252BSulfonamides%252Bas%252BAntagonists%252Bof%252Bthe%252BP2Y12%252BReceptor.%252BSeparation%252Bof%252Bthe%252BAntithrombotic%252BEffect%252Band%252BBleeding%252Bfor%252BCandidate%252BDrug%252BAZD1283%26aulast%3DBach%26aufirst%3DPeter%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03062013%26date%3D29082013%26date%3D12092013%26date%3D30072013%26volume%3D56%26issue%3D17%26spage%3D7015%26epage%3D7024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Younis  Baqi</span>, <span class="hlFld-ContribAuthor ">Kerstin  Atzler</span>, <span class="hlFld-ContribAuthor ">Meryem  Köse</span>, <span class="hlFld-ContribAuthor ">Markus  Glänzel</span> and <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>  . </span><span class="cited-content_cbyCitation_article-title">High-Affinity, Non-Nucleotide-Derived Competitive Antagonists of Platelet P2Y12 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (12)
                                     , 3784-3793. <a href="https://doi.org/10.1021/jm9003297" title="DOI URL">https://doi.org/10.1021/jm9003297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9003297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9003297%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Affinity%25252C%252BNon-Nucleotide-Derived%252BCompetitive%252BAntagonists%252Bof%252BPlatelet%252BP2Y12%252BReceptors%26aulast%3DBaqi%26aufirst%3DYounis%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D16%252003%25202009%26date%3D22052009%26date%3D25062009%26volume%3D52%26issue%3D12%26spage%3D3784%26epage%3D3793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shunlai  Li</span>, <span class="hlFld-ContribAuthor ">Cheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Mingwu  Yu</span>, <span class="hlFld-ContribAuthor ">Qiwen  He</span>, <span class="hlFld-ContribAuthor ">Hongguang  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, anti‐platelet aggregation activity evaluation and structure–activity relationships of a series of novel purine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>57 </em>
                                    (7)
                                     , 2889-2903. <a href="https://doi.org/10.1002/jhet.3997" title="DOI URL">https://doi.org/10.1002/jhet.3997</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3997%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%25252C%252Banti%2525E2%252580%252590platelet%252Baggregation%252Bactivity%252Bevaluation%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Ba%252Bseries%252Bof%252Bnovel%252Bpurine%252Bderivatives%26aulast%3DLi%26aufirst%3DShunlai%26date%3D2020%26date%3D2020%26volume%3D57%26issue%3D7%26spage%3D2889%26epage%3D2903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucie  Appy</span>, <span class="hlFld-ContribAuthor ">Crystalle  Chardet</span>, <span class="hlFld-ContribAuthor ">Suzanne  Peyrottes</span>, <span class="hlFld-ContribAuthor ">Béatrice  Roy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Strategies for Dinucleotides Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (23)
                                     , 4334. <a href="https://doi.org/10.3390/molecules24234334" title="DOI URL">https://doi.org/10.3390/molecules24234334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24234334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24234334%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthetic%252BStrategies%252Bfor%252BDinucleotides%252BSynthesis%26aulast%3DAppy%26aufirst%3DLucie%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D23%26spage%3D4334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucie  Appy</span>, <span class="hlFld-ContribAuthor ">Anaïs  Depaix</span>, <span class="hlFld-ContribAuthor ">Xavier  Bantreil</span>, <span class="hlFld-ContribAuthor ">Frédéric  Lamaty</span>, <span class="hlFld-ContribAuthor ">Suzanne  Peyrottes</span>, <span class="hlFld-ContribAuthor ">Béatrice  Roy</span>. </span><span class="cited-content_cbyCitation_article-title">Straightforward Ball‐Milling Access to Dinucleoside 5′,5′‐Polyphosphates via Phosphorimidazolide Intermediates. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (10)
                                     , 2477-2481. <a href="https://doi.org/10.1002/chem.201805924" title="DOI URL">https://doi.org/10.1002/chem.201805924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201805924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201805924%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DStraightforward%252BBall%2525E2%252580%252590Milling%252BAccess%252Bto%252BDinucleoside%252B5%2525E2%252580%2525B2%25252C5%2525E2%252580%2525B2%2525E2%252580%252590Polyphosphates%252Bvia%252BPhosphorimidazolide%252BIntermediates%26aulast%3DAppy%26aufirst%3DLucie%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D10%26spage%3D2477%26epage%3D2481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diego  Dal Ben</span>, <span class="hlFld-ContribAuthor ">Anna  Marchenkova</span>, <span class="hlFld-ContribAuthor ">Ajiroghene  Thomas</span>, <span class="hlFld-ContribAuthor ">Catia  Lambertucci</span>, <span class="hlFld-ContribAuthor ">Andrea  Spinaci</span>, <span class="hlFld-ContribAuthor ">Gabriella  Marucci</span>, <span class="hlFld-ContribAuthor ">Andrea  Nistri</span>, <span class="hlFld-ContribAuthor ">Rosaria  Volpini</span>. </span><span class="cited-content_cbyCitation_article-title">2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents. </span><span class="cited-content_cbyCitation_journal-name">Purinergic Signalling</span><span> <strong>2017,</strong> <em>13 </em>
                                    (1)
                                     , 61-74. <a href="https://doi.org/10.1007/s11302-016-9539-y" title="DOI URL">https://doi.org/10.1007/s11302-016-9539-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11302-016-9539-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11302-016-9539-y%26sid%3Dliteratum%253Aachs%26jtitle%3DPurinergic%2520Signalling%26atitle%3D2%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2-O-Substituted%252BATP%252Bderivatives%252Bas%252Bpotent%252Bantagonists%252Bof%252Bpurinergic%252BP2X3%252Breceptors%252Band%252Bpotential%252Banalgesic%252Bagents%26aulast%3DDal%2BBen%26aufirst%3DDiego%26date%3D2017%26date%3D2016%26volume%3D13%26issue%3D1%26spage%3D61%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.A.  Meyer</span>, <span class="hlFld-ContribAuthor ">E.  Caroff</span>, <span class="hlFld-ContribAuthor ">M.A.  Riederer</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Antiplatelet Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 556-599. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12431-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12431-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12431-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12431-X%26sid%3Dliteratum%253Aachs%26atitle%3DAdvances%252Bin%252BAntiplatelet%252BAgents%26aulast%3DMeyer%26aufirst%3DE.A.%26date%3D2017%26spage%3D556%26epage%3D599%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fredrik  Zetterberg</span>, <span class="hlFld-ContribAuthor ">Peder  Svensson</span>. </span><span class="cited-content_cbyCitation_article-title">State of affairs: Design and structure–activity relationships of reversible P2Y 12 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (12)
                                     , 2739-2754. <a href="https://doi.org/10.1016/j.bmcl.2016.04.030" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DState%252Bof%252Baffairs%25253A%252BDesign%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Breversible%252BP2Y%252B12%252Breceptor%252Bantagonists%26aulast%3DZetterberg%26aufirst%3DFredrik%26date%3D2016%26volume%3D26%26issue%3D12%26spage%3D2739%26epage%3D2754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivan B.  Yanachkov</span>, <span class="hlFld-ContribAuthor ">Hung  Chang</span>, <span class="hlFld-ContribAuthor ">Milka I.  Yanachkova</span>, <span class="hlFld-ContribAuthor ">Edward J.  Dix</span>, <span class="hlFld-ContribAuthor ">Michelle A.  Berny-Lang</span>, <span class="hlFld-ContribAuthor ">Thomas  Gremmel</span>, <span class="hlFld-ContribAuthor ">Alan D.  Michelson</span>, <span class="hlFld-ContribAuthor ">George E.  Wright</span>, <span class="hlFld-ContribAuthor ">Andrew L.  Frelinger</span>. </span><span class="cited-content_cbyCitation_article-title">New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>107 </em>, 204-218. <a href="https://doi.org/10.1016/j.ejmech.2015.10.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.10.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.10.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.10.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bhighly%252Bactive%252Bantiplatelet%252Bagents%252Bwith%252Bdual%252Bspecificity%252Bfor%252Bplatelet%252BP2Y1%252Band%252BP2Y12%252Badenosine%252Bdiphosphate%252Breceptors%26aulast%3DYanachkov%26aufirst%3DIvan%2BB.%26date%3D2016%26volume%3D107%26spage%3D204%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuliya V.  Sherstyuk</span>, <span class="hlFld-ContribAuthor ">Tatyana V.  Abramova</span>. </span><span class="cited-content_cbyCitation_article-title">How To Form a Phosphate Anhydride Linkage in Nucleotide Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2015,</strong> <em>16 </em>
                                    (18)
                                     , 2562-2570. <a href="https://doi.org/10.1002/cbic.201500406" title="DOI URL">https://doi.org/10.1002/cbic.201500406</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201500406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201500406%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DHow%252BTo%252BForm%252Ba%252BPhosphate%252BAnhydride%252BLinkage%252Bin%252BNucleotide%252BDerivatives%26aulast%3DSherstyuk%26aufirst%3DYuliya%2BV.%26date%3D2015%26date%3D2015%26volume%3D16%26issue%3D18%26spage%3D2562%26epage%3D2570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Paoletta</span>, <span class="hlFld-ContribAuthor ">Davide  Sabbadin</span>, <span class="hlFld-ContribAuthor ">Ivar  von Kügelgen</span>, <span class="hlFld-ContribAuthor ">Sonja  Hinz</span>, <span class="hlFld-ContribAuthor ">Vsevolod  Katritch</span>, <span class="hlFld-ContribAuthor ">Kristina  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Aliaa  Abdelrahman</span>, <span class="hlFld-ContribAuthor ">Jens  Straßburger</span>, <span class="hlFld-ContribAuthor ">Younis  Baqi</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Raymond C.  Stevens</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>, <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2015,</strong> <em>29 </em>
                                    (8)
                                     , 737-756. <a href="https://doi.org/10.1007/s10822-015-9858-z" title="DOI URL">https://doi.org/10.1007/s10822-015-9858-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-015-9858-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-015-9858-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DModeling%252Bligand%252Brecognition%252Bat%252Bthe%252BP2Y12%252Breceptor%252Bin%252Blight%252Bof%252BX-ray%252Bstructural%252Binformation%26aulast%3DPaoletta%26aufirst%3DSilvia%26date%3D2015%26date%3D2015%26volume%3D29%26issue%3D8%26spage%3D737%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Silvia  Paoletta</span>, <span class="hlFld-ContribAuthor ">Vsevolod  Katritch</span>, <span class="hlFld-ContribAuthor ">Beili  Wu</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Raymond C.  Stevens</span>, <span class="hlFld-ContribAuthor ">Evgeny  Kiselev</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleotides Acting at P2Y Receptors: Connecting Structure and Function. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2015,</strong> <em>88 </em>
                                    (2)
                                     , 220-230. <a href="https://doi.org/10.1124/mol.114.095711" title="DOI URL">https://doi.org/10.1124/mol.114.095711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.114.095711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.114.095711%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DNucleotides%252BActing%252Bat%252BP2Y%252BReceptors%25253A%252BConnecting%252BStructure%252Band%252BFunction%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2015%26date%3D2015%26volume%3D88%26issue%3D2%26spage%3D220%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Sun</span>, <span class="hlFld-ContribAuthor ">Jian  Sun</span>, <span class="hlFld-ContribAuthor ">Shan-Shan  Gong</span>, <span class="hlFld-ContribAuthor ">Cheng-Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Xing-Cong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis of symmetrical dinucleoside polyphosphates and analogs via 4,5-dicyanoimidazole-promoted tandem P–O coupling reactions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (42)
                                     , 5785-5788. <a href="https://doi.org/10.1016/j.tetlet.2014.08.109" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.08.109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.08.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.08.109%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DOne-pot%252Bsynthesis%252Bof%252Bsymmetrical%252Bdinucleoside%252Bpolyphosphates%252Band%252Banalogs%252Bvia%252B4%25252C5-dicyanoimidazole-promoted%252Btandem%252BP%2525E2%252580%252593O%252Bcoupling%252Breactions%26aulast%3DSun%26aufirst%3DQi%26date%3D2014%26volume%3D55%26issue%3D42%26spage%3D5785%26epage%3D5788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen Biao  Xie</span>, <span class="hlFld-ContribAuthor ">Shan Shan  Gong</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of Adenosine-Containing Artificial Dinucleoside Triphosphates. </span><span class="cited-content_cbyCitation_journal-name">Applied Mechanics and Materials</span><span> <strong>2014,</strong> <em>662 </em>, 71-74. <a href="https://doi.org/10.4028/www.scientific.net/AMM.662.71" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMM.662.71</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMM.662.71&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMM.662.71%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Mechanics%2520and%2520Materials%26atitle%3DPreparation%252Bof%252BAdenosine-Containing%252BArtificial%252BDinucleoside%252BTriphosphates%26aulast%3DXie%26aufirst%3DZhen%2BBiao%26date%3D2014%26date%3D2014%26volume%3D662%26spage%3D71%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Sun</span>, <span class="hlFld-ContribAuthor ">Shan Shan  Gong</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Symmetrical P1,P2-Dinucleoside Diphosphates with Pyrimidine Bases. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials Research</span><span> <strong>2014,</strong> <em>1023 </em>, 83-86. <a href="https://doi.org/10.4028/www.scientific.net/AMR.1023.83" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMR.1023.83</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMR.1023.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMR.1023.83%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%2520Research%26atitle%3DSynthesis%252Bof%252BSymmetrical%252BP1%25252CP2-Dinucleoside%252BDiphosphates%252Bwith%252BPyrimidine%252BBases%26aulast%3DSun%26aufirst%3DJian%26date%3D2014%26date%3D2014%26volume%3D1023%26spage%3D83%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Sun</span>, <span class="hlFld-ContribAuthor ">Shan-Shan  Gong</span>, <span class="hlFld-ContribAuthor ">Si  Liu</span>, <span class="hlFld-ContribAuthor ">Jian  Sun</span>, <span class="hlFld-ContribAuthor ">Guo-Dong  Liu</span>, <span class="hlFld-ContribAuthor ">Cha  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">4,5-Dicyanoimidazole-promoted synthesis of dinucleoside polyphosphates and their analogs. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (30)
                                     , 4500-4506. <a href="https://doi.org/10.1016/j.tet.2014.05.013" title="DOI URL">https://doi.org/10.1016/j.tet.2014.05.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.05.013%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D4%25252C5-Dicyanoimidazole-promoted%252Bsynthesis%252Bof%252Bdinucleoside%252Bpolyphosphates%252Band%252Btheir%252Banalogs%26aulast%3DSun%26aufirst%3DQi%26date%3D2014%26volume%3D70%26issue%3D30%26spage%3D4500%26epage%3D4506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Bach</span>, <span class="hlFld-ContribAuthor ">Jonas  Boström</span>, <span class="hlFld-ContribAuthor ">Kay  Brickmann</span>, <span class="hlFld-ContribAuthor ">Laurence E  Burgess</span>, <span class="hlFld-ContribAuthor ">David  Clarke</span>, <span class="hlFld-ContribAuthor ">Robert D  Groneberg</span>, <span class="hlFld-ContribAuthor ">Darren M  Harvey</span>, <span class="hlFld-ContribAuthor ">Ellen R  Laird</span>, <span class="hlFld-ContribAuthor ">Michael  O’Sullivan</span>, <span class="hlFld-ContribAuthor ">Fredrik  Zetterberg</span>. </span><span class="cited-content_cbyCitation_article-title">5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y
              12
              receptor. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2013,</strong> <em>5 </em>
                                    (17)
                                     , 2037-2056. <a href="https://doi.org/10.4155/fmc.13.171" title="DOI URL">https://doi.org/10.4155/fmc.13.171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.171%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3D5-alkyl-1%25252C3-oxazole%252Bderivatives%252Bof%252B6-amino-nicotinic%252Bacids%252Bas%252Balkyl%252Bester%252Bbioisosteres%252Bare%252Bantagonists%252Bof%252Bthe%252BP2Y%252B12%252Breceptor%26aulast%3DBach%26aufirst%3DPeter%26date%3D2013%26volume%3D5%26issue%3D17%26spage%3D2037%26epage%3D2056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Bach</span>, <span class="hlFld-ContribAuthor ">Jonas  Boström</span>, <span class="hlFld-ContribAuthor ">Kay  Brickmann</span>, <span class="hlFld-ContribAuthor ">J.J.J.  van Giezen</span>, <span class="hlFld-ContribAuthor ">Robert D.  Groneberg</span>, <span class="hlFld-ContribAuthor ">Darren M.  Harvey</span>, <span class="hlFld-ContribAuthor ">Michael  O'Sullivan</span>, <span class="hlFld-ContribAuthor ">Fredrik  Zetterberg</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structure–property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y12 receptor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>65 </em>, 360-375. <a href="https://doi.org/10.1016/j.ejmech.2013.04.007" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bstructure%2525E2%252580%252593property%252Brelationships%252Band%252Bpharmacokinetic%252Bevaluation%252Bof%252Bethyl%252B6-aminonicotinate%252Bsulfonylureas%252Bas%252Bantagonists%252Bof%252Bthe%252BP2Y12%252Breceptor%26aulast%3DBach%26aufirst%3DPeter%26date%3D2013%26volume%3D65%26spage%3D360%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanumantharao  Paritala</span>, <span class="hlFld-ContribAuthor ">Yuta  Suzuki</span>, <span class="hlFld-ContribAuthor ">Kate S.  Carroll</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient microwave-assisted solid phase coupling of nucleosides, small library generation, and mild conditions for release of nucleoside derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2013,</strong> <em>54 </em>
                                    (14)
                                     , 1869-1872. <a href="https://doi.org/10.1016/j.tetlet.2013.01.109" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.01.109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.01.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.01.109%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DEfficient%252Bmicrowave-assisted%252Bsolid%252Bphase%252Bcoupling%252Bof%252Bnucleosides%25252C%252Bsmall%252Blibrary%252Bgeneration%25252C%252Band%252Bmild%252Bconditions%252Bfor%252Brelease%252Bof%252Bnucleoside%252Bderivatives%26aulast%3DParitala%26aufirst%3DHanumantharao%26date%3D2013%26volume%3D54%26issue%3D14%26spage%3D1869%26epage%3D1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  CHANG</span>, <span class="hlFld-ContribAuthor ">I. B.  YANACHKOV</span>, <span class="hlFld-ContribAuthor ">E. J.  DIX</span>, <span class="hlFld-ContribAuthor ">Y. F.  LI</span>, <span class="hlFld-ContribAuthor ">M. R.  BARNARD</span>, <span class="hlFld-ContribAuthor ">G. E.  WRIGHT</span>, <span class="hlFld-ContribAuthor ">A. D.  MICHELSON</span>, <span class="hlFld-ContribAuthor ">A. L.  FRELINGER</span>. </span><span class="cited-content_cbyCitation_article-title">Modified diadenosine tetraphosphates with dual specificity for P2Y
              1
              and P2Y
              12
              are potent antagonists of ADP-induced platelet activation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Thrombosis and Haemostasis</span><span> <strong>2012,</strong> <em>10 </em>
                                    (12)
                                     , 2573-2580. <a href="https://doi.org/10.1111/jth.12035" title="DOI URL">https://doi.org/10.1111/jth.12035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jth.12035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjth.12035%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Thrombosis%2520and%2520Haemostasis%26atitle%3DModified%252Bdiadenosine%252Btetraphosphates%252Bwith%252Bdual%252Bspecificity%252Bfor%252BP2Y%252B1%252Band%252BP2Y%252B12%252Bare%252Bpotent%252Bantagonists%252Bof%252BADP-induced%252Bplatelet%252Bactivation%26aulast%3DCHANG%26aufirst%3DH.%26date%3D2012%26date%3D2012%26volume%3D10%26issue%3D12%26spage%3D2573%26epage%3D2580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noa  Stern</span>, <span class="hlFld-ContribAuthor ">Dan Thomas  Major</span>, <span class="hlFld-ContribAuthor ">Hugo Emilio  Gottlieb</span>, <span class="hlFld-ContribAuthor ">Daniel  Weizman</span>, <span class="hlFld-ContribAuthor ">Alon Haim  Sayer</span>, <span class="hlFld-ContribAuthor ">Eliav  Blum</span>, <span class="hlFld-ContribAuthor ">Bilha  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">Studies of Mg2+/Ca2+ complexes of naturally occurring dinucleotides: potentiometric titrations, NMR, and molecular dynamics. </span><span class="cited-content_cbyCitation_journal-name">JBIC Journal of Biological Inorganic Chemistry</span><span> <strong>2012,</strong> <em>17 </em>
                                    (6)
                                     , 861-879. <a href="https://doi.org/10.1007/s00775-012-0903-2" title="DOI URL">https://doi.org/10.1007/s00775-012-0903-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00775-012-0903-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00775-012-0903-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJBIC%2520Journal%2520of%2520Biological%2520Inorganic%2520Chemistry%26atitle%3DStudies%252Bof%252BMg2%25252B%25252FCa2%25252B%252Bcomplexes%252Bof%252Bnaturally%252Boccurring%252Bdinucleotides%25253A%252Bpotentiometric%252Btitrations%25252C%252BNMR%25252C%252Band%252Bmolecular%252Bdynamics%26aulast%3DStern%26aufirst%3DNoa%26date%3D2012%26date%3D2012%26volume%3D17%26issue%3D6%26spage%3D861%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Vertuani</span>, <span class="hlFld-ContribAuthor ">Anna  Baldisserotto</span>, <span class="hlFld-ContribAuthor ">Katia  Varani</span>, <span class="hlFld-ContribAuthor ">Pier Andrea  Borea</span>, <span class="hlFld-ContribAuthor ">Bonache  De Marcos Maria Cruz</span>, <span class="hlFld-ContribAuthor ">Luca  Ferraro</span>, <span class="hlFld-ContribAuthor ">Stefano  Manfredini</span>, <span class="hlFld-ContribAuthor ">Alessandro  Dalpiaz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro stability of nucleoside 5′-phosphonate derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>54 </em>, 202-209. <a href="https://doi.org/10.1016/j.ejmech.2012.04.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.04.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.04.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.04.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bin%2525C2%2525A0vitro%252Bstability%252Bof%252Bnucleoside%252B5%2525E2%252580%2525B2-phosphonate%252Bderivatives%26aulast%3DVertuani%26aufirst%3DSilvia%26date%3D2012%26volume%3D54%26spage%3D202%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Francesca  Deflorian</span>, <span class="hlFld-ContribAuthor ">Shilpi  Mishra</span>, <span class="hlFld-ContribAuthor ">Stefano  Costanzi</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacochemistry of the platelet purinergic receptors. </span><span class="cited-content_cbyCitation_journal-name">Purinergic Signalling</span><span> <strong>2011,</strong> <em>7 </em>
                                    (3)
                                     , 305-324. <a href="https://doi.org/10.1007/s11302-011-9216-0" title="DOI URL">https://doi.org/10.1007/s11302-011-9216-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11302-011-9216-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11302-011-9216-0%26sid%3Dliteratum%253Aachs%26jtitle%3DPurinergic%2520Signalling%26atitle%3DPharmacochemistry%252Bof%252Bthe%252Bplatelet%252Bpurinergic%252Breceptors%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2011%26date%3D2011%26volume%3D7%26issue%3D3%26spage%3D305%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joachim  Caron</span>, <span class="hlFld-ContribAuthor ">Elise  Lepeltier</span>, <span class="hlFld-ContribAuthor ">L. Harivardhan  Reddy</span>, <span class="hlFld-ContribAuthor ">Sinda  Lepêtre-Mouelhi</span>, <span class="hlFld-ContribAuthor ">Séverine  Wack</span>, <span class="hlFld-ContribAuthor ">Claudie  Bourgaux</span>, <span class="hlFld-ContribAuthor ">Patrick  Couvreur</span>, <span class="hlFld-ContribAuthor ">Didier  Desmaële</span>. </span><span class="cited-content_cbyCitation_article-title">Squalenoyl Gemcitabine Monophosphate: Synthesis, Characterisation of Nanoassemblies and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>2011 </em>
                                    (14)
                                     , 2615-2628. <a href="https://doi.org/10.1002/ejoc.201100036" title="DOI URL">https://doi.org/10.1002/ejoc.201100036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201100036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201100036%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSqualenoyl%252BGemcitabine%252BMonophosphate%25253A%252BSynthesis%25252C%252BCharacterisation%252Bof%252BNanoassemblies%252Band%252BBiological%252BEvaluation%26aulast%3DCaron%26aufirst%3DJoachim%26date%3D2011%26date%3D2011%26volume%3D2011%26issue%3D14%26spage%3D2615%26epage%3D2628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Bach</span>, <span class="hlFld-ContribAuthor ">Jonas  Boström</span>, <span class="hlFld-ContribAuthor ">Kay  Brickmann</span>, <span class="hlFld-ContribAuthor ">J.J.J.  van Giezen</span>, <span class="hlFld-ContribAuthor ">Ragnar  Hovland</span>, <span class="hlFld-ContribAuthor ">Annika U.  Petersson</span>, <span class="hlFld-ContribAuthor ">Asim  Ray</span>, <span class="hlFld-ContribAuthor ">Fredrik  Zetterberg</span>. </span><span class="cited-content_cbyCitation_article-title">A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (10)
                                     , 2877-2881. <a href="https://doi.org/10.1016/j.bmcl.2011.03.088" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.03.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.03.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.03.088%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bnovel%252Bseries%252Bof%252Bpiperazinyl-pyridine%252Bureas%252Bas%252Bantagonists%252Bof%252Bthe%252Bpurinergic%252BP2Y12%252Breceptor%26aulast%3DBach%26aufirst%3DPeter%26date%3D2011%26volume%3D21%26issue%3D10%26spage%3D2877%26epage%3D2881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivar  von Kügelgen</span>, <span class="hlFld-ContribAuthor ">T. Kendall  Harden</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Pharmacology, Physiology, and Structure of the P2Y Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 373-415. <a href="https://doi.org/10.1016/B978-0-12-385526-8.00012-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-385526-8.00012-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-385526-8.00012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-385526-8.00012-6%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252BPharmacology%25252C%252BPhysiology%25252C%252Band%252BStructure%252Bof%252Bthe%252BP2Y%252BReceptors%26aulast%3Dvon%2BK%25C3%25BCgelgen%26aufirst%3DIvar%26date%3D2011%26spage%3D373%26epage%3D415%26pub%3DElsevier%26atitle%3DPharmacology%252Bof%252BPurine%252Band%252BPyrimidine%252BReceptors%26date%3D2011%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivan B.  Yanachkov</span>, <span class="hlFld-ContribAuthor ">Edward J.  Dix</span>, <span class="hlFld-ContribAuthor ">Milka I.  Yanachkova</span>, <span class="hlFld-ContribAuthor ">George E.  Wright</span>. </span><span class="cited-content_cbyCitation_article-title">P
              1
              ,P
              2
              -Diimidazolyl derivatives of pyrophosphate and bis-phosphonates – synthesis, properties, and use in preparation of dinucleoside tetraphosphates and analogs. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2011,</strong> <em>9 </em>
                                    (3)
                                     , 730-738. <a href="https://doi.org/10.1039/C0OB00542H" title="DOI URL">https://doi.org/10.1039/C0OB00542H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C0OB00542H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC0OB00542H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DP%252B1%252B%25252CP%252B2%252B-Diimidazolyl%252Bderivatives%252Bof%252Bpyrophosphate%252Band%252Bbis-phosphonates%252B%2525E2%252580%252593%252Bsynthesis%25252C%252Bproperties%25252C%252Band%252Buse%252Bin%252Bpreparation%252Bof%252Bdinucleoside%252Btetraphosphates%252Band%252Banalogs%26aulast%3DYanachkov%26aufirst%3DIvan%2BB.%26date%3D2011%26date%3D2011%26volume%3D9%26issue%3D3%26spage%3D730%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noa  Stern</span>, <span class="hlFld-ContribAuthor ">Dan Thomas  Major</span>, <span class="hlFld-ContribAuthor ">Hugo Emilio  Gottlieb</span>, <span class="hlFld-ContribAuthor ">Daniel  Weizman</span>, <span class="hlFld-ContribAuthor ">Bilha  Fischer</span>. </span><span class="cited-content_cbyCitation_article-title">What is the conformation of physiologically-active dinucleoside polyphosphates in solution? Conformational analysis of free dinucleoside polyphosphates by NMR and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2010,</strong> <em>8 </em>
                                    (20)
                                     , 4637. <a href="https://doi.org/10.1039/c005122e" title="DOI URL">https://doi.org/10.1039/c005122e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c005122e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc005122e%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DWhat%252Bis%252Bthe%252Bconformation%252Bof%252Bphysiologically-active%252Bdinucleoside%252Bpolyphosphates%252Bin%252Bsolution%25253F%252BConformational%252Banalysis%252Bof%252Bfree%252Bdinucleoside%252Bpolyphosphates%252Bby%252BNMR%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DStern%26aufirst%3DNoa%26date%3D2010%26volume%3D8%26issue%3D20%26spage%3D4637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matt A.  Peterson</span>, <span class="hlFld-ContribAuthor ">Marcelio  Oliveira</span>, <span class="hlFld-ContribAuthor ">Michael A.  Christiansen</span>, <span class="hlFld-ContribAuthor ">Christopher E.  Cutler</span>. </span><span class="cited-content_cbyCitation_article-title">Preliminary SAR analysis of novel antiproliferative N6,5′-bis-ureidoadenosine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (23)
                                     , 6775-6779. <a href="https://doi.org/10.1016/j.bmcl.2009.09.083" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.09.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.09.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.09.083%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPreliminary%252BSAR%252Banalysis%252Bof%252Bnovel%252Bantiproliferative%252BN6%25252C5%2525E2%252580%2525B2-bis-ureidoadenosine%252Bderivatives%26aulast%3DPeterson%26aufirst%3DMatt%2BA.%26date%3D2009%26volume%3D19%26issue%3D23%26spage%3D6775%26epage%3D6779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roland  Sauer</span>, <span class="hlFld-ContribAuthor ">Ali  El-Tayeb</span>, <span class="hlFld-ContribAuthor ">Marko  Kaulich</span>, <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y2 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2009,</strong> <em>17 </em>
                                    (14)
                                     , 5071-5079. <a href="https://doi.org/10.1016/j.bmc.2009.05.062" title="DOI URL">https://doi.org/10.1016/j.bmc.2009.05.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2009.05.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Buracil%252Bnucleotide%252Banalogs%252Bwith%252Ba%252Bmodified%25252C%252Bacyclic%252Bribose%252Bmoiety%252Bas%252BP2Y2%252Breceptor%252Bantagonists%26aulast%3DSauer%26aufirst%3DRoland%26date%3D2009%26volume%3D17%26issue%3D14%26spage%3D5071%26epage%3D5079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Andrei A.  Ivanov</span>, <span class="hlFld-ContribAuthor ">Sonia  de Castro</span>, <span class="hlFld-ContribAuthor ">T. Kendall  Harden</span>, <span class="hlFld-ContribAuthor ">Hyojin  Ko</span>. </span><span class="cited-content_cbyCitation_article-title">Development of selective agonists and antagonists of P2Y receptors. </span><span class="cited-content_cbyCitation_journal-name">Purinergic Signalling</span><span> <strong>2009,</strong> <em>5 </em>
                                    (1)
                                     , 75-89. <a href="https://doi.org/10.1007/s11302-008-9106-2" title="DOI URL">https://doi.org/10.1007/s11302-008-9106-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11302-008-9106-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11302-008-9106-2%26sid%3Dliteratum%253Aachs%26jtitle%3DPurinergic%2520Signalling%26atitle%3DDevelopment%252Bof%252Bselective%252Bagonists%252Band%252Bantagonists%252Bof%252BP2Y%252Breceptors%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2009%26date%3D2008%26volume%3D5%26issue%3D1%26spage%3D75%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James G.  Douglass</span>, <span class="hlFld-ContribAuthor ">J. Bryan  deCamp</span>, <span class="hlFld-ContribAuthor ">Emilee H.  Fulcher</span>, <span class="hlFld-ContribAuthor ">William  Jones</span>, <span class="hlFld-ContribAuthor ">Sanjoy  Mahanty</span>, <span class="hlFld-ContribAuthor ">Anna  Morgan</span>, <span class="hlFld-ContribAuthor ">Dima  Smirnov</span>, <span class="hlFld-ContribAuthor ">José L.  Boyer</span>, <span class="hlFld-ContribAuthor ">Paul S.  Watson</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine analogues as inhibitors of P2Y12 receptor mediated platelet aggregation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (6)
                                     , 2167-2171. <a href="https://doi.org/10.1016/j.bmcl.2008.01.038" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.01.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.01.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.01.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAdenosine%252Banalogues%252Bas%252Binhibitors%252Bof%252BP2Y12%252Breceptor%252Bmediated%252Bplatelet%252Baggregation%26aulast%3DDouglass%26aufirst%3DJames%2BG.%26date%3D2008%26volume%3D18%26issue%3D6%26spage%3D2167%26epage%3D2171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0011.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Dinucleoside Polyphosphate Acetals</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0012.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Diadenosine Tetraphosphate and Adenosine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Phenylacetaldehyde dimethyl acetal, HCOOH, 35°C; (b) PhNCO, DMF, 45°C; (c) PhNCO, NBu<sub>3</sub>, DMF 30°C; (d) CDI, NBu<sub>3</sub>, DMF, rt.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0013.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Uridine Cytidine Tetraphosphate and Cytidine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Phenylacetaldehyde dimethyl acetal, HCOOH, rt; (b) <i>p</i>-F-PhNCO, DMF, 60°C, then 30°C; (c) <i>p</i>-F-PhNCO, NBu<sub>3</sub>, DMF, rt; (d) <b>5</b>·(NBu<sub>3</sub>)<sub>2</sub>, DCC, DMF, 30°C; (e) phenylacetaldehyde dimethyl acetal, HCOOH, 30°C.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0014.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Adenosine Monophosphate Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>CHO, TFA, or HCOOH, rt; (b) PhNCO, DMF, 45°C; (c) R<sub>2</sub>NCO, DMF.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Acetal diastereoisomerism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0009.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compound <b>21</b> on 2-MeS-ADP-promoted platelet aggregation. (A) Platelet aggregation was measured as described in <a class="ref internalNav" href="#sec4_1" aria-label="General Methods">General Methods</a>. Assays were in the presence of the indicated concentrations of 2-MeS-ADP alone or in the presence of 1, 3, 10, 30, or 100 µM compound <b>21</b>. (B) Arunlakshana−Schild plot from the data presented in A. The slope of the plot is 0.7425, and <i>K</i><sub>B</sub> is 0.251 µM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0010.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reversible inhibition of platelet aggregation by compound <b>21</b>. Platelets were incubated in the absence (control) or in the presence of 50 µM of <b>21</b>. In panel A, after a three minute incubation with drug, the indicated concentrations of 2-MeS-ADP and fibrinogen were added, and platelet aggregation was monitored during the following 6–8 min. In panel B, after the three minute incubation with drug, both control and compound <b>21</b>-treated platelets were centrifuged, the supernatant was removed, and the platelets were resuspended in drug-free media. Following this, the indicated concentrations of 2-MeS-ADP and fibrinogen were added, and the aggregation was monitored as described above.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/large/jm-2007-01348d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701348d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 51 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Burnstock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">P2 purinergic receptors: modulation of cell function and therapeutic potential</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">869</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11082418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=862-869&author=G.+Burnstockauthor=M.+Williams&title=P2+purinergic+receptors%3A+modulation+of+cell+function+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">P2 purinergic receptors: modulation of cell function and therapeutic potential</span></div><div class="casAuthors">Burnstock, Geoffrey; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">862-869</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with 57 refs.  In addn. to its key role in cellular metab. where it acts as a ubiquitous enzyme cofactor and as the key source of cellular energy unique to phosphate bond Testing, the purine nucleotide ATP also functions as a potent extracellular messenger in producing its effects via the activation of a family of distinct cell surface receptors, the P2 receptor family.  The pyrimidine nucleotide UTP as well as the dinucleotides ADP and UDP also modulate cell function via P2 receptor activation and thus, ATP, UTP, ADP and UDP play key roles in a diversity of tissue functions that include fast excitatory neurotransmission, developmental processing, pulmonary function, nociception, auditory and ocular function, the apoptotic cascade, astroglial cell function, metastasis formation, bone and cartilage disease, and platelet aggregation/homeostasis.  Advances in mol. biol. of the P2 receptor family are now being used concurrently to identify novel ligand that have the potency, selectivity, and bioavailability to characterize P2 responses in animals and intact tissues and to better understand the role of this receptor family in tissue function and disease.  It will be important as new approaches to human therapeutics target P2 receptors that the multiplicity of actions assocd. with ATP-esp. in regard to mol. targets distinct form the P2 receptor family-are factored the functional responses obsd. in model systems with ATP and its analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0VUaEB6gAjbVg90H21EOLACvtfcHk0lhv5kvaqmQsJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKju7s%253D&md5=628b0969220bc9f2dbd2ea86f3441f14</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DP2%2520purinergic%2520receptors%253A%2520modulation%2520of%2520cell%2520function%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D862%26epage%3D869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">Purine and pyrimidine (P2) receptors as drug targets</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4057</span><span class="NLM_x">–</span> <span class="NLM_lpage">4093</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020046y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4057-4093&author=K.+A.+Jacobsonauthor=M.+F.+Jarvisauthor=M.+Williams&title=Purine+and+pyrimidine+%28P2%29+receptors+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm020046y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020046y%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DJarvis%26aufirst%3DM.%2BF.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DPurine%2520and%2520pyrimidine%2520%2528P2%2529%2520receptors%2520as%2520drug%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4057%26epage%3D4093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Burnstock, G.</span><span> </span><span class="NLM_article-title">Potential therapeutic targets in the rapidly expanding field of purinergic signaling</span> <span class="citation_source-journal">Clin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1007%2Fs102380200006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11871639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A280%3ADC%252BD387js1yguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=45-53&author=G.+Burnstock&title=Potential+therapeutic+targets+in+the+rapidly+expanding+field+of+purinergic+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Potential therapeutic targets in the rapidly expanding field of purinergic signalling</span></div><div class="casAuthors">Burnstock G</div><div class="citationInfo"><span class="NLM_cas:title">Clinical medicine (London, England)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-53</span>
        ISSN:<span class="NLM_cas:issn">1470-2118</span>.
    </div><div class="casAbstract">The concept of a purinergic signalling system, using purine nucleotides and nucleosides as extracellular messengers, was first proposed over 30 years ago.  After a brief historical review and update of purinoceptor subtypes, this article focuses on the diverse physiological roles of adenosine triphosphate, adenosine diphosphate, uridine triphosphate and adenosine.  These molecules mediate short-term (acute) signalling functions in neurotransmission, secretion and vasodilation, and long-term (chronic) signalling functions in development, regeneration, proliferation and cell death.  Plasticity of purinoceptor expression in pathological conditions is frequently observed, including an increase in the purinergic component of parasympathetic nervous control of the human bladder in interstitial cystitis and outflow obstruction, and in sympathetic cotransmitter control of blood vessels in hypertensive rats.  The antithrombotic action of clopidogrel (Plavix), a P2Y12 receptor antagonist, has been shown to be particularly promising in the prevention of recurrent strokes and heart attacks in recent clinical trials (CAPRIE and CURE).  The role of P2X3 receptors in nociception and a new hypothesis concerning purinergic mechanosensory transduction in visceral pain will be considered, as will the therapeutic potential of purinergic agonists or antagonists for the treatment of supraventricular tachycardia, cancer, dry eye, bladder hyperactivity, erectile dysfunction, osteoporosis, diabetes, gut motility and vascular disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdks502CPyLPIW7hznt0zpfW6udTcc2eac1w6N1TMZLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387js1yguw%253D%253D&md5=65c059c551faa73fccf0d946ef56a0aa</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs102380200006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs102380200006%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26atitle%3DPotential%2520therapeutic%2520targets%2520in%2520the%2520rapidly%2520expanding%2520field%2520of%2520purinergic%2520signaling%26jtitle%3DClin.%2520Med.%26date%3D2002%26volume%3D2%26spage%3D45%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Abbracchio, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnstock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeynaems, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnard, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumagalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisman, G. A.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1124%2Fpr.58.3.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=16968944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=281-341&author=M.+P.+Abbracchioauthor=G.+Burnstockauthor=J.+M.+Boeynaemsauthor=E.+A.+Barnardauthor=J.+L.+Boyerauthor=C.+Kennedyauthor=G.+E.+Knightauthor=M.+Fumagalliauthor=C.+Gachetauthor=K.+A.+Jacobsonauthor=G.+A.+Weisman&title=International+Union+of+Pharmacology+LVIII%3A+update+on+the+P2Y+G+protein-coupled+nucleotide+receptors%3A+from+molecular+mechanisms+and+pathophysiology+to+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy</span></div><div class="casAuthors">Abbracchio, Maria P.; Burnstock, Geoffrey; Boeynaems, Jean-Marie; Barnard, Eric A.; Boyer, Jose L.; Kennedy, Charles; Knight, Gillian E.; Fumagalli, Marta; Gachet, Christian; Jacobson, Kenneth A.; Weisman, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-341</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  There have been many advances in our knowledge about different aspects of P2Y receptor signaling since the last review published by our International Union of Pharmacol. subcommittee.  More receptor subtypes have been cloned and characterized and most orphan receptors deorphanized, so that it is now possible to provide a basis for a future subdivision of P2Y receptor subtypes.  More is known about the functional elements of the P2Y receptor mols. and the signaling pathways involved, including interactions with ion channels.  There have been substantial developments in the design of selective agonists and antagonists to some of the P2Y receptor subtypes.  There are new findings about the mechanisms underlying nucleotide release and ectoenzymic nucleotide breakdown.  Interactions between P2Y receptors and receptors to other signaling mols. have been explored as well as P2Y-mediated control of gene transcription.  The distribution and roles of P2Y receptor subtypes in many different cell types are better understood and P2Y receptor-related compds. are being explored for therapeutic purposes.  These and other advances are discussed in the present review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3-m5Cf-JzaLVg90H21EOLACvtfcHk0ljmeIbihg2ciQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLbF&md5=b302ee34857a5f45d740e4f2e962ed42</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.3%26sid%3Dliteratum%253Aachs%26aulast%3DAbbracchio%26aufirst%3DM.%2BP.%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DBoeynaems%26aufirst%3DJ.%2BM.%26aulast%3DBarnard%26aufirst%3DE.%2BA.%26aulast%3DBoyer%26aufirst%3DJ.%2BL.%26aulast%3DKennedy%26aufirst%3DC.%26aulast%3DKnight%26aufirst%3DG.%2BE.%26aulast%3DFumagalli%26aufirst%3DM.%26aulast%3DGachet%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DWeisman%26aufirst%3DG.%2BA.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology%2520LVIII%253A%2520update%2520on%2520the%2520P2Y%2520G%2520protein-coupled%2520nucleotide%2520receptors%253A%2520from%2520molecular%2520mechanisms%2520and%2520pathophysiology%2520to%2520therapy%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D281%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Nichols, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yerxa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellerman, D. J.</span><span> </span><span class="NLM_article-title">Diquafosol tetrasodium: a novel dry eye therapy</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1517%2F13543784.13.1.47" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=14680452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVequ7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=47-54&author=K.+K.+Nicholsauthor=B.+Yerxaauthor=D.+J.+Kellerman&title=Diquafosol+tetrasodium%3A+a+novel+dry+eye+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Diquafosol tetrasodium: a novel dry eye therapy</span></div><div class="casAuthors">Nichols, Kelly K.; Yerxa, Ben; Kellerman, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-54</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The ophthalmic formulation of diquafosol tetrasodium (INS365), a P2Y2 receptor agonist, is targeted to treat dry eye disease through rehydration of the ocular surface.  Existing pharmacol. therapies for dry eye disease are limited, therefore, approval of this medication is anticipated.  This review summarizes key findings during development and in clin. trials including clin. effectiveness and safety.  The relevance of P2Y2 receptor technol. to dry eye disease and the disease process is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZv98y57kHe7Vg90H21EOLACvtfcHk0ljmeIbihg2ciQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVequ7k%253D&md5=e55e928b3e9fdefb96ff0e1237f867e2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543784.13.1.47&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.13.1.47%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DK.%2BK.%26aulast%3DYerxa%26aufirst%3DB.%26aulast%3DKellerman%26aufirst%3DD.%2BJ.%26atitle%3DDiquafosol%2520tetrasodium%253A%2520a%2520novel%2520dry%2520eye%2520therapy%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D13%26spage%3D47%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Yerxa, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabater, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutts, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang-Furr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowlen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, R. C.</span><span> </span><span class="NLM_article-title">Pharmacology of INS37217 [P(1)-(uridine 5′)-P(4)- (2′-deoxycytidine 5′)tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">880</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1124%2Fjpet.102.035485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=12183642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsF2hs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2002&pages=871-880&author=B.+R.+Yerxaauthor=J.+R.+Sabaterauthor=C.+W.+Davisauthor=M.+J.+Stuttsauthor=M.+Lang-Furrauthor=M.+Picherauthor=A.+C.+Jonesauthor=M.+Cowlenauthor=R.+Doughertyauthor=J.+Boyerauthor=W.+M.+Abrahamauthor=R.+C.+Boucher&title=Pharmacology+of+INS37217+%5BP%281%29-%28uridine+5%E2%80%B2%29-P%284%29-+%282%E2%80%B2-deoxycytidine+5%E2%80%B2%29tetraphosphate%2C+tetrasodium+salt%5D%2C+a+next-generation+P2Y%282%29+receptor+agonist+for+the+treatment+of+cystic+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of INS37217 [P1-(uridine 5')-P4-(2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y2 receptor agonist for the treatment of cystic fibrosis</span></div><div class="casAuthors">Yerxa, B. R.; Sabater, J. R.; Davis, C. W.; Stutts, M. J.; Lang-Furr, M.; Picher, M.; Jones, A. C.; Cowlen, M.; Dougherty, R.; Boyer, J.; Abraham, W. M.; Boucher, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">871-880</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">INS37217 [P1-(uridine 5')-P4-(2'-deoxycytidine 5')tetraphosphate, tetrasodium salt] is a deoxycytidine-uridine dinucleotide with agonist activity at the P2Y2 receptor.  In primate lung tissues, the P2Y2 receptor mRNA was located by in situ hybridization predominantly in epithelial cells and not in smooth muscle or stromal tissue.  The pharmacol. profile of INS37217 parallels that of UTP, leading to increased chloride and water secretion, increased cilia beat frequency, and increased mucin release.  The combined effect of these actions was confirmed in an animal model of tracheal mucus velocity that showed that a single administration of INS37217 significantly enhanced mucus transport for at least 8 h after dosing.  This extended duration of action is consistent with the ability of INS37217 to resist metab. by airway cells and sputum enzymes.  The enhanced metabolic stability and resultant increased duration of improved mucociliary clearance may confer significant advantages to INS37217 over other P2Y2 agonists in the treatment of diseases such as cystic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-amp_4RhjqbVg90H21EOLACvtfcHk0lgMywLUJ_98dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsF2hs7Y%253D&md5=c3730118238defb16024eeb0c29bab21</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.035485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.035485%26sid%3Dliteratum%253Aachs%26aulast%3DYerxa%26aufirst%3DB.%2BR.%26aulast%3DSabater%26aufirst%3DJ.%2BR.%26aulast%3DDavis%26aufirst%3DC.%2BW.%26aulast%3DStutts%26aufirst%3DM.%2BJ.%26aulast%3DLang-Furr%26aufirst%3DM.%26aulast%3DPicher%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DA.%2BC.%26aulast%3DCowlen%26aufirst%3DM.%26aulast%3DDougherty%26aufirst%3DR.%26aulast%3DBoyer%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DW.%2BM.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26atitle%3DPharmacology%2520of%2520INS37217%2520%255BP%25281%2529-%2528uridine%25205%25E2%2580%25B2%2529-P%25284%2529-%2520%25282%25E2%2580%25B2-deoxycytidine%25205%25E2%2580%25B2%2529tetraphosphate%252C%2520tetrasodium%2520salt%255D%252C%2520a%2520next-generation%2520P2Y%25282%2529%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520cystic%2520fibrosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D302%26spage%3D871%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hechler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenain, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchese, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vial, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazenave, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachet, C.</span><span> </span><span class="NLM_article-title">A role of the fast ATP-gated P2X<sub>1</sub> cation channel in thrombosis of small arteries in vivo</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">198</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1084%2Fjem.20030144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=12913094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1WisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2003&pages=661-667&author=B.+Hechlerauthor=N.+Lenainauthor=P.+Marcheseauthor=C.+Vialauthor=V.+Heimauthor=M.+Freundauthor=J.+P.+Cazenaveauthor=M.+Cattaneoauthor=Z.+M.+Ruggeriauthor=R.+Evansauthor=C.+Gachet&title=A+role+of+the+fast+ATP-gated+P2X1+cation+channel+in+thrombosis+of+small+arteries+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo</span></div><div class="casAuthors">Hechler, Beatrice; Lenain, Nadege; Marchese, Patrizia; Vial, Catherine; Heim, Veronique; Freund, Monique; Cazenave, Jean-Pierre; Cattaneo, Marco; Ruggeri, Zaverio M.; Evans, Richard; Gachet, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">661-667</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The P2X1 receptor is a fast ATP-gated cation channel expressed in blood platelets, where its role has been difficult to assess due to its rapid desensitization and the lack of pharmacol. tools.  In this paper, we have used P2X1-/- and wild-type mouse platelets, treated with apyrase to prevent desensitization, to demonstrate the function of P2X1 in the response to thrombogenic stimuli.  In vitro, the collagen-induced aggregation and secretion of P2X1-deficient platelets was decreased, as was adhesion and thrombus growth on a collagen-coated surface, particularly when the wall shear rate was elevated.  In vivo, the functional role of P2X1 could be demonstrated using two models of platelet-dependent thrombotic occlusion of small arteries, in which blood flow is characterized by a high shear rate.  The mortality of P2X1-/- mice in a model of systemic thromboembolism was reduced and the size of mural thrombi formed after a laser-induced vessel wall injury was decreased as compared with normal mice, whereas the time for complete thrombus removal was shortened.  Overall, the P2X1 receptor appears to contribute to the formation of platelet thrombi, particularly in arteries in which shear forces are high.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHh7SuXMrv7LVg90H21EOLACvtfcHk0lgMywLUJ_98dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1WisLc%253D&md5=f71b408b4adee16a3f09f8f2b2daa65d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1084%2Fjem.20030144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20030144%26sid%3Dliteratum%253Aachs%26aulast%3DHechler%26aufirst%3DB.%26aulast%3DLenain%26aufirst%3DN.%26aulast%3DMarchese%26aufirst%3DP.%26aulast%3DVial%26aufirst%3DC.%26aulast%3DHeim%26aufirst%3DV.%26aulast%3DFreund%26aufirst%3DM.%26aulast%3DCazenave%26aufirst%3DJ.%2BP.%26aulast%3DCattaneo%26aufirst%3DM.%26aulast%3DRuggeri%26aufirst%3DZ.%2BM.%26aulast%3DEvans%26aufirst%3DR.%26aulast%3DGachet%26aufirst%3DC.%26atitle%3DA%2520role%2520of%2520the%2520fast%2520ATP-gated%2520P2X1%2520cation%2520channel%2520in%2520thrombosis%2520of%2520small%2520arteries%2520in%2520vivo%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2003%26volume%3D198%26spage%3D661%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Cattaneo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachet, C.</span><span> </span><span class="NLM_article-title">ADP receptors and clinical bleeding disorders</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2281</span><span class="NLM_x">–</span> <span class="NLM_lpage">2285</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=10521355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFGitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=2281-2285&author=M.+Cattaneoauthor=C.+Gachet&title=ADP+receptors+and+clinical+bleeding+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">ADP receptors and clinical bleeding disorders</span></div><div class="casAuthors">Cattaneo, Marco; Gachet, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2281-2285</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  ADP plays a key role in hemostasis and thrombosis.  Despite its early identification in 1961 as the first known aggregating agent, the mol. basis of ADP-induced platelet activation is only beginning to be understood.  The present review proposes a model of 3 purinergic receptors contributing sep. to the complex process of ADP-induced platelet aggregation: the P2X1 ionotropic receptor, responsible for rapid influx of ionized calcium into the cytosol; the P2Y1 metabotropic receptor, responsible for mobilization of ionized calcium from internal stores, which initiates aggregation; and an as-yet-unidentified P2Y receptor coupled to Gαi2, which is essential for the full aggregation response to ADP.  It is probable that this as-yet-unidentified receptor is the mol. target of the ADP-selective antiaggregating drugs ticlopidine and clopidogrel.  In addn., it is probably defective in patients with a bleeding diathesis that is characterized by selective impairment of platelet responses to ADP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhpn3cL0czd7Vg90H21EOLACvtfcHk0li_A28_h-HN4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFGitrk%253D&md5=129bef84c60274c44fd8024b68fec686</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCattaneo%26aufirst%3DM.%26aulast%3DGachet%26aufirst%3DC.%26atitle%3DADP%2520receptors%2520and%2520clinical%2520bleeding%2520disorders%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D1999%26volume%3D19%26spage%3D2281%26epage%3D2285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hollopeter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantzen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishnan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurden, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conley, P. B.</span><span> </span><span class="NLM_article-title">Identification of the platelet ADP receptor targeted by antithrombotic drugs</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">409</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1038%2F35051599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11196645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFSktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=409&publication_year=2001&pages=202-207&author=G.+Hollopeterauthor=H.+M.+Jantzenauthor=D.+Vincentauthor=G.+Liauthor=L.+Englandauthor=V.+Ramakrishnanauthor=R.+B.+Yanauthor=A.+Nurdenauthor=D.+Juliusauthor=P.+B.+Conley&title=Identification+of+the+platelet+ADP+receptor+targeted+by+antithrombotic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the platelet ADP receptor targeted by antithrombotic drugs</span></div><div class="casAuthors">Hollopeter, Gunther; Jantzen, Hans-Michiel; Vincent, Diana; Li, Georgia; England, Laura; Ramakrishnan, Vanitha; Yang, Ruey-Bing; Nurden, Paquita; Nurden, Alan; Julius, David; Conley, Pamela B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">409</span>
        (<span class="NLM_cas:issue">6817</span>),
    <span class="NLM_cas:pages">202-207</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Platelets have a crucial role in the maintenance of normal hemostasis, and perturbations of this system can lead to pathol. thrombus formation and vascular occlusion, resulting in stroke; myocardial infarction and unstable angina.  ADP released from damaged vessels and red blood cells induces platelet aggregation through activation of the integrin GPIIb-IIIa and subsequent binding of fibrinogen.  ADP is also secreted from platelets on activation, providing pos. feedback that potentiates the actions of many platelet activators.  ADP mediates platelet aggregation through its action on two G-protein-coupled receptor subtypes.  The P2Y1 receptor couples to Gq and. mobilizes intracellular calcium ions to mediate platelet shape change and aggregation.  The second ADP receptor required for aggregation (variously called P2YADP, P2YAC, P2Ycyc or P2TAC) is coupled to the inhibition of adenylyl cyclase through Gi.  The mol. identity of the Gi-linked receptor is still elusive, even though it is the target of efficacious antithrombotic agents, such as ticlopidine and clopidogrel and AR-C66096. Here the authors describe the cloning of this receptor, designated P2Y12, and provide evidence that a patient with a bleeding disorder has a defect in this gene.  Cloning of the P2Y12 receptor should facilitate the development- of better antiplatelet agents to treat cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbNuDi2tNS7bVg90H21EOLACvtfcHk0li_A28_h-HN4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFSktQ%253D%253D&md5=fe30017f0d3bd9aacb4ad3bd6189c5d9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F35051599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35051599%26sid%3Dliteratum%253Aachs%26aulast%3DHollopeter%26aufirst%3DG.%26aulast%3DJantzen%26aufirst%3DH.%2BM.%26aulast%3DVincent%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DEngland%26aufirst%3DL.%26aulast%3DRamakrishnan%26aufirst%3DV.%26aulast%3DYan%26aufirst%3DR.%2BB.%26aulast%3DNurden%26aufirst%3DA.%26aulast%3DJulius%26aufirst%3DD.%26aulast%3DConley%26aufirst%3DP.%2BB.%26atitle%3DIdentification%2520of%2520the%2520platelet%2520ADP%2520receptor%2520targeted%2520by%2520antithrombotic%2520drugs%26jtitle%3DNature%26date%3D2001%26volume%3D409%26spage%3D202%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gachet, C.</span><span> </span><span class="NLM_article-title">Identification, characterization, and inhibition of the platelet ADP receptors</span> <span class="citation_source-journal">Int. J. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11794691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVCktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2001&pages=375-381&author=C.+Gachet&title=Identification%2C+characterization%2C+and+inhibition+of+the+platelet+ADP+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Identification, characterization, and inhibition of the platelet ADP receptors</span></div><div class="casAuthors">Gachet, Christian</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Hematology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">IJHEEY</span>;
        ISSN:<span class="NLM_cas:issn">0925-5710</span>.
    
            (<span class="NLM_cas:orgname">Carden Jennings Publishing</span>)
        </div><div class="casAbstract">A review.  ADP (ADP) plays a crucial role in hemostasis and thrombosis, and its receptors are potential targets for antithrombotic drugs.  Two G-protein-coupled P2 receptors contribute to platelet aggregation: the P2Y1 receptor initiates aggregation through mobilization of calcium stores, whereas the P2Y12 receptor coupled to adenylyl cyclase inhibition is essential for a full aggregation response to ADP and the stabilization of aggregates.  The latter is defective in certain patients with a selective congenital deficiency of aggregation to ADP.  It is also the target of the antithrombotic drug clopidogrel and of ATP analogs and other compds. currently under evaluation.  In addn., the P2X1 ionotropic receptor is present in platelets, but its role is not yet completely known.  Studies in P2Y1-knockout mice and exptl. thrombosis models using selective P2Y1 antagonists have shown that the P2Y1 receptor, like the P2Y12 receptor, is a potential target for new antithrombotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVFgMG2VsVULVg90H21EOLACvtfcHk0li_A28_h-HN4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVCktw%253D%253D&md5=c6cb4320d104c9bc181b7cd1803c5c90</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGachet%26aufirst%3DC.%26atitle%3DIdentification%252C%2520characterization%252C%2520and%2520inhibition%2520of%2520the%2520platelet%2520ADP%2520receptors%26jtitle%3DInt.%2520J.%2520Hematol.%26date%3D2001%26volume%3D74%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Dogne, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leval, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benoit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, J. L.</span><span> </span><span class="NLM_article-title">Recent advances in antiplatelet agents</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.2174%2F0929867024606948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11945125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD38XislGmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=577-589&author=J.+M.+Dogneauthor=X.+de+Levalauthor=P.+Benoitauthor=J.+Delargeauthor=B.+Masereelauthor=J.+L.+David&title=Recent+advances+in+antiplatelet+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in antiplatelet agents</span></div><div class="casAuthors">Dogne, Jean-Michel; De Leval, Xavier; Benoit, Patricia; Delarge, Jacques; Masereel, Bernard; David, Jean-Louis</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">577-589</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review.  Platelet aggregation plays a key role in the pathogenesis of thromboembolic diseases such as myocardial infarction, stroke, unstable angina and peripheral artery disease.  Until recently, aspirin was the only antiplatelet agent available to prevent or treat these events.  Over the past several years, there has been a substantial expansion in the antiplatelet armamentarium as well as in the understanding of the clin. importance of antiplatelet therapy in limiting the complications of thrombosis.  Aspirin was one of the first agents to be adopted and it remains as the std. therapy with the higher amt. of available clin. information.  Following aspirin, ADP receptor antagonists like ticlopidine and clopidogrel as well as phosphodiesterase inhibitors dipyridamole and cilostazol have been introduced.  Glycoprotein (GP) IIb/IIIa receptor antagonists like eptifibatide, tirofiban and abciximab are the newer antiplatelet agents which act at the end of the common pathway of platelet aggregation.  Although results of clin. studies with the first oral GPIIb/IIIa antagonists were disappointing, agents of the new generation might expand the potential application of GPIIb/IIIa targeted therapy.  This review will highlight recent advances in the development of aspirin, phosphodiesterase inhibitors, ADP receptor antagonists and the platelet glycoprotein IIb/IIIa inhibitors.  The emphasis of this paper has been placed on the chem. aspects of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiRrsDrA0l5bVg90H21EOLACvtfcHk0lgb-CZrwDrQkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislGmt7s%253D&md5=87aa6ec800724fef1c385969d75cc407</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F0929867024606948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867024606948%26sid%3Dliteratum%253Aachs%26aulast%3DDogne%26aufirst%3DJ.%2BM.%26aulast%3Dde%2BLeval%26aufirst%3DX.%26aulast%3DBenoit%26aufirst%3DP.%26aulast%3DDelarge%26aufirst%3DJ.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DDavid%26aufirst%3DJ.%2BL.%26atitle%3DRecent%2520advances%2520in%2520antiplatelet%2520agents%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2002%26volume%3D9%26spage%3D577%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ingall, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInally, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kindon, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teobald, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clegg, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, W.</span><span> </span><span class="NLM_article-title">Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm981072s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFartg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=213-220&author=A.+H.+Ingallauthor=J.+Dixonauthor=A.+Baileyauthor=M.+E.+Coombsauthor=D.+Coxauthor=J.+I.+McInallyauthor=S.+F.+Huntauthor=N.+D.+Kindonauthor=B.+J.+Teobaldauthor=P.+A.+Willisauthor=R.+G.+Humphriesauthor=P.+Leffauthor=J.+A.+Cleggauthor=J.+A.+Smithauthor=W.+Tomlinson&title=Antagonists+of+the+platelet+P2T+receptor%3A+a+novel+approach+to+antithrombotic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonists of the Platelet P2T Receptor: A Novel Approach to Antithrombotic Therapy</span></div><div class="casAuthors">Ingall, Anthony H.; Dixon, John; Bailey, Andrew; Coombs, Mandy E.; Cox, David; McInally, Judith I.; Hunt, Simon F.; Kindon, Nicholas D.; Teobald, Barry J.; Willis, Paul A.; Humphries, Robert G.; Leff, Paul; Clegg, Jane A.; Smith, James A.; Tomlinson, Wendy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-220</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The platelet P2T receptor plays a major role in platelet aggregation, and its antagonists are predicted to have significant therapeutic potential as antithrombotic agents.  We have explored analogs of ATP, which is a weak, nonselective but competitive P2T receptor antagonist.  Modification of the polyphosphate side chain to prevent breakdown to the agonist ADP and substitution of the adenine moiety to enhance affinity and selectivity for the P2T receptor led to the identification of compd. AR-C67085MX, having an IC50 of 2.5 nM against ADP-induced aggregation of human platelets.  This compd. was the first very potent antagonist of the P2T receptor, with a selectivity for that subtype of the P2 receptor family of >1000-fold.  Further modification of the structure produced compd. AR-C69931MX having an IC50 of 0.4 nM.  In vivo, at maximally effective antithrombotic doses, there is little prolongation of bleeding time (1.4-fold), which is in marked contrast to the 5-6-fold found with GPIIb/IIIa antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMgNOWrXPnEbVg90H21EOLACvtfcHk0lgb-CZrwDrQkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFartg%253D%253D&md5=82328b71981a7200181f7719b74248f8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm981072s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm981072s%26sid%3Dliteratum%253Aachs%26aulast%3DIngall%26aufirst%3DA.%2BH.%26aulast%3DDixon%26aufirst%3DJ.%26aulast%3DBailey%26aufirst%3DA.%26aulast%3DCoombs%26aufirst%3DM.%2BE.%26aulast%3DCox%26aufirst%3DD.%26aulast%3DMcInally%26aufirst%3DJ.%2BI.%26aulast%3DHunt%26aufirst%3DS.%2BF.%26aulast%3DKindon%26aufirst%3DN.%2BD.%26aulast%3DTeobald%26aufirst%3DB.%2BJ.%26aulast%3DWillis%26aufirst%3DP.%2BA.%26aulast%3DHumphries%26aufirst%3DR.%2BG.%26aulast%3DLeff%26aufirst%3DP.%26aulast%3DClegg%26aufirst%3DJ.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DTomlinson%26aufirst%3DW.%26atitle%3DAntagonists%2520of%2520the%2520platelet%2520P2T%2520receptor%253A%2520a%2520novel%2520approach%2520to%2520antithrombotic%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D213%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Leon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hechler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vial, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazenave, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachet, C.</span><span> </span><span class="NLM_article-title">The P2Y<sub>1</sub> receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">403</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=1997&pages=26-30&author=C.+Leonauthor=B.+Hechlerauthor=C.+Vialauthor=C.+Lerayauthor=J.+P.+Cazenaveauthor=C.+Gachet&title=The+P2Y1+receptor+is+an+ADP+receptor+antagonized+by+ATP+and+expressed+in+platelets+and+megakaryoblastic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeon%26aufirst%3DC.%26aulast%3DHechler%26aufirst%3DB.%26aulast%3DVial%26aufirst%3DC.%26aulast%3DLeray%26aufirst%3DC.%26aulast%3DCazenave%26aufirst%3DJ.%2BP.%26aulast%3DGachet%26aufirst%3DC.%26atitle%3DThe%2520P2Y1%2520receptor%2520is%2520an%2520ADP%2520receptor%2520antagonized%2520by%2520ATP%2520and%2520expressed%2520in%2520platelets%2520and%2520megakaryoblastic%2520cells%26jtitle%3DFEBS%2520Lett.%26date%3D1997%26volume%3D403%26spage%3D26%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kauffenstein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hechler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazenave, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gachet, C.</span><span> </span><span class="NLM_article-title">Adenine triphosphate nucleotides are antagonists at the P2Y receptor</span> <span class="citation_source-journal">Thromb. Haemost.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1980</span><span class="NLM_x">–</span> <span class="NLM_lpage">1988</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1111%2Fj.1538-7836.2004.00926.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFagsL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=1980-1988&author=G.+Kauffensteinauthor=B.+Hechlerauthor=J.+P.+Cazenaveauthor=C.+Gachet&title=Adenine+triphosphate+nucleotides+are+antagonists+at+the+P2Y+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Adenine triphosphate nucleotides are antagonists at the P2Y12 receptor</span></div><div class="casAuthors">Kauffenstein, G.; Hechler, B.; Cazenave, J.-P.; Gachet, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1980-1988</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The aim of the present study was to characterize the pharmacol. profile of the P2Y12 receptor for several adenine triphosphate nucleotides in view of their possible roles as partial agonists or true antagonists.  Two distinct cellular systems were used: P2Y1 receptor deficient mouse platelets (P2Y-/-1 platelets) previously shown to express a native and functional P2Y12 receptor and 1321 N1 astrocytoma cells stably expressing the human P2Y12 receptor (1321 N1 P2Y12).  ADP and its structural analogs inhibited cAMP accumulation in a dose-dependent manner in both P2Y-/-1 platelets and 1321 N1 P2Y12 cells with a similar rank order of potency, 2 methylthio-ADP (2MeSADP) > > ADP-Adenosine 5'-(βthio) diphosphate (ADPβS).  Com. ATP, 2 chloro-ATP (2ClATP) and 2 methylthio-ATP (2MeSATP) also inhibited cAMP accumulation in both cell systems.  In contrast, after creatine phosphate (CP)/creatine phosphokinase (CPK) regeneration, adenine triphosphate nucleotides lost their agonistic effect on P2Y-/-1 platelets and behaved as antagonists of ADP (0.5 μM)-induced adenylyl cyclase inhibition with IC50 of 13.5±4.8, 838±610, 1280±1246 μM for 2MeSATP, ATP and 2ClATP, resp.  In 1321 N1 P2Y12 cells, CP/CPK regenerated ATP and 2ClATP lost their agonistic effect only when CP/CPK was maintained during the cAMP assay.  The stable ATP analog ATPγS antagonized ADPβS-induced inhibition of cAMP accumulation in both P2Y-/-1 platelets and 1321 N1 P2Y12 cells.  Thus, ATP and its triphosphate analogs are not agonists but rather antagonists at the P2Y12 receptor expressed in platelets or transfected cells, provided care is taken to remove diphosphate contaminants and to prevent the generation of diphosphate nucleotide derivs. by cell Ectonucleotidases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI_kgO7RQAP7Vg90H21EOLACvtfcHk0li2uQXTjPuy8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFagsL3N&md5=9e468ae6832bb040db72eb0985ac0d69</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2004.00926.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2004.00926.x%26sid%3Dliteratum%253Aachs%26aulast%3DKauffenstein%26aufirst%3DG.%26aulast%3DHechler%26aufirst%3DB.%26aulast%3DCazenave%26aufirst%3DJ.%2BP.%26aulast%3DGachet%26aufirst%3DC.%26atitle%3DAdenine%2520triphosphate%2520nucleotides%2520are%2520antagonists%2520at%2520the%2520P2Y%2520receptor%26jtitle%3DThromb.%2520Haemost.%26date%3D2004%26volume%3D2%26spage%3D1980%26epage%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Humphries, R. G.</span><span> </span><span class="NLM_article-title">Pharmacology of AR-C69931MX and related compounds: from pharmacological tools to clinical trials</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=66-72&author=R.+G.+Humphries&title=Pharmacology+of+AR-C69931MX+and+related+compounds%3A+from+pharmacological+tools+to+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHumphries%26aufirst%3DR.%2BG.%26atitle%3DPharmacology%2520of%2520AR-C69931MX%2520and%2520related%2520compounds%253A%2520from%2520pharmacological%2520tools%2520to%2520clinical%2520trials%26jtitle%3DHaematologica%26date%3D2000%26volume%3D85%26spage%3D66%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Greenbaum, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grines, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kereiakes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilchrist, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clegg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stankowski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grogan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuelsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, W. D.</span><span> </span><span class="NLM_article-title">Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: result from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial</span> <span class="citation_source-journal">Am. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">689e1</span><span class="NLM_x">–</span> <span class="NLM_lpage">689e10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2006&pages=689e1-689e10&author=A.+B.+Greenbaumauthor=C.+L.+Grinesauthor=J.+A.+Bittlauthor=R.+C.+Beckerauthor=D.+J.+Kereiakesauthor=I.+C.+Gilchristauthor=J.+Cleggauthor=J.+E.+Stankowskiauthor=D.+R.+Groganauthor=R.+A.+Harringtonauthor=H.+Emanuelssonauthor=W.+D.+Weaver&title=Initial+experience+with+an+intravenous+P2Y12+platelet+receptor+antagonist+in+patients+undergoing+percutaneous+coronary+intervention%3A+result+from+a+2-part%2C+phase+II%2C+multicenter%2C+randomized%2C+placebo-+and+active-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreenbaum%26aufirst%3DA.%2BB.%26aulast%3DGrines%26aufirst%3DC.%2BL.%26aulast%3DBittl%26aufirst%3DJ.%2BA.%26aulast%3DBecker%26aufirst%3DR.%2BC.%26aulast%3DKereiakes%26aufirst%3DD.%2BJ.%26aulast%3DGilchrist%26aufirst%3DI.%2BC.%26aulast%3DClegg%26aufirst%3DJ.%26aulast%3DStankowski%26aufirst%3DJ.%2BE.%26aulast%3DGrogan%26aufirst%3DD.%2BR.%26aulast%3DHarrington%26aufirst%3DR.%2BA.%26aulast%3DEmanuelsson%26aufirst%3DH.%26aulast%3DWeaver%26aufirst%3DW.%2BD.%26atitle%3DInitial%2520experience%2520with%2520an%2520intravenous%2520P2Y12%2520platelet%2520receptor%2520antagonist%2520in%2520patients%2520undergoing%2520percutaneous%2520coronary%2520intervention%253A%2520result%2520from%2520a%25202-part%252C%2520phase%2520II%252C%2520multicenter%252C%2520randomized%252C%2520placebo-%2520and%2520active-controlled%2520trial%26jtitle%3DAm.%2520Heart%2520J.%26date%3D2006%26volume%3D151%26spage%3D689e1%26epage%3D689e10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Husted, S.; Emanuelsson, H.; Heptinstall, S.; Clark, S.; Peters, G.</span> Greater and Less Variable Inhibition of Platelet Aggregation (IPA) with AZD6140, the First Oral Reversible ADP Receptor Antagonist, Compared with Clopidogrel in Patients with Atherosclerosis (The DISPERSE Study). Presented at European Society of Cardiology (ESC), Stockholm, Sweden, 7th September,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Husted%2C+S.%3B+Emanuelsson%2C+H.%3B+Heptinstall%2C+S.%3B+Clark%2C+S.%3B+Peters%2C+G.+Greater+and+Less+Variable+Inhibition+of+Platelet+Aggregation+%28IPA%29+with+AZD6140%2C+the+First+Oral+Reversible+ADP+Receptor+Antagonist%2C+Compared+with+Clopidogrel+in+Patients+with+Atherosclerosis+%28The+DISPERSE+Study%29.+Presented+at+European+Society+of+Cardiology+%28ESC%29%2C+Stockholm%2C+Sweden%2C+7th+September%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHusted%26aufirst%3DS.%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Scarborough, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laibelman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clizbe, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fretto, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conley, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedlock, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantzen, H.</span><span> </span><span class="NLM_article-title">Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y(12))</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1805</span><span class="NLM_x">–</span> <span class="NLM_lpage">1808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1805-1808&author=R.+M.+Scarboroughauthor=A.+M.+Laibelmanauthor=L.+A.+Clizbeauthor=L.+J.+Frettoauthor=P.+B.+Conleyauthor=E.+E.+Reynoldsauthor=D.+M.+Sedlockauthor=H.+Jantzen&title=Novel+tricyclic+benzothiazolo%5B2%2C3-c%5Dthiadiazine+antagonists+of+the+platelet+ADP+receptor+%28P2Y%2812%29%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26aulast%3DLaibelman%26aufirst%3DA.%2BM.%26aulast%3DClizbe%26aufirst%3DL.%2BA.%26aulast%3DFretto%26aufirst%3DL.%2BJ.%26aulast%3DConley%26aufirst%3DP.%2BB.%26aulast%3DReynolds%26aufirst%3DE.%2BE.%26aulast%3DSedlock%26aufirst%3DD.%2BM.%26aulast%3DJantzen%26aufirst%3DH.%26atitle%3DNovel%2520tricyclic%2520benzothiazolo%255B2%252C3-c%255Dthiadiazine%2520antagonists%2520of%2520the%2520platelet%2520ADP%2520receptor%2520%2528P2Y%252812%2529%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1805%26epage%3D1808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Scarborough, R. W.; Grant, C. M.; Zhang, X.; Cannon, H.; Huang, W.; Mehrotra, M.</span> 4-(6-Halo-7-substituted-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl-5-chloro-thiophen-2-yl-sulfonylureas and Forms and Methods Related Thereto. PCT Intl. Pat. Appl. 2007/056219 May 18,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Scarborough%2C+R.+W.%3B+Grant%2C+C.+M.%3B+Zhang%2C+X.%3B+Cannon%2C+H.%3B+Huang%2C+W.%3B+Mehrotra%2C+M.+4-%286-Halo-7-substituted-2%2C4-dioxo-1%2C4-dihydro-2H-quinazolin-3-yl%29-phenyl-5-chloro-thiophen-2-yl-sulfonylureas+and+Forms+and+Methods+Related+Thereto.+PCT+Intl.+Pat.+Appl.+2007%2F056219+May+18%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DScarborough%26aufirst%3DR.%2BW.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Wang, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincelette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Cunha, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-McNulty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckman, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergona, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dole, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, J.</span><span> </span><span class="NLM_article-title">A novel P2Y<sub>12</sub> adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models</span> <span class="citation_source-journal">Thromb. Haemost.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=17479197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvVGrtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2007&pages=847-55&author=Y.+X.+Wangauthor=J.+Vinceletteauthor=V.+da+Cunhaauthor=B.+Martin-McNultyauthor=C.+Mallariauthor=R.+M.+Fitchauthor=S.+Alexanderauthor=I.+Islamauthor=B.+O.+Buckmanauthor=S.+Yuanauthor=J.+M.+Postauthor=B.+Subramanyamauthor=R.+Vergonaauthor=M.+E.+Sullivanauthor=W.+P.+Doleauthor=J.+Morserauthor=J.+Bryant&title=A+novel+P2Y12+adenosine+diphosphate+receptor+antagonist+that+inhibits+platelet+aggregation+and+thrombus+formation+in+rat+and+dog+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A novel P2Y12 adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models</span></div><div class="casAuthors">Wang, Yi-Xin; Vincelette, Jon; da Cunha, Valdeci; Martin-McNulty, Baby; Mallari, Cornell; Fitch, Richard M.; Alexander, Serene; Islam, Imadul; Buckman, Brad O.; Yuan, Shendong; Post, Joseph M.; Subramanyam, Babu; Vergona, Ronald; Sullivan, Mark E.; Dole, William P.; Morser, John; Bryant, Judi</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">847-855</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Irreversible platelet inhibitors, such as aspirin and clopidogrel, have limited antithrombotic efficacy in the clinic due to their bleeding risk.  We have developed an orally active reversible P2Y12 receptor antagonist, BX 667.  The aim of this study was to det. if the reversible antagonist BX 667 had a greater therapeutic index than the irreversible P2Y12 receptor antagonist clopidogrel.  Since BX 667 is rapidly converted to its active metabolite BX 048 in rats, we first injected BX 048 i.v. in a rat arterial venous (A-V) shunt model of thrombosis.  BX 048 dose- and concn.-dependently attenuated thrombosis.  When administered orally, BX 667 and clopidogrel had similar efficacy, but BX 667 caused less bleeding than clopidogrel.  In a rat model of a platelet-rich thrombus induced by vessel injury with FeCl2, both BX 667 and clopidogrel exhibited higher levels of thrombus inhibition after oral administration compared to their potency in the A-V shunt model.  Again, BX 667 caused less bleeding than clopidogrel.  In a dog cyclic flow model, i.v. injection of either BX 667 or clopidogrel dose-dependently reduced thrombus formation with lower bleeding for BX 667 than clopidogrel.  Inhibition of thrombosis was highly correlated with inhibition of ADP-induced platelet aggregation in these animal models.  In dogs pre-treated with aspirin, BX 667 maintained its wider therapeutic index, measured by inhibition of platelet aggregation over bleeding, compared to the aspirin-clopidogrel combination.  These data demonstrate that the reversible P2Y12 receptor antagonist, BX 667, has a wider therapeutic index than clopidogrel in exptl. models of thrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA0dlxE8Vj3LVg90H21EOLACvtfcHk0lhi1j0OGs2w5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvVGrtb4%253D&md5=96a72e2264df899f95bbf91ee6a8a0a6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BX.%26aulast%3DVincelette%26aufirst%3DJ.%26aulast%3Dda%2BCunha%26aufirst%3DV.%26aulast%3DMartin-McNulty%26aufirst%3DB.%26aulast%3DMallari%26aufirst%3DC.%26aulast%3DFitch%26aufirst%3DR.%2BM.%26aulast%3DAlexander%26aufirst%3DS.%26aulast%3DIslam%26aufirst%3DI.%26aulast%3DBuckman%26aufirst%3DB.%2BO.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DPost%26aufirst%3DJ.%2BM.%26aulast%3DSubramanyam%26aufirst%3DB.%26aulast%3DVergona%26aufirst%3DR.%26aulast%3DSullivan%26aufirst%3DM.%2BE.%26aulast%3DDole%26aufirst%3DW.%2BP.%26aulast%3DMorser%26aufirst%3DJ.%26aulast%3DBryant%26aufirst%3DJ.%26atitle%3DA%2520novel%2520P2Y12%2520adenosine%2520diphosphate%2520receptor%2520antagonist%2520that%2520inhibits%2520platelet%2520aggregation%2520and%2520thrombus%2520formation%2520in%2520rat%2520and%2520dog%2520models%26jtitle%3DThromb.%2520Haemost.%26date%3D2007%26volume%3D97%26spage%3D847%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Harker, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boissel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilgrim, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gent, M.</span><span> </span><span class="NLM_article-title">Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events</span> <span class="citation_source-journal">Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.2165%2F00002018-199921040-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=10514023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADyaK1MXmslGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=325-335&author=L.+A.+Harkerauthor=J.+P.+Boisselauthor=A.+J.+Pilgrimauthor=M.+Gent&title=Comparative+safety+and+tolerability+of+clopidogrel+and+aspirin%3A+results+from+CAPRIE.+CAPRIE+Steering+Committee+and+Investigators.+Clopidogrel+versus+aspirin+in+patients+at+risk+of+ischaemic+events"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE</span></div><div class="casAuthors">Harker, Laurence A.; Boissel, Jean-Pierre; Pilgrim, Alison J.; Gent, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">325-335</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">The objective of this study was to provide a comprehensive comparison of the long term safety and tolerability of clopidogrel, a new ADP receptor antagonist that inhibits platelet activation induced by ADP, and aspirin (acetylsalicylic acid).  The study population comprised 19 185 patients with symptomatic atherosclerosis manifested as recent ischemic stroke, recent myocardial infarction or symptomatic peripheral arterial disease.  Patients were randomized to receive clopidogrel 75 mg/day or aspirin 325 mg/day for a min. of 1 yr and a max. of 3 yr.  Compared with aspirin, clopidogrel reduced the combined risk of ischemic stroke, myocardial infarction or vascular death by 8.7% (p = 0.043).  The incidence of early permanent discontinuations of the study drug due to adverse events was almost identical in both treatment groups (11.94% for clopidogrel vs. 11.92% for aspirin).  Reported neutropenia was similar in the clopidogrel and aspirin groups (0.10 vs. 0.17%, resp.) with corresponding rates (0.05 vs. 0.04%, resp.) for severe neutropenia.  Thrombocytopenia was identical in the clopidogrel and aspirin groups (0.26%), with the rates of severe thrombocytopenia being 0.19 vs. 0.10%, resp.  None of these obsd. differences was statistically significant.  The overall incidence of hemorrhagic events did not differ statistically significantly between treatment groups (9.27% for clopidogrel vs. 9.28% for aspirin; p = 0.98).  There was a trend towards a lower incidence of intracranial hemorrhage in the clopidogrel group (0.31%) compared with the aspirin group (0.42%).  Any reported gastrointestinal hemorrhage was significantly less frequent with clopidogrel (1.99%) than with aspirin (2.66%) [p < 0.002].  The corresponding data for severe gastrointestinal bleeding were 0.49 vs. 0.71%; p < 0.05.  Overall, there were significantly fewer gastrointestinal adverse events with clopidogrel than with aspirin (27.1 vs. 29.8%; p < 0.001), with less abdominal pain, dyspepsia, constipation, or peptic, gastric, or duodenal ulceration with clopidogrel.  Diarrhea was significantly more common in the clopidogrel group (4.46 vs. 3.36%; p<0.001), although the incidence of severe diarrhea (0.23 vs. 0.11%) was low and was not significantly different between groups.  There were significantly more patients with rash in the clopidogrel group (6.0%) compared with the aspirin group (4.6%) [p < 0.001].  However, these events were generally mild and transient in nature.  Given the favorable benefit/risk ratio, clopidogrel represents a clin. important advance in the treatment of patients with manifest atherosclerotic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWxjl3EauDS7Vg90H21EOLACvtfcHk0lhfHVzCw4bQNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslGhs7s%253D&md5=926618bb12abe8d13fcd6cb5cf9adb31</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2165%2F00002018-199921040-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-199921040-00007%26sid%3Dliteratum%253Aachs%26aulast%3DHarker%26aufirst%3DL.%2BA.%26aulast%3DBoissel%26aufirst%3DJ.%2BP.%26aulast%3DPilgrim%26aufirst%3DA.%2BJ.%26aulast%3DGent%26aufirst%3DM.%26atitle%3DComparative%2520safety%2520and%2520tolerability%2520of%2520clopidogrel%2520and%2520aspirin%253A%2520results%2520from%2520CAPRIE.%2520CAPRIE%2520Steering%2520Committee%2520and%2520Investigators.%2520Clopidogrel%2520versus%2520aspirin%2520in%2520patients%2520at%2520risk%2520of%2520ischaemic%2520events%26jtitle%3DDrug%2520Saf.%26date%3D1999%26volume%3D21%26spage%3D325%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Gent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easton, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hachinski, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbison, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicurella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turpie, A. G.</span><span> </span><span class="NLM_article-title">The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1215</span><span class="NLM_x">–</span> <span class="NLM_lpage">1220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1989&pages=1215-1220&author=M.+Gentauthor=J.+A.+Blakelyauthor=J.+D.+Eastonauthor=D.+J.+Ellisauthor=V.+C.+Hachinskiauthor=J.+W.+Harbisonauthor=E.+Panakauthor=R.+S.+Robertsauthor=J.+Sicurellaauthor=A.+G.+Turpie&title=The+Canadian+American+Ticlopidine+Study+%28CATS%29+in+thromboembolic+stroke"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGent%26aufirst%3DM.%26aulast%3DBlakely%26aufirst%3DJ.%2BA.%26aulast%3DEaston%26aufirst%3DJ.%2BD.%26aulast%3DEllis%26aufirst%3DD.%2BJ.%26aulast%3DHachinski%26aufirst%3DV.%2BC.%26aulast%3DHarbison%26aufirst%3DJ.%2BW.%26aulast%3DPanak%26aufirst%3DE.%26aulast%3DRoberts%26aufirst%3DR.%2BS.%26aulast%3DSicurella%26aufirst%3DJ.%26aulast%3DTurpie%26aufirst%3DA.%2BG.%26atitle%3DThe%2520Canadian%2520American%2520Ticlopidine%2520Study%2520%2528CATS%2529%2520in%2520thromboembolic%2520stroke%26jtitle%3DLancet%26date%3D1989%26volume%3D1%26spage%3D1215%26epage%3D1220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Bertrand, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershlick, A. H.</span><span> </span><span class="NLM_article-title">Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS)</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=624-629&author=M.+E.+Bertrandauthor=H.+J.+Rupprechtauthor=P.+Urbanauthor=A.+H.+Gershlick&title=Double-blind+study+of+the+safety+of+clopidogrel+with+and+without+a+loading+dose+in+combination+with+aspirin+compared+with+ticlopidine+in+combination+with+aspirin+after+coronary+stenting%3A+the+clopidogrel+aspirin+stent+international+cooperative+study+%28CLASSICS%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DM.%2BE.%26aulast%3DRupprecht%26aufirst%3DH.%2BJ.%26aulast%3DUrban%26aufirst%3DP.%26aulast%3DGershlick%26aufirst%3DA.%2BH.%26atitle%3DDouble-blind%2520study%2520of%2520the%2520safety%2520of%2520clopidogrel%2520with%2520and%2520without%2520a%2520loading%2520dose%2520in%2520combination%2520with%2520aspirin%2520compared%2520with%2520ticlopidine%2520in%2520combination%2520with%2520aspirin%2520after%2520coronary%2520stenting%253A%2520the%2520clopidogrel%2520aspirin%2520stent%2520international%2520cooperative%2520study%2520%2528CLASSICS%2529%26jtitle%3DCirculation%26date%3D2000%26volume%3D102%26spage%3D624%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Savi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereillo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzabiaga, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combalbert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffrand, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbert, J. M.</span><span> </span><span class="NLM_article-title">Identification and biological activity of the active metabolite of clopidogrel</span> <span class="citation_source-journal">Thromb. Haemost.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">891</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1055%2Fs-0037-1614133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11127873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFCjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2000&pages=891-896&author=P.+Saviauthor=J.+M.+Pereilloauthor=M.+F.+Uzabiagaauthor=J.+Combalbertauthor=C.+Picardauthor=J.+P.+Maffrandauthor=M.+Pascalauthor=J.+M.+Herbert&title=Identification+and+biological+activity+of+the+active+metabolite+of+clopidogrel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and biological activity of the active metabolite of clopidogrel</span></div><div class="casAuthors">Savi, P.; Pereillo, J. M.; Uzabiaga, M. F.; Combalbert, J.; Picard, C.; Maffrand, J. P.; Pascal, M.; Herbert, J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">891-896</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">F. K. Schattauer Verlagsgesellschaft mbH</span>)
        </div><div class="casAbstract">Like ticlopidine, the ADP receptor antagonist clopidogrel is inactive in vitro and must be administered i.v. or orally to exhibit antiaggregatory and antithrombotic activities.  We have previously shown that hepatic metab. is necessary for activity.  This study demonstrates that an active metabolite can be generated from human liver microsomes incubated with clopidogrel.  Using several anal. methodologies (LC/MS, NMR, chiral supercrit. fluid chromatog.), we have identified its structure.  In vitro, this highly unstable compd., different from that formed from ticlopidine, exhibited all the biol. activities of clopidogrel obsd. ex vivo: Irreversible inhibition of the binding of 33P-2MeS-ADP to washed human platelets (IC50 = 0.53 μM), selective inhibition of ADP-induced platelet aggregation (IC50 = 1.8 μM) and ADP-induced adenylyl cyclase down-regulation.  The irreversible modification of the ADP-receptor site which is responsible for the biol. activity could be explained by the formation of a disulfide bridge between the reactive thiol group of the active metabolite and a cysteine residue of the platelet ADP receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp6q3TXPondbVg90H21EOLACvtfcHk0lhfHVzCw4bQNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFCjsbs%253D&md5=822a367258ccea5111da1ad6e94847ca</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1055%2Fs-0037-1614133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0037-1614133%26sid%3Dliteratum%253Aachs%26aulast%3DSavi%26aufirst%3DP.%26aulast%3DPereillo%26aufirst%3DJ.%2BM.%26aulast%3DUzabiaga%26aufirst%3DM.%2BF.%26aulast%3DCombalbert%26aufirst%3DJ.%26aulast%3DPicard%26aufirst%3DC.%26aulast%3DMaffrand%26aufirst%3DJ.%2BP.%26aulast%3DPascal%26aufirst%3DM.%26aulast%3DHerbert%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520and%2520biological%2520activity%2520of%2520the%2520active%2520metabolite%2520of%2520clopidogrel%26jtitle%3DThromb.%2520Haemost.%26date%3D2000%26volume%3D84%26spage%3D891%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Nguyen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diodati, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pharand, C.</span><span> </span><span class="NLM_article-title">Resistance to clopidogrel: a review of the evidence</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1016%2Fj.jacc.2005.01.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=15837243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlagsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2005&pages=1157-1164&author=T.+A.+Nguyenauthor=J.+G.+Diodatiauthor=C.+Pharand&title=Resistance+to+clopidogrel%3A+a+review+of+the+evidence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to clopidogrel: A review of the evidence</span></div><div class="casAuthors">Nguyen, Thuy Anh; Diodati, Jean G.; Pharand, Chantal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1157-1164</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Current available data show that about 4% to 30% of patients treated with conventional doses of clopidogrel do not display adequate antiplatelet response.  Clopidogrel resistance is a widely used term that remains to be clearly defined.  So far, it has been used to reflect failure of clopidogrel to achieve its antiaggregatory effect.  The interpatient variability in clopidogrel response is multifactorial.  It can be due to extrinsic or intrinsic mechanisms.  Among extrinsic mechanisms are the possibility of clopidogrel underdosing in patients undergoing stenting or with acute coronary syndrome, and drug-drug interactions involving CYP3A4.  Intrinsic mechanisms include genetic polymorphisms of the P2Y12 receptor and of the CYP3As, accrued release of ADP, or up-regulation of other platelet activation pathways.  Presently, there is no definite demonstration of an assocn. between low responsiveness to clopidogrel and thrombotic events.  The optimal level of clopidogrel-induced platelet inhibition, which will correlate quant. with clopidogrel's ability to prevent atherothrombotic events is still lacking.  Furthermore, because there is no single and validated platelet function assay to measure clopidogrel's antiplatelet effect, it is not justified to routinely look for clopidogrel resistance in the clin. setting.  This review discusses currently available evidence surrounding the variability in the antiplatelet response to clopidogrel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQhwpm4v6DQrVg90H21EOLACvtfcHk0lhwiK3AZKprSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlagsb8%253D&md5=83a7a7999b192cf3be07a1489719c755</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2005.01.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2005.01.034%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DT.%2BA.%26aulast%3DDiodati%26aufirst%3DJ.%2BG.%26aulast%3DPharand%26aufirst%3DC.%26atitle%3DResistance%2520to%2520clopidogrel%253A%2520a%2520review%2520of%2520the%2520evidence%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2005%26volume%3D45%26spage%3D1157%26epage%3D1164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bennett, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carwile, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moake, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarantolo, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarode, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatfield, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, H. M.</span><span> </span><span class="NLM_article-title">Thrombotic thrombocytopenic purpura associated with clopidogrel</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">1773</span><span class="NLM_x">–</span> <span class="NLM_lpage">1777</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1056%2FNEJM200006153422402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=10852999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A280%3ADC%252BD3c3psVOqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2000&pages=1773-1777&author=C.+L.+Bennettauthor=J.+M.+Connorsauthor=J.+M.+Carwileauthor=J.+L.+Moakeauthor=W.+R.+Bellauthor=S.+R.+Tarantoloauthor=L.+J.+McCarthyauthor=R.+Sarodeauthor=A.+J.+Hatfieldauthor=M.+D.+Feldmanauthor=C.+J.+Davidsonauthor=H.+M.+Tsai&title=Thrombotic+thrombocytopenic+purpura+associated+with+clopidogrel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombotic thrombocytopenic purpura associated with clopidogrel</span></div><div class="casAuthors">Bennett C L; Connors J M; Carwile J M; Moake J L; Bell W R; Tarantolo S R; McCarthy L J; Sarode R; Hatfield A J; Feldman M D; Davidson C J; Tsai H M</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">1773-7</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  The antiplatelet drug clopidogrel is a new thienopyridine derivative whose mechanism of action and chemical structure are similar to those of ticlopidine.  The estimated incidence of ticlopidine-associated thrombotic thrombocytopenic purpura is 1 per 1600 to 5000 patients treated, whereas no clopidogrel-associated cases were observed among 20,000 closely monitored patients treated in phase 3 clinical trials and cohort studies.  Because of the association between ticlopidine use and thrombotic thrombocytopenic purpura and other adverse effects, clopidogrel has largely replaced ticlopidine in clinical practice.  More than 3 million patients have received clopidogrel.  We report the clinical and laboratory findings in 11 patients in whom thrombotic thrombocytopenic purpura developed during or soon after treatment with clopidogrel.  METHODS:  The 11 patients were identified by active surveillance by the medical directors of blood banks (3 patients), hematologists (6), and the manufacturer of clopidogrel (2).  RESULTS:  Ten of the 11 patients received clopidogrel for 14 days or less before the onset of thrombotic thrombocytopenic purpura.  Although 10 of the 11 patients had a response to plasma exchange, 2 required 20 or more exchanges before clinical improvement occurred, and 2 had relapses while not receiving clopidogrel.  One patient died despite undergoing plasma exchange soon after diagnosis.  CONCLUSIONS:  Thrombotic thrombocytopenic purpura can occur after the initiation of clopidogrel therapy, often within the first two weeks of treatment.  Physicians should be aware of the possibility of this syndrome when initiating clopidogrel treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXveYHTxkPEGhHGZei4OW9fW6udTcc2eZQeQBojWL52rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3psVOqsg%253D%253D&md5=f37c00b9885e7ad857224952340546b8</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1056%2FNEJM200006153422402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200006153422402%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DC.%2BL.%26aulast%3DConnors%26aufirst%3DJ.%2BM.%26aulast%3DCarwile%26aufirst%3DJ.%2BM.%26aulast%3DMoake%26aufirst%3DJ.%2BL.%26aulast%3DBell%26aufirst%3DW.%2BR.%26aulast%3DTarantolo%26aufirst%3DS.%2BR.%26aulast%3DMcCarthy%26aufirst%3DL.%2BJ.%26aulast%3DSarode%26aufirst%3DR.%26aulast%3DHatfield%26aufirst%3DA.%2BJ.%26aulast%3DFeldman%26aufirst%3DM.%2BD.%26aulast%3DDavidson%26aufirst%3DC.%2BJ.%26aulast%3DTsai%26aufirst%3DH.%2BM.%26atitle%3DThrombotic%2520thrombocytopenic%2520purpura%2520associated%2520with%2520clopidogrel%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2000%26volume%3D342%26spage%3D1773%26epage%3D1777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Weerakkody, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naganuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, K. J.</span><span> </span><span class="NLM_article-title">Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: an integrated analysis</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1177%2F1074248407304731" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=205-12&author=G.+J.+Weerakkodyauthor=J.+A.+Jakubowskiauthor=J.+T.+Brandtauthor=C.+D.+Payneauthor=H.+Naganumaauthor=K.+J.+Winters&title=Greater+inhibition+of+platelet+aggregation+and+reduced+response+variability+with+prasugrel+versus+clopidogrel%3A+an+integrated+analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1177%2F1074248407304731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1074248407304731%26sid%3Dliteratum%253Aachs%26aulast%3DWeerakkody%26aufirst%3DG.%2BJ.%26aulast%3DJakubowski%26aufirst%3DJ.%2BA.%26aulast%3DBrandt%26aufirst%3DJ.%2BT.%26aulast%3DPayne%26aufirst%3DC.%2BD.%26aulast%3DNaganuma%26aufirst%3DH.%26aulast%3DWinters%26aufirst%3DK.%2BJ.%26atitle%3DGreater%2520inhibition%2520of%2520platelet%2520aggregation%2520and%2520reduced%2520response%2520variability%2520with%2520prasugrel%2520versus%2520clopidogrel%253A%2520an%2520integrated%2520analysis%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%2520Ther.%26date%3D2007%26volume%3D3%26spage%3D205%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Tantry, U. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliden, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurbel, P. A.</span><span> </span><span class="NLM_article-title">Prasugrel</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2006&pages=1627-33&author=U.+S.+Tantryauthor=K.+P.+Blidenauthor=P.+A.+Gurbel&title=Prasugrel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTantry%26aufirst%3DU.%2BS.%26aulast%3DBliden%26aufirst%3DK.%2BP.%26aulast%3DGurbel%26aufirst%3DP.%2BA.%26atitle%3DPrasugrel%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D15%26spage%3D1627%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Zamecnik, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janeway, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randerath, K.</span><span> </span><span class="NLM_article-title">Enzymatic synthesis of diadenosine tetraphosphate and diadenosine triphosphat with a purified lysyl-sRNA synthetase</span> <span class="citation_source-journal">Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1016%2F0006-291X%2866%2990415-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=5338216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADyaF28XksV2jtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1966&pages=91-97&author=P.+C.+Zamecnikauthor=M.+L.+Stephensonauthor=C.+M.+Janewayauthor=K.+Randerath&title=Enzymatic+synthesis+of+diadenosine+tetraphosphate+and+diadenosine+triphosphat+with+a+purified+lysyl-sRNA+synthetase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymic synthesis of diadenosine tetraphosphate and diadenosine triphosphate with a purified lysyl-sRNA synthetase</span></div><div class="casAuthors">Zamecnik, Paul C.; Stephenson, Mary L.; Janeway, Claude M.; Randerath, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-7</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">An optical rotatory dispersion study was employed to det. a possible change in conformation of L-lysine:sRNA (sol. RNA) ligase which is involved in L-lysine (I) activation for protein synthesis.  During I activation, the Cotton effect developed during a 30 min. incubation at 37°.  The appearance of this Cotton effect was dependent on the presence of lysyl-sRNA synthetase, I, ATP, and Mg2+.  The Cotton effect increased by increasing ATP concn. and by addn. of pyrophosphatase.  The material which was responsible for causing the Cotton effect was dialyzed, purified by thin-layer chromatography on poly(ethylenimine)-cellulose, and identified as P1,P4-di-51-adenosine-tetraphosphate (II).  A smaller amt. of P1,P3-di-51-adenosine triphosphate was also found.  II could be formed in small amts. from ATP in the presence of a purified (but not homogeneous) prepn. of Escherichia coli lysyl-sRNA synthetase.  It was maximally formed when a small amt. of E. coli sRNA (unfractionated) was added to an incubation medium contg. I, Tris buffer (pH 7.8), Mg2+, and ATP.  Under these conditions, the formation of II was strictly dependent on I  The reaction for the synthesis of II was reversible.  A possible involvement and the mechanism of formation of II during I activation for protein synthesis is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIJm2AcuUyYbVg90H21EOLACvtfcHk0ljFgVcLziaehA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28XksV2jtbs%253D&md5=f23fa079eb11e222b82a96afb2783b0b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2866%2990415-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252866%252990415-3%26sid%3Dliteratum%253Aachs%26aulast%3DZamecnik%26aufirst%3DP.%2BC.%26aulast%3DStephenson%26aufirst%3DM.%2BL.%26aulast%3DJaneway%26aufirst%3DC.%2BM.%26aulast%3DRanderath%26aufirst%3DK.%26atitle%3DEnzymatic%2520synthesis%2520of%2520diadenosine%2520tetraphosphate%2520and%2520diadenosine%2520triphosphat%2520with%2520a%2520purified%2520lysyl-sRNA%2520synthetase%26jtitle%3DBiophys.%2520Res.%2520Commun.%26date%3D1966%26volume%3D24%26spage%3D91%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Pintor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotllan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miras-Portugal, M. T.</span><span> </span><span class="NLM_article-title">Characterization and quantification of diadenosine hexaphosphate in chromaffin cells: granular storage and secretagogue-induced release</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">200</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=1992&pages=296-300&author=J.+Pintorauthor=P.+Rotllanauthor=M.+Torresauthor=M.+T.+Miras-Portugal&title=Characterization+and+quantification+of+diadenosine+hexaphosphate+in+chromaffin+cells%3A+granular+storage+and+secretagogue-induced+release"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPintor%26aufirst%3DJ.%26aulast%3DRotllan%26aufirst%3DP.%26aulast%3DTorres%26aufirst%3DM.%26aulast%3DMiras-Portugal%26aufirst%3DM.%2BT.%26atitle%3DCharacterization%2520and%2520quantification%2520of%2520diadenosine%2520hexaphosphate%2520in%2520chromaffin%2520cells%253A%2520granular%2520storage%2520and%2520secretagogue-induced%2520release%26jtitle%3DAnal.%2520Biochem.%26date%3D1992%26volume%3D200%26spage%3D296%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Rotllan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miras-Portugal, M. T.</span><span> </span><span class="NLM_article-title">Adenosine kinase from bovine adrenal medulla</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1111%2Fj.1432-1033.1985.tb09110.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=2992963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADyaL2MXltlOmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1985&pages=365-71&author=P.+Rotllanauthor=M.+T.+Miras-Portugal&title=Adenosine+kinase+from+bovine+adrenal+medulla"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine kinase from bovine adrenal medulla</span></div><div class="casAuthors">Rotllan, Pedro; Miras Portugal, Maria Teresa</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">365-71</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Adenosine kinase from bovine adrenal medulla was purified 1600-fold by using (NH4)2SO4 pptn., gel filtration, and affinity chromatog.  Gel filtration yielded a mol. wt. of ∼42,000 and Km values of 0.2 μM for adenosine and 20 μM for MgATP.  The enzyme showed a broad specificity for purine nucleoside triphosphates as phosphate donors.  Both free Mg2+ and ATP were inhibitors.  AMP was a competitive inhibitor with regard to adenosine and a noncompetitive inhibitor vs. MgATP, whereas ADP was a uncompetitive inhibitor with regard to adenosine and a noncompetitive inhibitor vs. MgATP.  Adenosine kinase was strongly inhibited by the bis(adenylyl)polyphosphates, Ap4A and Ap5A.  These compds. inhibited the enzyme competitively vs. MgATP (Ki = 0.06 μM for Ap4A and 0.4 μM for Ap5A) and uncompetitively with regard to adenosine.  The results of the kinetic anal. suggest an ordered bi-bi mechanism, with adenosine being the 1st substrate.  The phosphorylation of adenosine was unaffected by the presence of vanadate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopWGivyTmseLVg90H21EOLACvtfcHk0ljFgVcLziaehA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXltlOmtro%253D&md5=a1a8586c4cf55ce577bdf3dffa7e7c77</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1985.tb09110.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1985.tb09110.x%26sid%3Dliteratum%253Aachs%26aulast%3DRotllan%26aufirst%3DP.%26aulast%3DMiras-Portugal%26aufirst%3DM.%2BT.%26atitle%3DAdenosine%2520kinase%2520from%2520bovine%2520adrenal%2520medulla%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1985%26volume%3D151%26spage%3D365%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Hilderman, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, E. F.</span><span> </span><span class="NLM_article-title">P1,P4-diadenosine 5′ tetraphosphate induces nitric oxide release from bovine aortic endothelial cells</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=1998&pages=320-324&author=R.+H.+Hildermanauthor=E.+F.+Christensen&title=P1%2CP4-diadenosine+5%E2%80%B2+tetraphosphate+induces+nitric+oxide+release+from+bovine+aortic+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHilderman%26aufirst%3DR.%2BH.%26aulast%3DChristensen%26aufirst%3DE.%2BF.%26atitle%3DP1%252CP4-diadenosine%25205%25E2%2580%25B2%2520tetraphosphate%2520induces%2520nitric%2520oxide%2520release%2520from%2520bovine%2520aortic%2520endothelial%2520cells%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D427%26spage%3D320%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Pintor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Hernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualix, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Villafuertes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernando, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miras-Portugal, M. T.</span><span> </span><span class="NLM_article-title">Diadenosine polyphosphate receptors. from rat and guinea-pig brain to human nervous system</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1016%2FS0163-7258%2800%2900049-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=11007994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslOjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2000&pages=103-115&author=J.+Pintorauthor=M.+Diaz-Hernandezauthor=J.+Gualixauthor=R.+Gomez-Villafuertesauthor=F.+Hernandoauthor=M.+T.+Miras-Portugal&title=Diadenosine+polyphosphate+receptors.+from+rat+and+guinea-pig+brain+to+human+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Diadenosine polyphosphate receptors from rat and guinea-pig brain to human nervous system</span></div><div class="casAuthors">Pintor, J.; Diaz-Hernandez, M.; Gualix, J.; Gomez-Villafuertes, R.; Hernando, F.; Miras-Portugal, M. T.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">103-115</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with ∼87 refs.  Diadenosine polyphosphates are a family of naturally occurring nucleotidic compds. present in secretory vesicles together with other chem. messengers.  The exocytotic release of these compds. permits them to stimulate receptors termed "purinoceptors" or "ATP receptors.  " Purinoceptors for nucleotides are named P2 in contrast with those sensitive to nucleosides (P1).  P2 receptors are further subdivided into metabotropic P2Y receptors, further divided into 5 subtypes, and ionotropic P2X receptors, with 7 different subtypes.  Diadenosine polyphosphates can activate recombinant P2Y1, P2Y2, and P2Y4 and recombinant homomeric P2X1, P2X2, P2X3, P2X4, and P2X6.  Heteromeric P2X receptors change their sensitivity to diadenosine polyphosphates when co-assembly between different subunits occurs.  Diadenosine polyphosphates can activate specific receptors termed dinucleotide receptors or P4 receptors, which are insensitive to other nucleosides or nucleotides.  The P4 receptor is a receptor-operated Ca2+ channel present in rat brain synaptic terminals, stimulated by diadenosine pentaphosphate and diadenosine tetraphosphate.  This receptor is strongly modulated by protein kinases A and C and protein phosphatases.  The dinucleotide receptor is present in different brain areas, such as midbrain (in rat and guinea pig), cerebellum (in guinea pig), and cortex (in human).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppyWJKgXiysLVg90H21EOLACvtfcHk0lhD6H1AcRr4mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslOjtb4%253D&md5=23d6f1bef8f4a9b0de122be16c2a2743</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2800%2900049-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252800%252900049-8%26sid%3Dliteratum%253Aachs%26aulast%3DPintor%26aufirst%3DJ.%26aulast%3DDiaz-Hernandez%26aufirst%3DM.%26aulast%3DGualix%26aufirst%3DJ.%26aulast%3DGomez-Villafuertes%26aufirst%3DR.%26aulast%3DHernando%26aufirst%3DF.%26aulast%3DMiras-Portugal%26aufirst%3DM.%2BT.%26atitle%3DDiadenosine%2520polyphosphate%2520receptors.%2520from%2520rat%2520and%2520guinea-pig%2520brain%2520to%2520human%2520nervous%2520system%26jtitle%3DPharmacol.%2520Ther.%26date%3D2000%26volume%3D87%26spage%3D103%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Harrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brossmer, R.</span><span> </span><span class="NLM_article-title">Inhibition of platelet aggregation and the platelet release reaction by alpha, omega diadenosine polyphosphates</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1975&pages=57-60&author=M.+J.+Harrisonauthor=R.+Brossmer&title=Inhibition+of+platelet+aggregation+and+the+platelet+release+reaction+by+alpha%2C+omega+diadenosine+polyphosphates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DM.%2BJ.%26aulast%3DBrossmer%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520platelet%2520aggregation%2520and%2520the%2520platelet%2520release%2520reaction%2520by%2520alpha%252C%2520omega%2520diadenosine%2520polyphosphates%26jtitle%3DFEBS%2520Lett.%26date%3D1975%26volume%3D54%26spage%3D57%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Rapaport, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamecnik, P. C.</span><span> </span><span class="NLM_article-title">Presence of diadenosine 5′,5′′′-P1, P4-tetraphosphate (Ap4A) in mamalian cells in levels varying widely with proliferative activity of the tissue: a possible positive “pleiotypic activator”</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">3984</span><span class="NLM_x">–</span> <span class="NLM_lpage">3988</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1976&pages=3984-3988&author=E.+Rapaportauthor=P.+C.+Zamecnik&title=Presence+of+diadenosine+5%E2%80%B2%2C5%E2%80%B2%E2%80%B2%E2%80%B2-P1%2C+P4-tetraphosphate+%28Ap4A%29+in+mamalian+cells+in+levels+varying+widely+with+proliferative+activity+of+the+tissue%3A+a+possible+positive+%E2%80%9Cpleiotypic+activator%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRapaport%26aufirst%3DE.%26aulast%3DZamecnik%26aufirst%3DP.%2BC.%26atitle%3DPresence%2520of%2520diadenosine%25205%25E2%2580%25B2%252C5%25E2%2580%25B2%25E2%2580%25B2%25E2%2580%25B2-P1%252C%2520P4-tetraphosphate%2520%2528Ap4A%2529%2520in%2520mamalian%2520cells%2520in%2520levels%2520varying%2520widely%2520with%2520proliferative%2520activity%2520of%2520the%2520tissue%253A%2520a%2520possible%2520positive%2520%25E2%2580%259Cpleiotypic%2520activator%25E2%2580%259D%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1976%26volume%3D73%26spage%3D3984%26epage%3D3988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Chan, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamecnik, P. C.</span><span> </span><span class="NLM_article-title">P1,P4-dithio-P2,P3-monochloromethylene diadenosine 5′,5′′′-P1,P4-tetraphosphate: a novel antiplatelet agent</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">4034</span><span class="NLM_x">–</span> <span class="NLM_lpage">4039</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=4034-4039&author=S.+W.+Chanauthor=S.+J.+Galloauthor=B.+K.+Kimauthor=M.+J.+Guoauthor=G.+M.+Blackburnauthor=P.+C.+Zamecnik&title=P1%2CP4-dithio-P2%2CP3-monochloromethylene+diadenosine+5%E2%80%B2%2C5%E2%80%B2%E2%80%B2%E2%80%B2-P1%2CP4-tetraphosphate%3A+a+novel+antiplatelet+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DS.%2BW.%26aulast%3DGallo%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DB.%2BK.%26aulast%3DGuo%26aufirst%3DM.%2BJ.%26aulast%3DBlackburn%26aufirst%3DG.%2BM.%26aulast%3DZamecnik%26aufirst%3DP.%2BC.%26atitle%3DP1%252CP4-dithio-P2%252CP3-monochloromethylene%2520diadenosine%25205%25E2%2580%25B2%252C5%25E2%2580%25B2%25E2%2580%25B2%25E2%2580%25B2-P1%252CP4-tetraphosphate%253A%2520a%2520novel%2520antiplatelet%2520agent%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D4034%26epage%3D4039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Bhattacharyya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerzmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feig, A. L.</span><span> </span><span class="NLM_article-title">Fluorescent analogs of UDP-glucose and their use in characterizing substrate binding by toxin A from Clostridium difficile</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">3425</span><span class="NLM_x">–</span> <span class="NLM_lpage">3432</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm701348d&amp;key=10.1046%2Fj.1432-1033.2002.03013.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm701348d&amp;key=12135481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm701348d&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtF2hurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=2002&pages=3425-3432&author=S.+Bhattacharyyaauthor=A.+Kerzmannauthor=A.+L.+Feig&title=Fluorescent+analogs+of+UDP-glucose+and+their+use+in+characterizing+substrate+binding+by+toxin+A+from+Clostridium+difficile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent analogs of UDP-glucose and their use in characterizing substrate binding by toxin A from Clostridium difficile</span></div><div class="casAuthors">Bhattacharyya, Sudeep; Kerzmann, Amy; Feig, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3425-3432</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Uridine-5'-diphospho-1-α-D-glucose (UDP-Glc) is a common substrate used by glucosyltransferases, including certain bacterial toxins such as Toxins A and B from Clostridium difficile.  Fluorescent analogs of UDP-Glc have been prepd. for use in our studies of the clostridial toxins.  These compds. are related to the methylanthraniloyl-ATP compds. commonly used to probe the chem. of ATP-dependent enzymes.  The reaction of excess methylisatoic anhydride with UDP-Glc in aq. soln. yields primarily the 2' and 3' isomers of methylanthraniloyl-UDP-Glc (MUG).  As the 2' and 3' isomers readily interconvert, this isomeric mixt. was copurified by HPLC away from the other isomeric products, and was characterized by a combination of NMR, fluorescence and mass spectrometric methods.  TcdA binds MUG competitively with respect to UDP-Glc with an affinity of 15±2 μM in the absence of Mg2+.  There is currently no evidence that the fluorescent substrate analog is turned over by the toxin in either glucosyltransferase or glucosylhydrolase reactions.  Using a competition assay, the affinity of UDP-Glc was detd. to be 45±10 μM in the absence of Mg2+.  The binding of UDP-Glc and Mg2+ are highly coupled with Mg2+ affinities in the range of 90-600 μM, depending on the exptl. conditions.  These results imply that one of the significant roles of the metal ion might be to stabilize the enzyme-substrate complex prior to initiation of the transferase chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPjQGC0fnLxLVg90H21EOLACvtfcHk0lhD6H1AcRr4mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtF2hurY%253D&md5=f7f66c12c22054acc767b9713c5e672f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1033.2002.03013.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1033.2002.03013.x%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharyya%26aufirst%3DS.%26aulast%3DKerzmann%26aufirst%3DA.%26aulast%3DFeig%26aufirst%3DA.%2BL.%26atitle%3DFluorescent%2520analogs%2520of%2520UDP-glucose%2520and%2520their%2520use%2520in%2520characterizing%2520substrate%2520binding%2520by%2520toxin%2520A%2520from%2520Clostridium%2520difficile%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2002%26volume%3D269%26spage%3D3425%26epage%3D3432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Martin, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gero, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusack, N. J.</span><span> </span><span class="NLM_article-title">Structure-activity studies of analogs of β, γ-methylene-ATP at P2x-purinoreceptors in the rabbit ear central artery</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=153-165&author=P.+L.+Martinauthor=T.+W.+Geroauthor=A.+A.+Pottsauthor=N.+J.+Cusack&title=Structure-activity+studies+of+analogs+of+%CE%B2%2C+%CE%B3-methylene-ATP+at+P2x-purinoreceptors+in+the+rabbit+ear+central+artery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DP.%2BL.%26aulast%3DGero%26aufirst%3DT.%2BW.%26aulast%3DPotts%26aufirst%3DA.%2BA.%26aulast%3DCusack%26aufirst%3DN.%2BJ.%26atitle%3DStructure-activity%2520studies%2520of%2520analogs%2520of%2520%25CE%25B2%252C%2520%25CE%25B3-methylene-ATP%2520at%2520P2x-purinoreceptors%2520in%2520the%2520rabbit%2520ear%2520central%2520artery%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1995%26volume%3D36%26spage%3D153%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pineda de Las Infantas, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagnoli, R.; Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of a new series of N<sup>6</sup>-arylcarbamoyl, 2-(Ar)alkynyl-N<sup>6</sup>-arylcarbamoyl, and N<sup>6</sup>-carboxamido derivatives of adenosine 5′-N-ethyluronamide as A<sub>1</sub> and A<sub>3</sub> adenosine receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">3174</span><span class="NLM_x">–</span> <span class="NLM_lpage">3185</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980147p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=3174-3185&author=P.+G.+Baraldiauthor=B.+Cacciariauthor=M.+J.+Pineda+de+Las+Infantasauthor=G.+Romagnoli%2C+R.%3B+Spallutoauthor=R.+Volpiniauthor=S.+Costanziauthor=S.+Vittoriauthor=G.+Cristalliauthor=N.+Melmanauthor=K.+S.+Parkauthor=X.+Jiauthor=K.+A.+Jacobson&title=Synthesis+and+biological+activity+of+a+new+series+of+N6-arylcarbamoyl%2C+2-%28Ar%29alkynyl-N6-arylcarbamoyl%2C+and+N6-carboxamido+derivatives+of+adenosine+5%E2%80%B2-N-ethyluronamide+as+A1+and+A3+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm980147p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980147p%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DPineda%2Bde%2BLas%2BInfantas%26aufirst%3DM.%2BJ.%26aulast%3DRomagnoli%252C%2BR.%253B%2BSpalluto%26aufirst%3DG.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DPark%26aufirst%3DK.%2BS.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520a%2520new%2520series%2520of%2520N6-arylcarbamoyl%252C%25202-%2528Ar%2529alkynyl-N6-arylcarbamoyl%252C%2520and%2520N6-carboxamido%2520derivatives%2520of%2520adenosine%25205%25E2%2580%25B2-N-ethyluronamide%2520as%2520A1%2520and%2520A3%2520adenosine%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D3174%26epage%3D3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Knorre, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurbatov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samukov, V. V.</span><span> </span><span class="NLM_article-title">General method for the synthesis of ATP gamma-derivatives</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1976&pages=105-108&author=D.+G.+Knorreauthor=V.+A.+Kurbatovauthor=V.+V.+Samukov&title=General+method+for+the+synthesis+of+ATP+gamma-derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnorre%26aufirst%3DD.%2BG.%26aulast%3DKurbatov%26aufirst%3DV.%2BA.%26aulast%3DSamukov%26aufirst%3DV.%2BV.%26atitle%3DGeneral%2520method%2520for%2520the%2520synthesis%2520of%2520ATP%2520gamma-derivatives%26jtitle%3DFEBS%2520Lett.%26date%3D1976%26volume%3D70%26spage%3D105%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Wakuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, J.</span><span> </span><span class="NLM_article-title">Conformational Analysis of 2′,3′-<i>O</i>-Alkylideneadenosines</span> <span class="citation_source-journal">Nippon Kagaku Kaishi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1998&pages=40-44&author=H.+Wakudaauthor=M.+Ideauthor=Y.+Maedaauthor=J.+Kimura&title=Conformational+Analysis+of+2%E2%80%B2%2C3%E2%80%B2-O-Alkylideneadenosines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWakuda%26aufirst%3DH.%26aulast%3DIde%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DJ.%26atitle%3DConformational%2520Analysis%2520of%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-O-Alkylideneadenosines%26jtitle%3DNippon%2520Kagaku%2520Kaishi%26date%3D1998%26volume%3D1%26spage%3D40%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Bakthavachalam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee-Gin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherian, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarnik, A. W.</span><span> </span><span class="NLM_article-title">Synthesis, stereochemistry, intramolecular cyclization, and rates of hydrolysis of adenosine 2′,3′-acetals</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=1987&pages=124-135&author=V.+Bakthavachalamauthor=L.+Lee-Ginauthor=X.+M.+Cherianauthor=A.+W.+Czarnik&title=Synthesis%2C+stereochemistry%2C+intramolecular+cyclization%2C+and+rates+of+hydrolysis+of+adenosine+2%E2%80%B2%2C3%E2%80%B2-acetals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBakthavachalam%26aufirst%3DV.%26aulast%3DLee-Gin%26aufirst%3DL.%26aulast%3DCherian%26aufirst%3DX.%2BM.%26aulast%3DCzarnik%26aufirst%3DA.%2BW.%26atitle%3DSynthesis%252C%2520stereochemistry%252C%2520intramolecular%2520cyclization%252C%2520and%2520rates%2520of%2520hydrolysis%2520of%2520adenosine%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-acetals%26jtitle%3DCarbohydr.%2520Res.%26date%3D1987%26volume%3D170%26spage%3D124%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><div class="note"><p class="first last">Further proof of structure for compounds <b>21</b>, <b>31</b>, <b>38</b>, <b>45</b>, <b>58</b>, and <b>62</b> may be found in the Supporting Information</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Further+proof+of+structure+for+compounds+21%2C+31%2C+38%2C+45%2C+58%2C+and+62+may+be+found+in+the+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="note"><p class="first last">One plausible explanation to describe the selectivity of the acetal ring-forming reactions can be illustrated by examining the following transition states (<b>A</b>−<b>D</b>). The final ring closure could be described as a 5-endo trig cyclization of a free 2′ or 3′ hydroxyl group of the ribose ring on to the oxonium ion derived from the complementary hydroxyl group. The transition states are drawn using the 2′-hydroxyl as a nucleophile and the 3′-oxonium ion as an electrophile for illustrative purposes only. To minimize steric congestion, the conformation of the ribose ring places the base and the side chain in pseudo equatorial positions. Transition states <b>A</b> and <b>B</b>, which place the pivotal forming stereogenic center of the new ring in a pseudo exo-orientation relative to the ribose ring, should govern formation of kinetically favored products. Transition states <b>C</b> and <b>D</b>, which place the pivotal forming stereogenic center of the new ring in a pseudo endo-orientation, should be less favored. Therefore, the kinetically favored product would be derived from transition state <b>A</b>, which places the substituent in a pseudo equatorial position. Kinetic products (products derived from aldehydes that generate very unstable oxonium ions) should give predominantly the cis-product. In circumstances where the formation of products is under thermodynamic control, acetals derived from aldehydes that can generate stable oxonium ions (cinnamaldehyde, benzaldehyde, and ethynyl phenyl aldehyde), the favored product (whether derived from an open or closed oxonium ion intermediate), would result from the substituent being in the energetically more favored exo-face of the 5,5-bicyclic acetal. Thermodynamic products should give predominantly the trans-product. <span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-4/jm701348d/production/images/medium/jm-2007-01348d_0001.tif.gif" alt="" /></img></span></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Shaver, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rideout, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendergas, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglass, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redick, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yerxa, B. R.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of dinucleotides: Potent and selective agonists of P2Y receptors</span> <span class="citation_source-journal">Purinergic Signal</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=183-191&author=S.+R.+Shaverauthor=J.+L.+Rideoutauthor=W.+Pendergasauthor=J.+G.+Douglassauthor=E.+G.+Brownauthor=J.+L.+Boyerauthor=R.+I.+Patelauthor=C.+C.+Redickauthor=A.+C.+Jonesauthor=M.+Picherauthor=B.+R.+Yerxa&title=Structure-activity+relationships+of+dinucleotides%3A+Potent+and+selective+agonists+of+P2Y+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaver%26aufirst%3DS.%2BR.%26aulast%3DRideout%26aufirst%3DJ.%2BL.%26aulast%3DPendergas%26aufirst%3DW.%26aulast%3DDouglass%26aufirst%3DJ.%2BG.%26aulast%3DBrown%26aufirst%3DE.%2BG.%26aulast%3DBoyer%26aufirst%3DJ.%2BL.%26aulast%3DPatel%26aufirst%3DR.%2BI.%26aulast%3DRedick%26aufirst%3DC.%2BC.%26aulast%3DJones%26aufirst%3DA.%2BC.%26aulast%3DPicher%26aufirst%3DM.%26aulast%3DYerxa%26aufirst%3DB.%2BR.%26atitle%3DStructure-activity%2520relationships%2520of%2520dinucleotides%253A%2520Potent%2520and%2520selective%2520agonists%2520of%2520P2Y%2520receptors%26jtitle%3DPurinergic%2520Signal%26date%3D2005%26volume%3D1%26spage%3D183%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Hiratsuka, T.</span><span> </span><span class="NLM_article-title">New ribose-modified fluorescent analogs of adenine and guanine nucleotides available as substrates for various enzymes</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">742</span><span class="NLM_x">, </span> <span class="NLM_fpage">496</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=742&publication_year=1983&pages=496-508&author=T.+Hiratsuka&title=New+ribose-modified+fluorescent+analogs+of+adenine+and+guanine+nucleotides+available+as+substrates+for+various+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHiratsuka%26aufirst%3DT.%26atitle%3DNew%2520ribose-modified%2520fluorescent%2520analogs%2520of%2520adenine%2520and%2520guanine%2520nucleotides%2520available%2520as%2520substrates%2520for%2520various%2520enzymes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1983%26volume%3D742%26spage%3D496%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Wright, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. D.</span><span> </span><span class="NLM_article-title">Synthesis of novel fluorescent-labeled dinucleoside polyphosphates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2813</span><span class="NLM_x">–</span> <span class="NLM_lpage">2816</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2813-2816&author=M.+Wrightauthor=A.+D.+Miller&title=Synthesis+of+novel+fluorescent-labeled+dinucleoside+polyphosphates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DA.%2BD.%26atitle%3DSynthesis%2520of%2520novel%2520fluorescent-labeled%2520dinucleoside%2520polyphosphates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2813%26epage%3D2816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="note"><p class="first last">In addition to the aforementioned regiochemistry problems, the ribose esters were also less stable as solids and in solution than acetals. At room temperature and a pH of greater than 7, which would be the typical physiological situation, compounds <b>15</b>–<b>17</b> showed significant decomposition after a few days. The acetal compounds were stable in solution under these conditions. Solid ester compounds typically were stored at −80 °C in their ammonium salt forms to avoid decomposition over the long term, whereas solid acetals (in their sodium or ammonium salt forms) could be stored on the benchtop for many months without ill effect. The general trend for stability of the aromatic acetals under acidic conditions was styryl < phenyl < benzyl.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="note"><p class="first last">In general, the rank order of hydrolytic stability of the phosphates that we observed was dinucleoside polyphosphates > nucleoside monophosphates > nucleoside diphosphates > nucleoside triphosphates. Dinucleoside polyphosphates and nucleoside monophosphates modified with the lipophilic moieties described in this article could be stored in their salt forms (sodium, ammonium, or tributylammonium) at ambient temperature for months without significant decomposition. As noted in the preparation of <b>41</b>, it was nearly impossible to avoid some degradation of the nucleoside diphosphate to the monophosphate (<b>56</b>), even with optimal handling. The corresponding triphosphate analogue to <b>41</b>and<b>56</b>(not included in this article) proved to be much more troublesome and was not pursued.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span>These data have been partially reported in poster format at the 4th International Symposium of Nucleosides and Nucleotides, Chapel Hill, North Carolina, June, 2004. <span class="NLM_contrib-group">Douglass, J. G.; Patel, R. I.; Redick, C. C.; Jones, A. C.; Shave, S. R.; Boyer, J. L.</span> (Poster 70W) Lipophilic Adenine Nucleotides as Reversible Inhibitors of P2Y<sub>12</sub>-Mediated Platelet Aggregation. 4th International Symposium of Nucleosides and Nucleotides, Chapel Hill, North Carolina, June,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=These+data+have+been+partially+reported+in+poster+format+at+the+4th+International+Symposium+of+Nucleosides+and+Nucleotides%2C+Chapel+Hill%2C+North+Carolina%2C+June%2C+2004.+Douglass%2C+J.+G.%3B+Patel%2C+R.+I.%3B+Redick%2C+C.+C.%3B+Jones%2C+A.+C.%3B+Shave%2C+S.+R.%3B+Boyer%2C+J.+L.+%28Poster+70W%29+Lipophilic+Adenine+Nucleotides+as+Reversible+Inhibitors+of+P2Y12-Mediated+Platelet+Aggregation.+4th+International+Symposium+of+Nucleosides+and+Nucleotides%2C+Chapel+Hill%2C+North+Carolina%2C+June%2C+2004."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DDouglass%26aufirst%3DJ.%2BG.%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Arunlakshana, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schild, H. O.</span><span> </span><span class="NLM_article-title">Some quantitative uses of drug antagonists</span> <span class="citation_source-journal">Br. J. Pharmacol. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1959&pages=48-58&author=O.+Arunlakshanaauthor=H.+O.+Schild&title=Some+quantitative+uses+of+drug+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArunlakshana%26aufirst%3DO.%26aulast%3DSchild%26aufirst%3DH.%2BO.%26atitle%3DSome%2520quantitative%2520uses%2520of%2520drug%2520antagonists%26jtitle%3DBr.%2520J.%2520Pharmacol.%2520Chemother.%26date%3D1959%26volume%3D1%26spage%3D48%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Johnson, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crean, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamoorthy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellerman, D. J.</span><span> </span><span class="NLM_article-title">Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589</span> <span class="citation_source-journal">Platelets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=346-356&author=F.+L.+Johnsonauthor=J.+L.+Boyerauthor=P.+T.+Leeseauthor=C.+Creanauthor=R.+Krishnamoorthyauthor=T.+Durhamauthor=A.+W.+Foxauthor=D.+J.+Kellerman&title=Rapid+and+reversible+modulation+of+platelet+function+in+man+by+a+novel+P2Y%2812%29+ADP-receptor+antagonist%2C+INS50589"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DF.%2BL.%26aulast%3DBoyer%26aufirst%3DJ.%2BL.%26aulast%3DLeese%26aufirst%3DP.%2BT.%26aulast%3DCrean%26aufirst%3DC.%26aulast%3DKrishnamoorthy%26aufirst%3DR.%26aulast%3DDurham%26aufirst%3DT.%26aulast%3DFox%26aufirst%3DA.%2BW.%26aulast%3DKellerman%26aufirst%3DD.%2BJ.%26atitle%3DRapid%2520and%2520reversible%2520modulation%2520of%2520platelet%2520function%2520in%2520man%2520by%2520a%2520novel%2520P2Y%252812%2529%2520ADP-receptor%2520antagonist%252C%2520INS50589%26jtitle%3DPlatelets%26date%3D2007%26volume%3D18%26spage%3D346%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i60"><a href="/doi/suppl/10.1021/jm701348d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26128"></div></div></div></div></div><hr /></hr><p class="last"><sup>1</sup>H NMR (D<sub>2</sub>O, 300 MHz) for compounds <b>11</b>, <b>13</b>, <b>18</b>, <b>21</b>, <b>53</b>−<b>56</b>, <b>59</b>–<b>62</b>, <b>65</b>, and <b>66</b>. NOE (D<sub>2</sub>O, 300 MHz) correlations for compounds <b>21</b>, <b>31</b>, <b>38</b>, <b>45</b>, <b>58</b>, and <b>62</b>. This material is available free of charge via the Internet at http://pubs.acs.org.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701348d/suppl_file/jm701348d-file003.pdf">jm701348d-file003.pdf (194.02 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm701348d&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm701348d%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-4%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm701348d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                393KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679953d8ac113d24","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
